(this["webpackJsonpsero-can-webapp"]=this["webpackJsonpsero-can-webapp"]||[]).push([[0],{121:function(e,t,a){e.exports=a.p+"static/media/Prepublication.0b43b193.png"},225:function(e,t,a){e.exports=a.p+"static/media/WHO-EN-C-H.92cca4d5.png"},232:function(e,t,a){e.exports=a.p+"static/media/1200px-The_Economist_Logo.svg.d48720c3.png"},233:function(e,t,a){e.exports=a.p+"static/media/joule.18ac378a.png"},234:function(e,t,a){e.exports=a.p+"static/media/mckinsey_logo.f6f0eba5.png"},313:function(e,t,a){},333:function(e){e.exports=JSON.parse('{",":",","95%ConfidenceInterval":"95% Confidence Interval","95%ConfidenceIntervalTooltip":"Wider error bars indicate greater uncertainty in the pooled seroprevalence estimate.","About":"About","AboutPage":{"AboutSection":{"Covid19ImmunityTaskForce":"COVID-19 Immunity Task Force.","GlobalSerologicalKnowledgeHub":"Global Serological Knowledge Hub","HealthInformatics":"University of Calgary\'s Centre for Health Informatics.","HostedAt":"SeroTracker is also hosted at the","MappingTheExtent":"The COVID-19 Immunity Task Force is mapping the extent of SARS-CoV-2 infection in Canada, and SeroTracker also provides content for their","PartOne":"SeroTracker synthesizes findings from thousands of COVID-19 seroprevalence studies worldwide, providing a data platform and interactive dashboard for SARS-CoV-2 serosurveillance.","PartTwo":"Confirmed COVID-19 cases are just the tip of the iceberg - they undercount the true number of SARS-CoV-2 infections because many people have asymptomatic infections or lack access to diagnostic testing. In contrast, seroprevalence studies measure antibodies against SARS-CoV-2 in the population. Because people with these antibodies have been previously infected or vaccinated, these studies are crucial to understanding the true extent of the pandemic and in measuring population antibody levels.","PublicHealthAgency":"Public Health Agency of Canada","SupportedBy":"SeroTracker is supported by the","ThroughThe":"through the","UnityStudies":"Unity seroprevalence studies.","WHO1":"SeroTracker is working with the","WHO2":"to visualize and synthesize results from the","WHO3":"SeroTracker and the World Health Organization are grateful for German Federal Ministry of Health (BMG) COVID-19 Research and Development funding to support this effort.","WorldHealthOrganization":"World Health Organization"},"ContactSection":{"BulletPointFive":{"PartOne":"To make us aware of","PartThree":"or studies that we have not yet captured, please fill out","PartTwo":"new SARS-CoV-2 seroprevalence studies","PartFour":"."},"BulletPointOne":{"PartFour":"and Kelly Johnston at","PartOne":"For all SeroTracker inquiries (including to support our efforts, collaborate with us, or if you are a journalist interested in reporting on our findings), please contact Rahul Arora at ","PartThree":"Journalists and members of the media: please contact Caroline Phaneuf at","PartTwo":"and Tingting Yan at "},"SectionOne":"We are an interdisciplinary team of researchers and engineers at the University of Oxford, University of Toronto, University of Waterloo, University of Calgary, and Harvard University."},"Headers":{"AboutSeroTracker":"About SeroTracker","ContactUs":"Contact Us","OurTeam":"Our Team"},"SubHeaders":{"Alumni":"Alumni","DataCuration":"Evidence Synthesis and Data Curation Team","DataInfrastructure":"Data Infrastructure and Analytics Team","GlobalPartnerships":"Global Health Partnerships Team","DevelopmentTeam":"Development Team","ProjectStaff":"Project Staff","ScientificAdvisors":"Scientific Advisors","TeamLead":"Team Leads"},"Mapbox":"supports SeroTracker\'s mapping infrastructure."},"Accept":"Accept","AcceptCookies":"Accept Cookies","AccessGithub":"Access Github","AdditionalGraphs":"Additional Graphs","Age":"Age","AgeGroup":"Age Group","AgeOptions":{"Adults(18-64)":"Adults (18-64)","All":"All","Children(0-12)":"Children (0-12)","Seniors(65+)":"Seniors (65+)","Unspecified":"Unspecified","Youth(13-17)":"Youth (13-17)"},"AggregatedPrevalence":"Aggregated Prevalence","Aggregating":"Aggregating","AnalysisMethods":{"FirstParagraph":{"FirstSentence":"The seroprevalence shown for each country or factor is calculated by ","SecondSentence":"all seroprevalence estimates that match the filters you specify."},"SecondParagraph":"Default filters: Country/Territory-Wide and regional estimates, in the general population and blood donors. ","ThirdParagraph":"These aggregated estimates should be interpreted with caution, especially if the studies that were aggregated did not include representative samples or were at high Risk of bias.","Title":"Analysis Methods","Tooltip":"The aggregation technique used is fixed-effects, inverse-variance-weighted meta-analysis of prevalence, with the Freeman-Tukey double arcsin transform used to stabilize variance. Records over sample size MIN_DENOMINATOR considered."},"Analyze":"Analyze","AntibodyTarget":"Antibody Target","AntibodyTargetOptions":{"EnvelopeProtein":"Envelope protein","MembraneProtein":"Membrane protein","NR":"NR","NotReported":"Not reported","Nucleocapsid(N-protein)":"Nucleocapsid (N-protein)","Spike":"Spike","WholeVirusAntigen":"Whole-virus antigen"},"Article":"Article","Authors":"Authors","AuthorAndLeadOrganizationNotReported":"Author and lead organization not reported","BestSeroprevalenceEstimate":"Seroprevalence","BiblioDigestCard":{"Title":"Serotracker Key Insights from","Published":"Published:","NewSerosurveys":"New serosurveys identified","AFRO":"African","EMRO":"Eastern Mediterranean","EURO":"European","PAHO":"Region of the Americas","SEARO":"South-East Asia","WPRO":"Western Pacific","NonMember":"Non-Member States","NewSources":"New sources added"},"BlankUniversity":"NAME University","ByCountry":"By Country","ByPopulation":"By Population","CentreHealthInformatics":"Centre for Health Informatics","ChangeLog":"Change log","ClearAllFilters":"Clear all filters","CPPInvestmentBoard":"CPP Investment Board","ChangeSettings":"Change Settings","CoDirector":"Co-Director","ContactUs":"Contact Us","CookiePolicy":"Cookie Policy","CookiePolicyBody":"We use cookies to help us deliver a better user experience and we never collect any personal data. By using our website, you signify that you have read and agree to our ","Countries":"Countries","CountriesIncluded":{"PartOne":"in","PartTwo":"countries and territories"},"CountriesAndAreas":"Countries and Areas","CountryEstimatesExist":"Seroprevalence Estimates","CountryEstimatesNotExist":"No Seroprevalence Estimates","CountryOptions":{"England":"England","Iran":"Iran","Scotland":"Scotland","UnitedStates":"United States"},"COVIDImmunityTaskForce":"COVID-19 Immunity Task Force","Dashboard":"Dashboard","Data":"Data","DatabaseUptoDateTo":"Database up to date to","DateRangeTo":"to","DataDictionary":"Data dictionary","DataDictionaryText":{"FirstParagraph":"For more information and context about our data, please take a look at our","SecondParagraph":"and"},"DataDownload":"To download a list of all studies in our database and summary seroprevalence estimates, please click the \'Download CSV\' link on the bottom right of this page. If you require additional data or information about this data to conduct your analysis, please do not hesitate to contact the","DateRange":"Date Range","DateRangeTooltip":"Filter studies by their sampling end dates.","Demographics":"Demographics","DemographicsTooltip":"Filter on demographic variables, including population group, sex, and age group.","Details":"Details","DisclaimerFooter":" *The representatives of SeroTracker are listed on the SeroTracker website. ","DisclaimerList1":"This website and its contents herein, including all data, mapping, and analysis (\u201cWebsite\u201d), copyright 2020 SeroTracker, all rights reserved, is provided solely for non-profit public health, educational, and academic research purposes. You should not rely on this Website for medical advice or guidance. ","DisclaimerList2":"Use of the Website by commercial parties and/or in commerce without explicit written permission by a representative* of SeroTracker is strictly prohibited. Redistribution of the Website or the aggregated data set underlying the Website without explicit written permission by a representative* of SeroTracker is also strictly prohibited.","DisclaimerList3":"When using information from the website or linking to the website, attribute the Website as SeroTracker by the SeroTracker Collaboration.","DisclaimerList4":"The Website relies upon publicly available data from multiple sources that do not always agree. The SeroTracker team and The COVID-19 Immunity Task Force hereby disclaims any and all representations and warranties with respect to the Website, including accuracy, fitness for use, reliability, completeness, and non-infringement of third party rights. ","DisclaimerList5":"Any use of the SeroTracker or The COVID-19 Immunity Task Force names, logos, trademarks, and/or trade dress in a factually inaccurate manner or for marketing, promotional or commercial purposes without explicit written permission by a representative* of SeroTracker is strictly prohibited. ","DisclaimerList6":"These terms and conditions are subject to change. Your use of the Website constitutes your acceptance of these terms and conditions and any future modifications thereof.","DisclaimerListHeader":"Terms and Conditions of Website Use:","DropdownQuestions":{"Question1":{"Question":"Where does SeroTracker\'s data come from?","Answer":{"Part1":"We collect all seroprevalence data from published peer reviewed research articles, preprints, reports, and media (unpublished grey literature). Data related to vaccination status and case counts is pulled from the","Part2":"The sources included in our dashboard to date are in the table below."},"Links":{"Link1":"https://github.com/owid/covid-19-data"},"LinkTexts":{"LinkText1":"OWID GitHub repository. "}},"Question2":{"Question":"How does SeroTracker collect their data?","Answer":"We conduct regular searches of several databases including Medline, EMBASE, Web of Science, and Europe PMC and targeted google searches. In addition, anyone can submit sources for us to screen and include in our review using the \\"Submit source\\" button above."},"Question3":{"Question":"How does SeroTracker extract data from their sources?","Answer":"We have an extensive research team trained in health sciences and epidemiology who manually reviews articles and records seroprevalence estimates into a data management platform called AirTable. The processes and rules we follow to extract data are available in our study protocol document and AirTable data dictionary."},"Question4":{"Question":"How often is SeroTracker Data Updated?","Answer":"SeroTracker data is updated approximately every week. Our team scans new literature every Friday and data is added over the course of the following week."},"Question5":{"Question":"How does SeroTracker\u2019s data show up on the map?","Answer":"Data inputted into Airtable is automatically run through a software pipeline that cleans it and computes additional information (e.g. a study\u2019s geographic coordinates). The outputs of the pipeline are then stored in a separate database, which is queried by serotracker.com to serve the \\"Explore\\" tab."},"Question6":{"Question":"Can I download SeroTracker\'s data for my own analysis?","Answer":"Yes, our data is open-source and free for anyone to use. You can download our complete .csv file using the \\"Download CSV\\" button above. You will first be asked to fill out a form indicating your role, affiliation (if relevant), and type of research you\u2019re conducting - This helps us create datasets that are most useful to you. "},"Question7":{"Question":"Do I need to be an AirTable user to use SeroTracker\'s data?","Answer":"No. Although our data is presented in an AirTable file, you can export this easily to Excel or other formats."},"Question8":{"Question":"How do I interpret the variables in SeroTracker\'s data set?","Answer":"Please see our Data Dictionary (using the button above) for explanations of our variables, data types, and descriptions as well as insight into how our data is collected by our research team. It is structured to help interpret our downloadable data set. "},"Question9":{"Question":"How has SeroTracker\'s data been used by others?","Answer":{"Part1":"SeroTracker data is used by many public health professionals and health agencies such as the World Health Organization and Public Health Agency of Canada, among others. The \\"Publications\\" tab has links to internal reports, publications we have produced, and features of SeroTracker data and work in the media. Our most recent","Part2":"analyzes global seroprevalence from January - December, 2020."},"Links":{"Link1":"https://www.medrxiv.org/content/10.1101/2020.11.17.20233460v2"},"LinkTexts":{"LinkText1":"publication"}}},"DownloadAirtable":"Click to access and download our SARS-CoV-2 seroprevalence data on Airtable","DownloadCsv":"Download CSV","DownloadData":"Download Data","DownloadGithub":"Click to programmatically download our SARS-CoV-2 seroprevalence data on GitHub","EconomicsTeam":"Economics Team","EndDate":"End Date","English":"English","Estimate":"Estimate","EstimateGrade":"Estimate Grade","EstimateGradeOptions":{"Hyperlocal":"Hyperlocal","Local":"Local","National":"Country/Territory-Wide","Regional":"Regional"},"EstimateRange":"Estimate Range","ExecutiveDirector":"Executive Director","Explore":"Explore","ExploreBlurb":{"FirstParagraph":"SeroTracker is a dashboard and data platform for SARS-CoV-2 serosurveys.","SecondParagraph":"We conduct an ongoing systematic review to track serosurveys (antibody testing-based surveillance efforts) around the world and visualize findings on this dashboard.","ThirdParagraph":"Antibodies against SARS-CoV-2, the virus that causes COVID-19, indicate previous infection or vaccination. "},"Filter":"Filter","FilterTooltip":"Filter the SeroTracker dataset based on geography, study, demographics, and test. Only studies matching all of the listed filters will be included.","For":"For","Footer":{"CiteAs":"Cite as: ","LastUpdated":"Database up to date to","LancetInfDis":"Lancet Inf Dis","Article":"article"},"French":"Fran\xe7ais","FAQ":"FAQ","FrequentlyAskedQuestions":"Frequently Asked Questions","GeneralSerotrackerCommunications":"General SeroTracker Communications","GeneralTerms":"General Terms","Geographies":"Geographies","Geography":"Geography","GeographyTooltip":"Select countries of interest.","Here":"Here","IncludingParticipants":{"PartOne":"including","PartTwo":"participants"},"IndustryMediaTitles":{"UnderstandingVirus":"Understanding the Virus and Its Unanswered Questions","KnowledgeHub":"Knowledge hub developed to track SARS-CoV antibody studies","GlobalLaunch":"Global launch of SeroTracker: a COVID-19 antibody testing hub, in partnership with Canada\'s COVID-19 Immunity Task Force","StudentsBuild":"Students build online dashboard to track COVID-19 antibody studies","NewlyLaunched":"Newly launched SeroTracker will monitor global antibody testing efforts","VeteranDoctor":"What if there is no COVID-19 vaccine? A veteran doctor of the HIV/AIDS crisis provides alternatives","CovidRadar":"Covid Radar: taxa de subnotifica\xe7\xe3o de casos de covid-19 na Rocinha chega a 62 vezes [COVID-19 underreporting rate in Rocinha reaches 62 times].","HowMany":"How many of us are likely to have caught the coronavirus so far?","Lecturership":"Adjunct lecturership for CHI Lab DPhil student Rahul Arora.","HomeTests":"Cheap, Daily Home Tests Are The First Step To Containing The Pandemic","Webinar":"SeroTracker COVID-19 Journey: HIMSS Canadian Prairies Chapter Webinar","AlumniAndStudents":"The Serotracker: Alumni and students develop tool to track Covid-19 spread","InfectionRate":"Study on the global coronavirus infection rate: the number of unreported cases","McKinseyHealthcare":"McKinsey on healthcare: 2020 year in review","JouleRecipients":"Joule announces 2020 Innovation grant recipients","JouleInnovation":"SeroTracker: Joule innovation grant recipient","WhenEnd":"When will the COVID-19 pandemic end?","JouleAnnounce":"Joule announces 2020 Innovation grant recipients","StillVulnerable":"The world\'s population is still vulnerable to COVID-19","NYTIndia":"Just how big could India\u2019s true Covid toll be?","EconomistDeathToll":"How we estimated the true death toll of the pandemic","EconomistDeathToll2":"The pandemic\u2019s true death toll","InventoryEvidenceSynthesis":"Inventory of Best Evidence Synthesis"},"IndustryReportTitles":{"AugustReport":"August Report","BloodBank":"SeroTracker Blood Bank Seroprevalence Preliminary Report","JulyReport":"July Report","JuneReport":"June Report","MayReport":"May Report","OctoberReport":"October Report","PreliminaryReport":"Preliminary Report","SeptemberReport":"September Report","YearInReview2020":"SeroTracker 2020 Year in Review","InsuringTheEconomy":"Insuring the Economy Against a Second Pandemic Wave"},"ResearchArticleTitles":{"MedRxivNLP":"A real-world evaluation of the implementation of NLP technology in abstract screening of a systematic review","MedRxivMeta":"Global epidemiology of SARS-CoV-2 infection: a systematic review and meta-analysis of standardized population-based seroprevalence studies, Jan 2020-Oct 2021","MedRxivROB":"SeroTracker-ROB: reproducible decision rules for risk of bias assessment of seroprevalence studies","MedRxivPrivate":"Uptake of SARS-CoV-2 workplace testing programs, March 2020 to March 2021","PlosOnePub":"Global seroprevalence of SARS-CoV-2 antibodies: a systematic review and meta-analysis","LancetID":"SeroTracker: a global SARS-CoV-2 seroprevalence dashboard","PrePrint":"Lessons from a rapid systematic review of early SARS-CoV-2 serosurveys"},"BiblioDigestTitles":{"December":"December Literature Update Report","November":"November Literature Update Report","LateOctober":"Late October Literature Update Report","October":"October Literature Update Report","September":"September Literature Update Report","August":"August Literature Update Report","July":"July Literature Update Report","June":"June Literature Update Report"},"BiblioDigests":"Literature Update Reports","InitInfoModalText":{"PartOne":"Welcome to the SeroTracker Analyze tab! We are conducting a systematic review of SARS-CoV-2 serosurveys, and using the data from our review to build this dashboard.","PartThree":"These aggregated estimates should be interpreted with caution, especially if the studies that were aggregated did not include representative samples or were at high Risk of bias. You can explore the source literature in depth on the references card at the bottom of this page.","PartTwo":"Our dashboard aggregates seroprevalence estimates in each country. By default, these aggregated estimates include Country/Territory-Wide and regional seroprevalence estimates of the general population or blood donors, and excludes estimates presented only in the news."},"Insights":"Insights","Isotypes":"Isotypes","IsotypesReported":"Isotypes Reported","IsotypesReportedOptions":{"IgA":"IgA","IgG":"IgG","IgM":"IgM","IgMIgG":"IgM IgG"},"LancetArticle":"Lancet ID","LancetID":"The Lancet Infectious Diseases","Language":"Language","LastUpdatedTooltip":"SeroTracker is continuously updated with findings from newly-released serological studies. We include new studies from our search within 48 hours of publication.","Legalese":"Legalese","LocalEstimateRange":"Local Estimate Range","LocalEstimates":"Local Estimates","LocalStudies":"Local Studies","LocalStudyDetails":"Local study","Location":"Location","Manufacturers":"Manufacturers","ManuscriptAndPreprint":"Manuscript and Preprint","ManuscriptAppendixText":{"FirstParagraph":"full methods","SecondParagraph":"(from the appendix to our full systematic review and meta-analysis of SARS-CoV-2 serosurveys)"},"Map":"Map","Media":"Media","MediaMentions":"Media Mentions","MemorialUniversityOfNewfoundland":"Memorial university of Newfoundland","PrivateSectorReports":"Private Sector Reports","Months":{"January":"January","February":"February","March":"March","April":"April","May":"May","June":"June","July":"July","August":"August","September":"September","October":"October","November":"November","December":"December"},"N":"N","Name":"Name","NationalEstimateRange":"Country/Territory-Wide Estimate Range","NationalEstimates":"Country/Territory-Wide Estimates","NationalStudies":"Country/Territory-Wide Studies","NationalStudyDetails":"National study","NoData":"No Data","NoDataAnalyze":{"PartOne":"No data is available for the filters you\'ve specified.","PartTwo":"Please try a different filter combination."},"NotApplicable":"Not Applicable","NotFound":{"PartOne":"Page Not Found","PartTwo":"Uh oh, we couldn\'t find the page you\'re looking for! Please try another URL or visit our Explore page to get back on track.","Button":"Visit Explore Page"},"NotReported":"Not Reported","NumberEstimates":"Number of Estimates","NumSeroprevalenceEstimates":"Number of Seroprevalence Estimates","Okay":"Okay, I Understand!","OptimisedFunctionality":"For optimized site functionality, please visit us on a desktop device.","OurData":"Our Data","OurDataText":{"PointOne":"captures all studies reporting prevalence estimates","PointTwo":"describes studies that have not yet reported seroprevalence estimates","Text":"The table below describes our findings, including detailed information about each study, each prevalence estimate, and the associated Risk of bias."},"OurProtocol":"Our protocol","OverallRiskOfBias":"Overall Risk of bias","Paper":"Paper","PaperText":"Our first manuscript, describing lessons from serosurveys up to May 1, can be found on","PaperTextTwo":"More information about our dashboard can be found in","Partnerships":"Partnerships","PartnershipsList":{"Canada":"Canada (CITF)"},"PartnershipsPageTitle":{"Canada":"Canadian Covid-19 Immunity Task Force"},"PartnershipsPageDescription":{"Canada":{"PartOne":"SeroTracker is financially supported by the Public Health Agency of Canada through the COVID-19 Immunity Task Force (CITF). The CITF has funded many high-calibre serological surveys among other immunity related research that you can learn more about on","PartTwo":"their website.","PartThree":"They also provide modelled estimates of seroprevalence due to infection in the Canadian population which you can find","PartFour":"here."}},"PartnershipsView":{"MapNote1":"The map displays seroprevalence estimates for all geographic based estimates (including sub-estimates reported e.g. regional provincial estimates reported in a country-wide study). Pins are arranged around the center of their geographic location(s).","MapNote2":"Case and death counts (at the midpoint in study sampling) are taken at a national level from ourworldindata.org (subsource: coronavirus.jhu.edu)"},"Per100":" per 100","PlannedSerosurveys":"Planned Serosurveys","Population":"Population","PopulationGroup":"Population group","PopulationGroupOptions":{"All":"All","BloodDonors":"Blood donors","Children":"Children","CommunityResident":"Community resident","FactoryWorker":"Factory worker","FirstResponders":"First responders","GeneralPopulation":"General population","HealthCareWorkers":"Health care workers","HotelStaffMember":"Hotel staff member","IndustrySpecificEmployees":"Industry specific employees","NonCovidHospitalizedPatients":"Non-COVID hospitalized patients","NonCovidPatientsInHealthCareSettings":"Non-COVID patients in health care settings","PregnantOrParturientWomen":"Pregnant or Parturient Women","RelativeOfHealthCareWorker":"Relative of health care worker","ResidualSera":"Residual sera","Students":"Students","Unspecified":"Unspecified"},"Populations":"Populations","PositiveCases":"Positive cases","Prevalence":"Prevalence","PrevalenceEstimateDetails":"Prevalence Estimate Details","PrivacyPolicy":"Privacy Policy","Publication":"Publication","PublicationDescriptions":{"Publications":"Learn more about SeroTracker\u2019s impact in research articles, summaries, and media mentions","ResearchArticles":"Peer-reviewed and pre-print research papers published by the SeroTracker team","LiteratureUpdateReports":"Monthly overviews and updates on trends in serosurvey literature and WHO-supplied metrics","GeneralSerotrackerCommunications":"Updates and insights from across the SeroTracker team","MediaMentions":"Worldwide media publications featuring SeroTracker","PrivateSectorReports":"Reports on COVID-19 screening and testing practices across Canada\u2019s private sector in 2020"},"Publications":"Publications","Published":"Published","DataTable":"Data Table","RegionalEstimateRange":"Regional Estimate Range","RegionalEstimates":"Regional Estimates","RegionalStudies":"Regional Studies","RegionalStudyDetails":"Regional study","RegulatoryApproval":"Regulatory Approval","Report":"Report","ReportsAndArticles":"Reports & Articles","ResearchArticles":"Research Articles","RiskOfBias":"Risk of bias","RiskOfBiasOptions":{"High":"High","Low":"Low","Moderate":"Moderate","Unclear":"Unclear"},"SampleSize":"Sample Size","Sampling":"Sampling","SamplingEndDate":"Sampling End Date","SamplingDates":"Sampling dates","SamplingMethod":"Sampling Method","SchoolName":{"Cumming":"Cumming School of Medicine","Schulich":"Schulich School of Engineering"},"ScientificLead":"Scientific Lead","SelectDate":"Select date...","Sensitivity":"Sensitivity","SeroPrevalenceByCountry":"Aggregated Seroprevalence Estimates in Different Countries","Seroprevalence":"Seroprevalence","SeroprevalenceBy":"Seroprevalence by","SeroprevalenceScale":"Seroprevalence Scale","SeroprevalenceScaleTooltip":"Made from the logit transform of the maximum value to determine the \'bins\'","SeroprevalenceStudies":"seroprevalence studies","SeroprevalenceTooltip":{"FirstParagraph":"Prevalence of antibodies against SARS-CoV-2, aggregated within the filters you have selected.","SecondParagraph":"NB: This should not be interpreted as a representative estimate of seroprevalence in the region of interest, especially if the aggregated studies have biased samples.","ThirdParagraph":"Pooling technique: fixed effects inverse-variance weighted aggregation of records with sample size over MIN_DENOMINATOR."},"Serosurveys":"Serosurveys","SerosurveysReportingPrevalence":"Serosurveys Reporting Prevalence","SeroprevalenceEstimatesInRegion":"Seroprevalence Estimates in Canada by Geographic Area","SeroTrackerTeam":"SeroTracker team","Settings":"Settings","Sex":"Sex","SexOptions":{"All":"All","Female":"Female","Male":"Male","Unspecified":"Unspecified"},"Source":"Source","SourceType":"Source Type","SourceTypeOptions":{"InstitutionalReport":"Institutional Report","NewsAndMedia":"News and Media","Preprint":"Preprint","Publication":"Publication"},"Specificity":"Specificity","StartDate":"Start Date","Status":"Status","StudiesPerPage":"Studies per page","Study":"Study","StudyDetailsAuthorString":{"LeadOrg":"By FIRST_AUTHOR at LEAD_ORG","NoLeadOrg":"By FIRST_AUTHOR"},"StudyDetailsPublishString":{"NoPublishDate":"Published by PUBLISHER","NoPublisher":"Published on PUBLISH_DATE","PublisherAndDate":"Published on PUBLISH_DATE by PUBLISHER"},"StudyInformation":"Study Information","StudyInformationTooltip":{"FirstParagraph":"Filter on study details, including source type (publication, preprint, news, or report), study status (ongoing, completed), and alignment with the WHO Unity protocol.","SecondParagraph":{"PartOne":"Risk of bias:","PartTwo":"Reflects the extent to which the true prevalence may be different from the estimated prevalence. Estimated by SeroTracker reviewers based on the Joanna Briggs Institute critical appraisal tool for prevalence estimates."},"ThirdParagraph":{"PartOne":"WHO Unity protocol:","PartTwo":"The WHO developed several standardized generic protocols for robust investigations for COVID-19:","PartThree":"the Unity studies.","PartFour":"SeroTracker is collaborating with the WHO to support and visualize studies aligned with the population-based seroepidemiological Unity protocol."}},"StudyName":"Study name","StudyPins":"Show Study Pins","StudySize":"Study Size","StudyStatus":"Study Status","StudyStatusOptions":{"Completed":"Completed","Ongoing":"Ongoing"},"StudyType":"Study Type","SublocalEstimateRange":"Sublocal Estimate Range","SublocalEstimates":"Sublocal Estimates","SublocalStudyDetails":"Sublocal Study","SubmitSource":"Submit source","Summary":"Summary","SummaryStatistics":"Summary Statistics","Team":"Team","TeamLead":"Team Leads","TemporaryMaintenance":"Temporary Maintenance","TemporaryMaintenanceDescription":"We are down for scheduled maintenance, service will return shortly.","TermsOfUse":"Terms of Use","TestDetails":"Test Details","TestInformation":"Test Information","TestInformationTooltip":"Filter on test details, including assay type and antibody isotype.","TestsAdministered":"Antibody Tests Administered","TestType":"Test Type","TestTypeOptions":{"ChemiluminescenceImmunoassay":"Chemiluminescence Immunoassay","ColloidalGold":"Colloidal gold","ELISA":"ELISA","ElectroChemiluminescenceImmunoassay":"Electro Chemiluminescence Immunoassay","LFIA":"LFIA","LIPS":"LIPS","MicrosphereImmunoassay":"Microsphere immunoassay","NeutralizationAssay":"Neutralization assay","NotReported":"NotReported","RDT":"RDT","RapidImmunochromatographicTest":"Rapid immunochromatographic test","SolidPhaseImmunochromatography":"Solid phase immunochromatography"},"TestUsed":"Test Used","ThisForm":"this form","Today":"Today","TotalEstimates":"Total Estimates","TotalTests":"Total Tests","UnityBanner":{"Currently":"Currently, only ","ProtocolLink":"WHO Unity sero-epidemiological protocol ","ViewDatabase":"aligned studies are displayed. To view our full database, uncheck the ","WHOUnityFilter":"WHO Unity Only","Filter":"filter"},"UnityStudiesOnly":"WHO Unity only","UnityStudiesOnlyLong":"Show WHO Unity-aligned studies only","UniversityOf":"University of NAME","UseOfData":"Use of this data is governed by SeroTracker\'s","Vaccinations":"Vaccinations","VaccineRolloutStatus":"Vaccine availability during study","VaccinationPolicyLow":"Vaccines unavailable","VaccinationPolicyMed":"Vaccines available to certain groups","VaccinationPolicyHigh":"Vaccines available to broader population","ViewPartnership":"View Partnership","ViewFile":"View File","ViewHere":"View Here","Welcome":"Welcome to SeroTracker","WhatWeDoText":{"FirstParagraph":"At SeroTracker, we collect data and information on SARS-CoV-2 seroprevalence studies by conducting a live systematic review and meta-analysis of published and unpublished data on  seroprevalence. Data is extracted for each source\'s primary estimate and certain relevant subgroups. Full methods are available in our protocol.","SecondParagraph":"We produce data for both academic and public use on our dashboard. We aim to update our dashboard weekly. For further information beyond the following high-level summary, please see our study protocol and supplementary methods for a detailed explanation of our research processes."},"WhoDisclaimerSmall":"The designations employed and the presentation of the material available on this platform does not imply the expression of any opinion whatsoever on the part of WHO concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement.","WhoDisclaimer":"Disclaimer: the designations employed and the presentation of the material available on this platform does not imply the expression of any opinion whatsoever on the part of WHO concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers\u2019 products in materials available on this platform does not imply that they are endorsed or recommended by WHO in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. By listing materials on this platform does not mean that WHO endorses or recommends those publications or sites, or has verified the content contained within them. The platform has been created without warranty of any kind, either expressed or implied by WHO. The responsibility for the interpretation and use of publications and materials available on this platform lies with the reader. In no event shall WHO be liable for damages arising from its use.","WhoSerotrackAndPartnersDisclaimerSmall":"The designations employed and the presentation of the material available on this platform does not imply the expression of any opinion whatsoever on the part of WHO, SeroTracker, or SeroTracker\'s partners concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement.","WhoSerotrackAndPartnersDisclaimer1":"The designations employed and the presentation of the material available on this platform does not imply the expression of any opinion whatsoever on the part of WHO, SeroTracker, or SeroTracker\'s partners concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement. ","WhoSerotrackAndPartnersDisclaimer2":"The mention of specific companies or of certain manufacturers\u2019 products in materials available on this platform does not imply that they are endorsed or recommended by WHO, SeroTracker, or SeroTracker\'s partners in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. By listing materials on this platform does not mean that WHO, SeroTracker, or SeroTracker\'s partners endorse or recommend those publications or sites, or has verified the content contained within them. ","WhoSerotrackAndPartnersDisclaimer3":"The platform has been created without warranty of any kind, either expressed or implied by WHO, SeroTracker, or SeroTracker\'s partners. The responsibility for the interpretation and use of publications and materials available on this platform lies with the reader. In no event shall WHO, SeroTracker, or SeroTracker\'s partners be liable for damages arising from its use.","WhoUnity":"WHO Unity"}')},334:function(e){e.exports=JSON.parse('{",":" ","95%ConfidenceInterval":"Intervalle de confiance de 95 %","95%ConfidenceIntervalTooltip":"Les barres d\'erreur plus larges indiquent une incertitude plus accentu\xe9e dans l\'estimation regroup\xe9e de s\xe9ropr\xe9valence.","About":"\xc0 propos","AboutPage":{"AboutSection":{"Covid19ImmunityTaskForce":"Groupe de travail sur l\'immunit\xe9 face \xe0 la COVID-19,","GlobalSerologicalKnowledgeHub":"Portail de connaissances internationales sur les tests s\xe9rologiques du Groupe de travail.","HealthInformatics":"le Centre d\'informatique de sant\xe9 de l\'Universit\xe9 de Calgary.","HostedAt":"et est h\xe9berg\xe9 par","MappingTheExtent":"Le Groupe de travail sur l\u2019immunit\xe9 face \xe0 la COVID-19 est la cartographie l\'\xe9tendue de l\'infection par le SRAS-CoV-2 au Canada et SeroTracker fournit \xe9galement du contenu pour leur","PartOne":"SeroTracker synth\xe9tise les r\xe9sultats de milliers d\'\xe9tudes de s\xe9ropr\xe9valence de la COVID-19 dans le monde, fournissant une plate-forme de donn\xe9es et un tableau de bord interactif pour la s\xe9rosurveillance du SRAS-CoV-2.","PartTwo":"Les cas confirm\xe9s de la COVID-19 ne sont que la pointe de l\'iceberg - ils sous-estiment le nombre r\xe9el d\'infections au SRAS-CoV-2 car de nombreuses personnes ont des infections asymptomatiques ou n\'ont pas acc\xe8s aux tests diagnostiques. En revanche, les \xe9tudes de s\xe9ropr\xe9valence mesurent les anticorps contre le SRAS-CoV-2 dans la population. \xc9tant donn\xe9 que les personnes avec ces anticorps ont d\xe9j\xe0 \xe9t\xe9 infect\xe9es ou vaccin\xe9es, ces \xe9tudes sont cruciales pour comprendre l\'ampleur r\xe9elle de la pand\xe9mie et mesurer les niveaux d\'anticorps dans la population.","PublicHealthAgency":"l\'Agence de la sant\xe9 publique du Canada","SupportedBy":"SeroTracker dispose du soutien de","ThroughThe":"\xe0 travers le","UnityStudies":"s\xe9ropr\xe9valence Unity.","WHO1":"SeroTracker travaille avec","WHO2":"de la sant\xe9 pour visualiser et synth\xe9tiser les r\xe9sultats des \xe9tudes de","WHO3":"SeroTracker et l\u2019Organisation mondiale de la sant\xe9 remercions le Minist\xe8re F\xe9d\xe9ral Allemand de la Sant\xe9 (BMG) Recherche et D\xe9veloppement COVID-19 pour le financement pour soutenir cet effort.","WorldHealthOrganization":"l\u2019Organisation mondiale de la sant\xe9"},"ContactSection":{"BulletPointFive":{"PartOne":"Pour nous signaler","PartThree":"ou des \xe9tudes que nous n\'avons pas encore captur\xe9es, veuillez remplir","PartTwo":"de nouvelles \xe9tudes sur la s\xe9ropr\xe9valence du SRAS-CoV-2","PartFour":"."},"BulletPointOne":{"PartFour":"et Kelly Johnston","PartOne":"Pour toute demande li\xe9e \xe0 SeroTracker (y compris pour soutenir nos efforts, pour collaborer avec nous, ou si vous \xeates un journaliste qui cherche \xe0 rendre compte de nos observations), veuillez contacter Rahul Arora \xe0 ","PartThree":"Les journalistes et les membres des m\xe9dias: Pour Caroline Phaneuf s\'il vous pla\xeet \xe0","PartTwo":"et Tingting Yan \xe0 "},"SectionOne":"Nous sommes une \xe9quipe interdisciplinaire de chercheurs et d\'ing\xe9nieurs \xe0 l\'Universit\xe9 d\u2019Oxford, l\'Universit\xe9 de Toronto, l\'Universit\xe9 de Waterloo, l\'Universit\xe9 de Calgary et \xe0 l\'Universit\xe9 de Harvard."},"Headers":{"AboutSeroTracker":"\xc0 propos de SeroTracker","ContactUs":"Nous contacter","OurTeam":"Notre \xe9quipe"},"SubHeaders":{"Alumni":"Anciens","DataCuration":"\xc9quipe de synth\xe8se des preuves et de conservation des donn\xe9es","DataInfrastructure":"\\n\xc9quipe d\'infrastructure de donn\xe9es et d\'analyse","DevelopmentTeam":"\xc9quipe de d\xe9veloppement","GlobalPartnerships":"\xc9quipe des partenariats mondiaux pour la sant\xe9","ProjectStaff":"Personnel du projet","ScientificAdvisors":"Conseillers et collaborateurs scientifiques","TeamLead":"Responsables d\'\xe9quipes"},"Mapbox":"prend en charge l\'infrastructure de mappage de SeroTracker."},"Accept":"Accepter","AcceptCookies":"Accepter les fichiers t\xe9moins","AccessGithub":"Acc\xe9der \xe0 Github","AdditionalGraphs":"Graphiques suppl\xe9mentaires","Age":"\xc2ge","AgeGroup":"Groupe d\'\xe2ge","AgeOptions":{"Adults1864Years":"Adultes (18-64 ans)","ChildrenAndYouth017Years":"Enfants et jeunes (0-17 ans)","Seniors65Years":"A\xeen\xe9s (65 ans et plus)"},"AggregatedPrevalence":"Fr\xe9quence cumulative","Aggregating":"agr\xe9geant ","AnalysisMethods":{"FirstParagraph":{"FirstSentence":"La s\xe9ropr\xe9valence de chaque pays indiqu\xe9 est calcul\xe9e en ","SecondSentence":"de toutes les estimations de s\xe9ropr\xe9valence qui correspondent aux filtres que vous sp\xe9cifiez."},"SecondParagraph":"filtres par d\xe9faut: Estimations nationales et r\xe9gionales, dans la population g\xe9n\xe9rale et les donneurs de sang","ThirdParagraph":"Ces estimations agr\xe9g\xe9es doivent \xeatre interpr\xe9t\xe9es avec prudence, surtout si les \xe9tudes qui ont \xe9t\xe9 agr\xe9g\xe9es ne comportaient pas des \xe9chantillons repr\xe9sentatifs ou \xe9taient \xe0 risque \xe9lev\xe9 de biais","Title":"M\xe9thodes d\'analyse","Tooltip":"La technique d\'agr\xe9gation est \xe0 effets fixes, m\xe9ta-analyse pond\xe9r\xe9e inverse la variance de la pr\xe9valence, avec la double arcsin Freeman-Tukey transform\xe9e utilis\xe9s pour stabiliser la variance sur la taille des \xe9chantillons MIN_DENOMINATOR dossiers consid\xe9r\xe9s."},"Analyze":"Analyser","AntibodyTarget":"Cible d\'anticorps","AntibodyTargetOptions":{"EnvelopeProtein":"Prot\xe9ine d\'enveloppe","MembraneProtein":"Prot\xe9ine membranaire","NR":"NR","NotReported":"Non report\xe9","Nucleocapsid(N-protein)":"Nucl\xe9ocapside (Prot\xe9ine N)","Spike":"P\xe9plom\xe8re","WholeVirusAntigen":"Antig\xe8ne de virus entier"},"Article":"Article","Authors":"Auteurs","AuthorAndLeadOrganizationNotReported":"Auteur et organisation responsable non indiqu\xe9s","BiblioDigestCard":{"Title":"Aper\xe7us cl\xe9s de Serotracker du","Published":"Publi\xe9:","NewSerosurveys":"Nouvelles enqu\xeates s\xe9rologiques identifi\xe9es","AFRO":"Afrique","EMRO":"M\xe9diterran\xe9e orientale","EURO":"Europe","PAHO":"Am\xe9riques","SEARO":"Asie du Sud-Est","WPRO":"Pacifique occidental","NonMember":"\xc9tats non membres","NewSources":"Nouvelles sources ajout\xe9es"},"BlankUniversity":"Universit\xe9 de NAME","ByCountry":"Par pays","ByPopulation":"Par population","CentreHealthInformatics":"Centre d\'informatique de la sant\xe9","ChangeLog":"Un registre de modifications","ClearAllFilters":"Effacer tous les filtres","ChangeSettings":"Modifier les param\xe8tres","CoDirector":"Codirecteur","CookiePolicy":"Politique sur les fichiers t\xe9moins","CookiePolicyBody":"Nous utilisons des fichiers t\xe9moins pour nous permettre de livrer une meilleure exp\xe9rience d\'utilisation et nous ne collectons jamais de donn\xe9es personnelles. En utilisant notre site Internet, vous confirmez que vous avez lu et accept\xe9 nos ","Countries":"Pays","CountriesIncluded":{"PartOne":"dans","PartTwo":"pays et territories"},"CountriesAndAreas":"Pays et r\xe9gions","CountryEstimatesExist":"Pays dot\xe9s d\'estimations de s\xe9ropr\xe9valence","CountryEstimatesNotExist":"Aucune estimation de s\xe9ropr\xe9valence","CountryOptions":{"England":"Angleterre","Iran":"Iran","Scotland":"\xc9cosse","UnitedStates":"\xc9tats-Unis"},"CPPInvestmentBoard":"Office d\'investissement du RPC","COVIDImmunityTaskForce":"Groupe de travail sur l\'immunit\xe9 face \xe0 COVID-19","Dashboard":"Tableau de bord","Data":"Donn\xe9es","DatabaseUptoDateTo":"Base de donn\xe9es \xe0 jour jusqu\'au","DateRangeTo":"au","DataDictionary":"Dictionnaire de donn\xe9es","DataDictionaryText":{"FirstParagraph":"Pour plus d\'informations et de contexte sur nos donn\xe9es, veuillez s\'il vous plait consulter notre","SecondParagraph":"et"},"DataDownload":"Pour t\xe9l\xe9charger une liste de toutes les \xe9tudes de notre base de donn\xe9es et des estimations sommaires de la s\xe9ropr\xe9valence, veuillez s\u2019il vous plait cliquer sur le lien \xabT\xe9l\xe9charger CSV\xbb en bas \xe0 droite de cette page. Si vous avez besoin de donn\xe9es suppl\xe9mentaires ou d\u2019informations sur ces donn\xe9es pour effectuer votre analyse, n\u2019h\xe9sitez pas de contacter","DateRange":"Plage de donn\xe9es","DateRangeTooltip":"Des \xe9tudes Filtrer par leurs dates de fin d\'\xe9chantillonnage.","Demographics":"Donn\xe9es d\xe9mographiques","DemographicsTooltip":"Filtrer les variables d\xe9mographiques, y compris le groupe de population, le sexe et le groupe d\'\xe2ge.","Details":"D\xe9tails","DisclaimerBody":"Les noms des emplacements apparaissant sur le site Web correspondent aux d\xe9signations officielles de simplemaps.com. Le contenu du site n\u2019exprime aucune opinion de la part de l\u2019\xe9quipe de SeroTracker, de ses membres et des organisations auxquelles ceux-ci sont affili\xe9s, ou du Groupe de travail sur l\u2019immunit\xe9 face \xe0 la COVID-19 en ce qui concerne la situation juridique d\u2019un pays, d\u2019un territoire ou de ses autorit\xe9s. Nous ne garantissons pas l\u2019absence d\u2019erreur au sein des fronti\xe8res, des noms g\xe9ographiques et des donn\xe9es connexes s\u2019affichant sur les cartes ou dans les listes, les tableaux, les documents et les bases de donn\xe9es du site Web. L\u2019emploi de ces renseignements ne constitue par ailleurs pas un cautionnement officiel par l\u2019\xe9quipe de SeroTracker, ses membres et les organisations auxquelles ceux-ci sont affili\xe9s, ou le Groupe de travail sur l\u2019immunit\xe9 face \xe0 la COVID-19.","DisclaimerFooter":"* Les repr\xe9sentants de SeroTracker sont list\xe9s sur le site Web de l\u2019entreprise.","DisclaimerList1":"Le pr\xe9sent site Web et son contenu, y compris toute donn\xe9e, carte et analyse (\xab site Web \xbb), est la propri\xe9t\xe9 intellectuelle de SeroTracker (2020, tous droits r\xe9serv\xe9s). Le site Web est offert exclusivement pour un usage \xe0 but non lucratif \xe0 des fins de sant\xe9, d\u2019\xe9ducation et de recherche. Le pr\xe9sent site Web ne constitue pas des conseils m\xe9dicaux.","DisclaimerList2":"L\u2019utilisation du pr\xe9sent site Web par des organismes \xe0 but lucratif ou \xe0 une fin lucrative sans le consentement \xe9crit explicite d\u2019un repr\xe9sentant* de SeroTracker est strictement interdite. La redistribution du site Web ou de ses donn\xe9es sous-jacentes sans le consentement \xe9crit explicite d\u2019un repr\xe9sentant* de SeroTracker est \xe9galement strictement interdite.","DisclaimerList3":"Si vous utilisez les renseignements du site Web ou publiez un lien vers celui-ci, attribuez les droits \xe0 SeroTracker par SeroTracker Collaboration.","DisclaimerList4":"Le site Web d\xe9pend de donn\xe9es publiques provenant de diverses sources qui se contredisent parfois. L\u2019\xe9quipe de SeroTracker et le Groupe de travail sur l\u2019immunit\xe9 face \xe0 la COVID-19 se d\xe9gagent de toute responsabilit\xe9 par rapport \xe0 toute d\xe9claration ou garantie au sujet du site Web, qu\u2019il soit question de sa pr\xe9cision, de son accessibilit\xe9, de sa fiabilit\xe9, de son exhaustivit\xe9 ou du respect des droits de tierces parties.","DisclaimerList5":"Toute utilisation inexacte ou \xe0 des fins publicitaires ou commerciales des noms, des logos, des marques de commerce ou de l\u2019habillage commercial de SeroTracker ou du Groupe de travail sur l\u2019immunit\xe9 face \xe0 la COVID-19 est strictement interdite, sauf avec le consentement \xe9crit explicite d\u2019un repr\xe9sentant* de SeroTracker. ","DisclaimerList6":"Les pr\xe9sentes conditions d\u2019utilisation sont sujettes \xe0 modification. En utilisant le site Web, vous reconnaissez que vous acceptez ces conditions et leurs \xe9ventuelles modifications","DisclaimerListHeader":"Conditions d\u2019utilisation du site Web:","DropdownQuestions":{"Question1":{"Question":"D\'o\xf9 viennent les donn\xe9es de SeroTracker?","Answer":{"Part1":"Nous recueillons toutes les donn\xe9es de s\xe9ropr\xe9valence \xe0 partir d\'articles \xe9valu\xe9s par des pairs, de pr\xe9publications, de rapports et de m\xe9dias (litt\xe9rature grise non publi\xe9e). Les donn\xe9es reli\xe9es au statut vaccinal et au nombre de cas sont extraites du ","Part2":"Les sources incluses dans notre tableau de bord jusqu\'\xe0 pr\xe9sent sont dans le tableau ci-dessous."},"Links":{"Link1":"https://github.com/owid/covid-19-data"},"LinkTexts":{"LinkText1":"r\xe9f\xe9rentiel GitHub de Our World In Data (OWID). "}},"Question2":{"Question":"Comment SeroTracker recueille-t-il des donn\xe9es?  ","Answer":"Nous effectuons des recherches habituelles sur Google et sur des bases de donn\xe9es telles que Medline, EMBASE, Web of Science, et Europe PMC. De plus, nous acceptons des soumissions d\'\xe9tudes - vous pouvez soumettre un article en utilisant le bouton \\"Soumettre un article\\" au-dessus."},"Question3":{"Question":"Comment SeroTracker extrait-t-il des donn\xe9es de ses sources?  ","Answer":"Nous avons une \xe9quipe de chercheurs qui ont une formation en sciences de la sant\xe9 et en \xe9pid\xe9miologie. Les membres de notre \'\xe9quipe r\xe9visent les \xe9tudes et enregistrent manuellement les valeurs de s\xe9ropr\xe9valence dans nos base de donn\xe9es sur une plate-forme de gestion de donn\xe9es appel\xe9e AirTable. Les processus et les r\xe8gles que nous suivons chez SeroTracker pour extraire les donn\xe9es sont disponibles dans le protocole et le document dictionnaire des donn\xe9es."},"Question4":{"Question":"\xc0 quelle fr\xe9quence les donn\xe9es SeroTracker sont-elles mises \xe0 jour ?","Answer":"Les donn\xe9es de SeroTracker sont mises \xe0 jour environ toutes les semaines. Notre \xe9quipe analyse la nouvelle litt\xe9rature chaque vendredi et les donn\xe9es sont ajout\xe9es au cours de la semaine suivante."},"Question5":{"Question":"Comment les donn\xe9es sont-elles visualis\xe9es sur la carte interactive?  ","Answer":"Les donn\xe9es qui sont sur AirTable sont ex\xe9cut\xe9es automatiquement \xe0 travers une pipeline de logiciels. Les donn\xe9es sont v\xe9rifi\xe9es et les informations suppl\xe9mentaires (telles que l\u2019emplacement g\xe9ographique de l\'\xe9tude) sont ajout\xe9es. Ces nouvelles donn\xe9es sont retenues dans un logiciel s\xe9par\xe9 - utilis\xe9 par le page \\"Explore\\"."},"Question6":{"Question":"Est-ce que je peux utiliser les donn\xe9es de SeroTracker pour effectuer ma propre analyse?  ","Answer":"Absolument! Notre base de donn\xe9es est gratuite pour tout le monde. Vous pouvez t\xe9l\xe9charger notre document .csv complet avec le bouton \\"T\xe9l\xe9charger CSV\\" au-dessus. Avant de vous fournier ces donn\xe9es, nous vous demandons de compl\xe9ter un questionnaire avec votre r\xf4le, votre affiliation acad\xe9mique (si pertinent), et le type de recherche que vous faites. Cette information nous aide beaucoup \xe0 cr\xe9er les donn\xe9es les plus utiles pour vous."},"Question7":{"Question":"Est-ce que je dois \xeatre un utilisateur de AirTable pour utiliser les donn\xe9es de SeroTracker?  ","Answer":"Non. Bien que nos donn\xe9es soient pr\xe9sent\xe9es dans un format AirTable, vous pouvez facilement le transformer en format Excel ou en autres formats. "},"Question8":{"Question":"Comment est-ce que les variables doivent \xeatre interpr\xe9t\xe9es?","Answer":"Veuillez consulter notre dictionnaire de donn\xe9es (avec le bouton associ\xe9 au dessus) pour les explications de nos variables, types des donn\xe9es, et descriptions. Il poss\xe8de aussi de l\u2019information \xe0 propos de notre collection de donn\xe9es. Le document est structur\xe9 de mani\xe8re  \xe0 faciliter la compr\xe9hension de notre base des donn\xe9es. "},"Question9":{"Question":"Comment les donn\xe9es de SeroTracker ont-elles \xe9t\xe9 utilis\xe9es par les autres?","Answer":{"Part1":"Les donn\xe9es de SeroTracker sont utilis\xe9es par beaucoup de professionnels de la sant\xe9 publique et par les agences de sant\xe9 telles que l\u2019Organisation Mondial de la Sant\xe9, et l\u2019Agence de la Sant\xe9 Publique du Canada. Dans la section \\"Publications\\" de notre site Web, vous pouvez acc\xe9der aux rapports, aux articles acad\xe9miques, et aux nouvelles/m\xe9dias avec SeroTracker. Notre","Part2":"la plus r\xe9cente analyse la s\xe9ropr\xe9valence mondiale de janvier \xe0 d\xe9cembre 2020."},"Links":{"Link1":"https://www.medrxiv.org/content/10.1101/2020.11.17.20233460v2"},"LinkTexts":{"LinkText1":"publication"}}},"DownloadAirtable":"Cliquez pour acc\xe9der et t\xe9l\xe9charger nos donn\xe9es de s\xe9ropr\xe9valence SARS-CoV-2 sur Airtable","DownloadCsv":"T\xe9l\xe9charger CSV","DownloadData":"T\xe9l\xe9charger les donn\xe9es","DownloadGithub":"Cliquez pour t\xe9l\xe9charger nos donn\xe9es de s\xe9ropr\xe9valence SARS-CoV-2 par programmation sur GitHub","EconomicsTeam":"\xc9quipe \xe9conomique","EndDate":"Date de fin","English":"anglais","Estimate":"Estimation","EstimateGrade":"Niveau d\'estimation","EstimateGradeOptions":{"Hyperlocal":"Hyperlocal","Local":"Local","National":"National","Regional":"R\xe9gional"},"EstimateRange":"Plage d\'estimation","ExecutiveDirector":"Directeur g\xe9n\xe9ral","Explore":"Explorer","ExploreBlurb":{"FirstParagraph":"SeroTracker est un tableau de bord et une plate-forme de donn\xe9es pour les enqu\xeates s\xe9rologiques sur le SRAS-CoV-2. Les anticorps contre le SRAS-CoV-2, le virus qui cause la COVID-19, indiquent une infection ou une vaccination ant\xe9rieure. Nous menons une revue syst\xe9matique continue pour suivre les enqu\xeates s\xe9rologiques (efforts de surveillance bas\xe9s sur les tests d\u2019anticorps) \xe0 travers le monde, et nous visualisons les r\xe9sultats sur ce tableau de bord.","SecondParagraph":"Vous pouvez configurer les donn\xe9es affich\xe9es utilisant le barre \'filtre\' \xe0 droite, et consulter la liste compl\xe8te des \xe9tudes que nous suivons sur la page \'Les donn\xe9es\'. "},"Filter":"Filtrer","FilterTooltip":"Filtrer le fichier de donn\xe9es SeroTracker selon l\'emplacement g\xe9ographique, l\'\xe9tude, les donn\xe9es d\xe9mographiques et le type de test. Seules les \xe9tudes correspondant aux filtres s\xe9lectionn\xe9s seront choisies.","For":"Pour","Footer":{"CiteAs":"Citez ceci comme: ","LastUpdated":"Base de donn\xe9es \xe0 jour jusqu\'au","LancetInfDis":"Lancet Inf Dis","Article":"article"},"French":"fran\xe7ais","FAQ":"FAQ","FrequentlyAskedQuestions":"Foire aux questions","GeneralSerotrackerCommunications":"Communications g\xe9n\xe9rales SeroTracker","GeneralTerms":"Conditions g\xe9n\xe9rales","Geographies":"G\xe9ographies","Geography":"G\xe9ographie","GeographyTooltip":"S\xe9lectionner les pays concern\xe9s.","Here":"Ici","IncludingParticipants":{"PartOne":"dont","PartTwo":"participants"},"IndustryMediaTitles":{"UnderstandingVirus":"Comprendre le virus et ses questions sans r\xe9ponse","KnowledgeHub":"Un centre de connaissances d\xe9velopp\xe9 afin de suivre les \xe9tudes sur les anticorps anti-SRAS-CoV","GlobalLaunch":"Lancement mondial de SeroTracker : un portail de tests d\'anticorps contre la COVID-19, en partenariat avec le groupe de travail sur l\'immunit\xe9 face \xe0 la COVID-19 du Canada","StudentsBuild":"Les \xe9tudiants cr\xe9ent un tableau de bord en ligne pour suivre les \xe9tudes sur les anticorps contre la COVID-19","NewlyLaunched":"SeroTracker, r\xe9cemment lanc\xe9, surveillera les efforts mondiaux de d\xe9pistage des anticorps","VeteranDoctor":"Et s\'il n\'y a pas de vaccin contre la COVID-19 ? Un m\xe9decin v\xe9t\xe9ran de la crise du VIH/SIDA propose des alternatives","CovidRadar":"Covid Radar: taxa de subnotifica\xe7\xe3o de casos de covid-19 na Rocinha chega a 62 vezes [Le taux de sous-d\xe9claration de la COVID-19 \xe0 Rocinha atteint 62 fois].","HowMany":"Combien d\'entre nous sont susceptibles d\'avoir attrap\xe9 le coronavirus jusqu\'\xe0 pr\xe9sent?","Lecturership":"Poste de charg\xe9 de cours auxiliaire pour l\'\xe9tudiant en doctorat du CHI Lab, Rahul Arora","HomeTests":"Des tests bon march\xe9, \xe0 domicile et quotidiens sont la premi\xe8re \xe9tape pour contenir la pand\xe9mie","Webinar":"\xabSeroTracker COVID-19 Journey\xbb: Webinaire HIMSS de la section des Prairies canadiennes","AlumniAndStudents":"Le \xabSerotracker\xbb : les anciens \xe9l\xe8ves et les \xe9tudiants d\xe9veloppent un outil pour suivre la propagation de la COVID-19","InfectionRate":"\xc9tude sur le taux mondial d\'infection par le coronavirus : le nombre de cas non d\xe9clar\xe9s","McKinseyHealthcare":"McKinsey sur les soins de sant\xe9 : bilan de l\'ann\xe9e 2020","JouleRecipients":"Joule annonce les laur\xe9ats des bourses \xabInnovation\xbb 2020","JouleInnovation":"SeroTracker : b\xe9n\xe9ficiaire de la bourse \xabInnovation\xbb de Joule","WhenEnd":"Quand la pand\xe9mie de COVID-19 prendra-t-elle fin?","JouleAnnounce":"Joule annonce les laur\xe9ats des bourses \xabInnovation\xbb 2020","StillVulnerable":"La population mondiale toujours vuln\xe9rable \xe0 la COVID-19","NYTIndia":"Quelle pourrait \xeatre la vraie ampleur de la propagation de Covid en Inde?","EconomistDeathToll":"Comment avons-nous estim\xe9 le v\xe9ritable nombre de morts de la pand\xe9mie?","EconomistDeathToll2":"Le v\xe9ritable bilan de la pand\xe9mie","InventoryEvidenceSynthesis":"Inventaire des meilleures synth\xe8ses de preuves"},"IndustryReportTitles":{"AugustReport":"Le bulletin d\'Ao\xfbt","BloodBank":"SeroTracker banque de sang s\xe9ropr\xe9valence Rapport pr\xe9liminaire","JulyReport":"Le bulletin de Juillet","JuneReport":"Le bulletin de Juin","MayReport":"Le bulletin de mai","OctoberReport":"Le bulletin d\'Octobre","PreliminaryReport":"Le bulletin pr\xe9liminaire","SeptemberReport":"Le bulletin de Septembre","YearInReview2020":"Bilan de l\u2019ann\xe9e 2020 de SeroTracker","InsuringTheEconomy":"Assurer l\'\xe9conomie contre une deuxi\xe8me vague de pand\xe9mie"},"ResearchArticleTitles":{"MedRxivNLP":"Une \xe9valuation concr\xe8te de la mise en oeuvre de la technologie NLP dans le triage d\'abstraits pour une revue syst\xe9matique","MedRxivMeta":"\xc9pid\xe9miologie mondiale de l\'infection par le SRAS-CoV-2: une revue syst\xe9matique et une m\xe9ta-analyse d\'\xe9tudes de s\xe9ropr\xe9valence standardis\xe9es bas\xe9es sur la population, janvier 2020-octobre 2021","MedRxivROB":"SeroTracker-ROB: r\xe8gles de d\xe9cision reproductibles pour l\'\xe9valuation du risque de biais des \xe9tudes de s\xe9ropr\xe9valence","MedRxivPrivate":"Adoption des programmes de d\xe9pistage du SRAS-CoV-2 sur le lieu de travail, mars 2020 \xe0 mars 2021","PlosOnePub":"S\xe9ropr\xe9valence globale des anticorps contre la SRAS-CoV-2: une revue syst\xe9matique et m\xe9ta-analyse","LancetID":"SeroTracker: un tableau de bord global de s\xe9ropr\xe9valence du SRAS-CoV-2","PrePrint":"Le\xe7ons d\'un examen rapide et syst\xe9matique du d\xe9but des SRAS-CoV-2 enqu\xeates s\xe9rologiques"},"BiblioDigestTitles":{"December":"Le bulletin de mise \xe0 jour de la litt\xe9rature de decembre","November":"Le bulletin de mise \xe0 jour de la litt\xe9rature de novembre","LateOctober":"Le bulletin de mise \xe0 jour de la litt\xe9rature de fin octobre","October":"Le bulletin de mise \xe0 jour de la litt\xe9rature de octobre","September":"Le bulletin de mise \xe0 jour de la litt\xe9rature de septembre","August":"Le bulletin de mise \xe0 jour de la litt\xe9rature d\'ao\xfbt","July":"Le bulletin de mise \xe0 jour de la litt\xe9rature de juillet","June":"Le bulletin de mise \xe0 jour de la litt\xe9rature de juin"},"BiblioDigests":"Les bulletins de mise \xe0 jour de la litt\xe9rature","InitInfoModalText":{"PartOne":"Bienvenue dans l\'onglet Analyse de SeroTracker ! Nous menons un examen syst\xe9matique des s\xe9rosondages du SRAS-CoV-2 et nous utilisons les donn\xe9es provenant de cet examen afin de constituer ce tableau de bord.","PartThree":"Ces estimations agr\xe9g\xe9es doivent \xeatre interpr\xe9t\xe9es avec prudence, surtout si les \xe9tudes concern\xe9es ne comprennent pas d\'\xe9chantillons repr\xe9sentatifs ou si elles pr\xe9sentent un risque \xe9lev\xe9 de partialit\xe9. Vous pouvez consulter les publications d\'origine plus en profondeur gr\xe2ce \xe0 la liste de r\xe9f\xe9rences en bas de page.","PartTwo":"Notre tableau de bord agr\xe8ge les estimations de s\xe9ropr\xe9valence pour chaque pays. Ces estimations agr\xe9g\xe9es comportent par d\xe9faut des estimations nationales et r\xe9gionales de s\xe9ropr\xe9valence dans la population g\xe9n\xe9rale ou chez les donneurs de sang. Elles excluent les estimations pr\xe9sent\xe9es uniquement dans l\'actualit\xe9."},"Insights":"Perspectives","Isotypes":"Isotypes","IsotypesReported":"Isotypes signal\xe9s","IsotypesReportedOptions":{"IgA":"IgA","IgG":"IgG","IgM":"IgM","IgMIgG":"IgM IgG"},"LancetArticle":"Num\xe9ro d\'identification Lancet","LancetID":"The Lancet Infectious Diseases","Language":"Langue","LastUpdatedTooltip":"SeroTracker est constamment mis \xe0 jour avec des r\xe9sultats d\'\xe9tudes s\xe9rologiques nouvellement parues. Les nouvelles \xe9tudes que nous trouvons sont incluses dans les 48 heures suivant leur publication.","Legalese":"Jargon juridique","LocalEstimateRange":"Plage d\'estimation locale","LocalEstimates":"Estimations locales","LocalStudyDetails":"\xc9tude locale","Location":"Lieu","Manufacturers":"Fabricants","ManuscriptAndPreprint":"Manuscrit et pr\xe9impression","ManuscriptAppendixText":{"FirstParagraph":"m\xe9thodes compl\xe8tes","SecondParagraph":"(de l\u2019annexe \xe0 notre revue syst\xe9matique compl\xe8te et m\xe9ta-analyse des enqu\xeates s\xe9rologiques SARS-CoV-2)"},"Map":"Carte","Media":"M\xe9dias","MediaMentions":"Mentions dans les m\xe9dias","MemorialUniversityOfNewfoundland":"Universit\xe9 comm\xe9morative de Terre-Neuve","PrivateSectorReports":"Rapports du secteur priv\xe9","Months":{"January":"janvier","February":"f\xe9vrier","March":"mars","April":"avril","May":"mai","June":"juin","July":"juillet","August":"ao\xfbt","September":"septembre","October":"octobre","November":"novembre","December":"d\xe9cembre"},"N":"N","Name":"Nom","NationalEstimateRange":"Plage d\'estimation nationale","NationalEstimates":"Estimations nationales","NationalStudyDetails":"\xc9tude nationale","NotApplicable":"","NoData":"Aucune donn\xe9e","NoDataAnalyze":{"PartOne":"Il n\'y pas de donn\xe9es correspondant a vos filtres.","PartTwo":"Veuillez modifier vos filtres et r\xe9essayer pour visualizer des r\xe9sultats."},"NationalStudies":"\xc9tudes nationale","RegionalStudies":"\xc9tudes r\xe9gionale","LocalStudies":"\xc9tudes locale","NotFound":{"PartOne":"Page Non Trouv\xe9e","PartTwo":"Nous n\'avons pas trouv\xe9 la page Web que vous cherchez.  Veuillez essayer un autre lien ou visiter notre page \xabExplorer\xbb.","Button":"Visiter Notre Page \xabExplorer\xbb"},"NotReported":"Non signal\xe9e","BestSeroprevalenceEstimate":"S\xe9ropr\xe9valence","VaccineRolloutStatus":"Circulation des vaccins pendant l\'\xe9tude","VaccinationPolicyLow":"Vaccins indisponibles","VaccinationPolicyMed":"Vaccins disponibles pour certains groupes","VaccinationPolicyHigh":"Vaccins disponibles pour la population enti\xe8re","NumberEstimates":"Nombre d\'estimations","NumSeroprevalenceEstimates":"Nombre d\'estimations de s\xe9ropr\xe9valence","Okay":"Ok, je comprends!","OptimisedFunctionality":"Pour une fonctionnalit\xe9 optimis\xe9e du site, veuillez nous rendre visite sur un appareil de bureau.","OurData":"Nos donn\xe9es","OurDataText":{"PointOne":"saisissent la totalit\xe9 des \xe9tudes indiquant des estimations de pr\xe9valence","PointTwo":"d\xe9crivent des \xe9tudes qui n\'ont pas encore signal\xe9 d\'estimations de s\xe9ropr\xe9valence","Text":"Le tableau ci-dessous d\xe9crit nos r\xe9sultats, y compris des informations d\xe9taill\xe9es pour chaque \xe9tude, chaque estimation de pr\xe9valence et les risques de partialit\xe9 associ\xe9s."},"OurProtocol":"Notre protocole","OverallRiskOfBias":"Risque g\xe9n\xe9ral de partialit\xe9","Paper":"Article","PaperText":"Vous trouverez notre premier manuscrit d\xe9crivant les enseignements des s\xe9rosondages jusqu\'au 1er mai sur","PaperTextTwo":"Pour plus d\'informations sur notre tableau de bord, consultez","Partnerships":"Partenariats","PartnershipsList":{"Canada":"Canada (GTIC)"},"PartnershipsPageTitle":{"Canada":"Groupe de travail canadien sur l\'immunit\xe9 contre le Covid-19"},"PartnershipsPageDescription":{"Canada":{"PartOne":"SeroTracker est soutenu financi\xe8rement par l\'Agence de la sant\xe9 publique du Canada par le biais du Groupe de travail sur l\u2019immunit\xe9 face \xe0 la COVID-19 (GTIC). Le GTIC a financ\xe9 de nombreuses enqu\xeates s\xe9rologiques de haut calibre parmi d\'autres recherches sur lesquelles vous pouvez en apprendre davantage sur","PartTwo":"leur site Web.","PartThree":"Ils fournissent \xe9galement des estimations mod\xe9lis\xe9es de la s\xe9ropr\xe9valence due \xe0 l\'infection dans la population canadienne que vous pouvez trouver","PartFour":"ici."}},"PartnershipsView":{"MapNote1":"La carte affiche des estimations pour toutes les estimations g\xe9ographiques (y compris les sous-estimations rapport\xe9es, par exemple les estimations r\xe9gionales provinciales rapport\xe9es dans une \xe9tude nationale). Les \xe9pingles sont dispos\xe9es autour du centre de leur(s) emplacement(s) g\xe9ographique(s).","MapNote2":"Le nombre de cas et de d\xe9c\xe8s (au milieu de l\'\xe9chantillonnage de l\'\xe9tude) est tir\xe9 au niveau national du SITE WEB (sous-source : coronavirus.jhu.edu)"},"Per100":" pour 100","PlannedSerosurveys":"S\xe9rosondages planifi\xe9s","Population":"Population","PopulationGroup":"Groupe de population","PopulationGroupOptions":{"All":"Tous","BloodDonors":"Donneurs de sang","Children":"Enfants","CommunityResident":"Habitant de la communaut\xe9","FactoryWorker":"Travailleur d\'usine","FirstResponders":"Premiers r\xe9pondants","GeneralPopulation":"Population g\xe9n\xe9rale","HealthCareWorkers":"Travailleurs de la sant\xe9","HotelStaffMember":"Membre d\'\xe9quipe h\xf4teli\xe8re","IndustrySpecificEmployees":"Employ\xe9s sp\xe9cifiques \xe0 une industrie","NonCovidHospitalizedPatients":"Patients hospitalis\xe9s hors COVID","NonCovidPatientsInHealthCareSettings":"Patients hors COVID dans des lieux de soins","PregnantOrParturientWomen":"Femmes enceintes ou parturientes","RelativeOfHealthCareWorker":"Proche d\'un travailleur de la sant\xe9","ResidualSera":"S\xe9rums r\xe9siduels","Students":"\xc9tudiants","Unspecified":"Non sp\xe9cifi\xe9"},"Populations":"Populations","PositiveCases":"Cas positifs","Prevalence":"Pr\xe9valence","PrevalenceEstimateDetails":"D\xe9tails de l\'estimation de pr\xe9valence","PrivacyPolicy":"Politique de confidentialit\xe9","Publication":"Publication","PublicationDescriptions":{"Publications":"Apprenez-en plus sur l\'impact de SeroTracker dans des articles de recherche, des r\xe9sum\xe9s et des mentions dans les m\xe9dias","ResearchArticles":"Articles de recherche \xe9valu\xe9s par des pairs et pr\xe9-imprim\xe9s publi\xe9s par l\'\xe9quipe SeroTracker","LiteratureUpdateReports":"Aper\xe7us mensuels et mises \xe0 jour sur les tendances dans la litt\xe9rature des enqu\xeates s\xe9rologiques et les param\xe8tres fournis par l\'OMS","GeneralSerotrackerCommunications":"Mises \xe0 jour et r\xe9flexions de l\'ensemble de l\'\xe9quipe SeroTracker","MediaMentions":"Publications m\xe9diatiques mondiales mettant en vedette SeroTracker","PrivateSectorReports":"Rapports sur les pratiques de d\xe9pistage et de test de la COVID-19 dans le secteur priv\xe9 canadien en 2020"},"Publications":"Publications","Published":"Publi\xe9","DataTable":"Table de donn\xe9es","RegionalEstimateRange":"Plage d\'estimation r\xe9gionale","RegionalEstimates":"Estimations r\xe9gionales","RegionalStudyDetails":"\xc9tude r\xe9gionale","RegulatoryApproval":"Autorisation r\xe9glementaire","Report":"Rapport","ReportsAndArticles":"Rapports et articles","ResearchArticles":"Articles de recherche","RiskOfBias":"risque de partialit\xe9","RiskOfBiasOptions":{"High":"\xc9lev\xe9","Low":"Faible","Moderate":"Moyen","Unclear":"Incertain"},"SampleSize":"Taille de l\'\xe9chantillon","Sampling":"\xc9chantillonnage","SamplingDates":"Dates d\'\xe9chantillonnage","SamplingMethod":"M\xe9thode d\'\xe9chantillonnage","SchoolName":{"Cumming":"\xc9cole de m\xe9decine Cumming","Schulich":"\xc9cole d\'ing\xe9nieurs Schulich"},"ScientificLead":"Responsable scientifique","SelectDate":"S\xe9lectionner une date...","Sensitivity":"Sensibilit\xe9","Seroprevalence":"S\xe9ropr\xe9valence","SeroprevalenceBy":"S\xe9ropr\xe9valence par","SeroPrevalenceByCountry":"Estimations cumulatives de s\xe9ropr\xe9valence dans diff\xe9rents pays","SeroprevalenceScale":"\xc9chelle de s\xe9ropr\xe9valence","SeroprevalenceStudies":"etudes de s\xe9ropr\xe9valence","SeroprevalenceScaleTooltip":"Cr\xe9\xe9 \xe0 partir de la transformation par logit de la valeur maximale afin de d\xe9terminer les \'coffres\'","SeroprevalenceTooltip":{"FirstParagraph":"Pr\xe9valence d\'anticorps contre le SRAS-CoV-2, cumul\xe9e dans les filtres que vous avez s\xe9lectionn\xe9s.","SecondParagraph":"NB: Cela ne devrait pas \xeatre interpr\xe9t\xe9e comme une estimation repr\xe9sentative de s\xe9ropr\xe9valence dans la r\xe9gion d\'int\xe9r\xeat, en particulier si les \xe9tudes agr\xe9g\xe9es ont biais\xe9 des \xe9chantillons","ThirdParagraph":"technique Pooling: effets fixes agr\xe9gation pond\xe9r\xe9s inverse variance des enregistrements avec taille de l\'\xe9chantillon sur MIN_DENOMINATOR."},"Serosurveys":"S\xe9rosondages","SerosurveysReportingPrevalence":"Pr\xe9valence de signalement des s\xe9rosondages","SeroprevalenceEstimatesInRegion":"Estimations de la s\xe9ropr\xe9valence dans Canada par zone g\xe9ographique","SeroTrackerTeam":"l\u2019\xe9quipe SeroTracker","Settings":"Param\xe8tres","Sex":"Sexe","SexOptions":{"Female":"Femme","Male":"Homme","Other":"Autre"},"Source":"Source","SourceType":"Type de source","SourceTypeOptions":{"JournalArticlePeerReviewed":"Article de revue (\xe9valu\xe9 par les pairs)","InstitutionalReport":"Rapport institutionnel","NewsAndMedia":"Actualit\xe9s et m\xe9dias","Preprint":"Pr\xe9impression","Publication":"Publication"},"Specificity":"Sp\xe9cificit\xe9","StartDate":"Date de d\xe9but","Status":"\xc9tat","StudiesPerPage":"\xc9tudes par page","Study":"\xc9tude","StudyDetailsAuthorString":{"LeadOrg":"Par FIRST_AUTHOR \xe0 LEAD_ORG","NoLeadOrg":"Par FIRST_AUTHOR"},"StudyDetailsPublishString":{"NoPublishDate":"Publi\xe9 par PUBLISHER","NoPublisher":"Publi\xe9 le PUBLISH_DATE","PublisherAndDate":"Publi\xe9 le PUBLISH_DATE par PUBLISHER"},"StudyInformation":"Informations sur l\'\xe9tude","StudyInformationTooltip":{"FirstParagraph":"Trier selon les d\xe9tails d\'\xe9tude, y compris le type de source (publication, pr\xe9impression, actualit\xe9 ou rapport), l\'\xe9tat de l\'\xe9tude (en cours, compl\xe9t\xe9e), et l\'alignement avec le protocole Unit\xe9.","SecondParagraph":{"PartOne":"Risque de partialit\xe9:","PartTwo":"Refl\xe8te la mesure dans laquelle la pr\xe9valence r\xe9elle peut \xeatre diff\xe9rente de la pr\xe9valence estim\xe9e par les examinateurs de SeroTracker en fonction de l\u2019outil d\u2019evaluation critique de l\u2019Institut Joanna Briggs."},"ThirdParagraph":{"PartOne":"Le protocole Unit\xe9 de l\u2019OMS:","PartTwo":"L\u2019OMS a developp\xe9 plusieurs protocoles standardis\xe9s pour les enqu\xeates sur la COVID-19:","PartThree":"Les \xe9tudes Unit\xe9.","PartFour":"S\xe9roTracker travaille avec l\u2019OMS pour soutenir et visualiser les \xe9tudes s\xe9ro-\xe9pid\xe9miologique sur les populations align\xe9es avec le protocole Unit\xe9."}},"StudySize":"Taille de l\'\xe9tude","StudyStatus":"\xc9tat de l\'\xe9tude","StudyStatusOptions":{"Completed":"Compl\xe9t\xe9e","Ongoing":"En cours"},"StudyType":"Type d\'\xe9tude","StudyName":"Nom de l\'\xe9tude","StudyPins":"Afficher les lieux d\'\xe9tude","Sublocal":"Sous-local","SublocalEstimateRange":"Plage d\'estimation sous-locale","SublocalEstimates":"Estimations sous-locales","SublocalStudyDetails":"\xc9tude sous-locale","SubmitSource":"Soumettre un article","Summary":"R\xe9sum\xe9","SummaryStatistics":"Statistiques sommaires","Team":"L\'\xe9quipe","TeamLead":"Responsables d\'\xe9quipes","TemporaryMaintenance":"Entretien provisoire","TemporaryMaintenanceDescription":"Nous sommes en cours de maintenance programm\xe9e, le service sera de retour sous peu.","TermsOfUse":"Conditions d\'utilisation","TestDetails":"D\xe9tails des tests","TestInformation":"Informations sur les tests","TestInformationTooltip":"Trier par d\xe9tail de test, y compris le type d\'examen et l\'isotype d\'anticorps.","TestsAdministered":"Tests d\'anticorps administr\xe9s","TestType":"Type de test","TestTypeOptions":{"Neutralization":"Neutralisation","Clia":"CLIA","Elisa":"ELISA","Lfia":"LFIA","Other":"Autre"},"TestUsed":"Test utilis\xe9","ThisForm":"ce formulaire","Today":"Aujourd\'hui","TotalEstimates":"Estimations totales","TotalTests":"Total des tests","UnityBanner":{"Currently":"En ce moment, seulement les \xe9tudes align\xe9es sur le ","ProtocolLink":"protocole s\xe9ro-\xe9pid\xe9miologique de l\'OMS Unity ","ViewDatabase":"sont affich\xe9es. Pour afficher notre base de donn\xe9es compl\xe8te, d\xe9cochez le filtre","WHOUnityFilter":"seulement OMS Unity.","Filter":""},"UnityStudiesOnly":"Seulement OMS Unity","UnityStudiesOnlyLong":"Afficher seulement des \xe9tudes align\xe9es avec l\'OMS-UNITY","UniversityOf":"Universit\xe9 de NAME","UseOfData":"L\'utilisation de ces donn\xe9es est r\xe9gie par SeroTracker de","Vaccinations":"Vaccins","ViewPartnership":"Voir le partenariat","ViewFile":"Consulter le fichier","ViewHere":"Consulter ici","Welcome":"Bienvenue \xe0 SeroTracker","WhatWeDoText":{"FirstParagraph":"Chez SeroTracker, nous collectons les donn\xe9es publi\xe9es et non publi\xe9es de s\xe9ropr\xe9valence pour informer une revue syst\xe9matique et m\xe9ta-analyse du SRAS-CoV-2 au niveau mondial. Les donn\xe9es sont collect\xe9es pour l\u2019estimation primaire pour chaque source et certains sous-groupes pertinents. Nos m\xe9thodes compl\xe8tes sont accessibles dans le protocole. ","SecondParagraph":"Nous produisons les donn\xe9es pour l\u2019usage acad\xe9mique et publique sur notre site Web. Notre objectif est de mettre \xe0 jour nos donn\xe9es chaque semaine. Pour l\u2019information suppl\xe9mentaire en addition du sommaire g\xe9n\xe9ral qui suit, s\'il vous pla\xeet consultez nos m\xe9thodes compl\xe8tes, accessible dans le protocole de SeroTracker. "},"WhoDisclaimerSmall":"Les appellations employ\xe9es dans la pr\xe9sente publication et la pr\xe9sentation des donn\xe9es qui y figurent n\u2019impliquent de la part de l\u2019OMS aucune prise de position quant au statut juridique des pays, territoires, villes ou zones, ou de leurs autorit\xe9s, ni quant au trac\xe9 de leurs fronti\xe8res ou limites. Les traits discontinus form\xe9s d\u2019une succession de points ou de tirets sur les cartes repr\xe9sentent des fronti\xe8res approximatives dont le trac\xe9 peut ne pas avoir fait l\'objet d\'un accord d\xe9finitif.","WhoDisclaimer":"Les appellations employ\xe9es dans la pr\xe9sente publication et la pr\xe9sentation des donn\xe9es qui y figurent n\u2019impliquent de la part de l\u2019OMS aucune prise de position quant au statut juridique des pays, territoires, villes ou zones, ou de leurs autorit\xe9s, ni quant au trac\xe9 de leurs fronti\xe8res ou limites. Les traits discontinus form\xe9s d\u2019une succession de points ou de tirets sur les cartes repr\xe9sentent des fronti\xe8res approximatives dont le trac\xe9 peut ne pas avoir fait l\'objet d\'un accord d\xe9finitif. La mention de certaines firmes ou de produits commerciaux dans le mat\xe9riel publi\xe9 sur cette plateforme ne signifie pas que ces firmes et ces produits commerciaux sont agr\xe9\xe9s ou recommand\xe9s par l\u2019OMS de pr\xe9f\xe9rence \xe0 d\u2019autres de nature analogue qui ne sont pas mentionn\xe9s. Sauf erreur ou omission, une majuscule initiale indique qu\u2019il s\u2019agit d\u2019un nom d\xe9pos\xe9. La mention de certains mat\xe9riels dans cette plateforme ne signifie pas que ces mat\xe9riels sont agr\xe9\xe9s ou recommand\xe9s par l\u2019OMS ni que ces derniers ont v\xe9rifi\xe9 les informations contenues dans ces mat\xe9riels. La plateforme a \xe9t\xe9 cr\xe9\xe9e sans aucune garantie, expresse ou implicite de la part de l\u2019OMS. La responsabilit\xe9 de l\'interpr\xe9tation et de l\'utilisation dudit mat\xe9riel incombe au lecteur. En aucun cas, l\u2019OMS ne saurait \xeatre tenus responsable des pr\xe9judices subis du fait de son utilisation.","WhoSerotrackAndPartnersDisclaimerSmall":"Les appellations employ\xe9es dans la pr\xe9sente publication et la pr\xe9sentation des donn\xe9es qui y figurent n\u2019impliquent de la part de l\u2019OMS, SeroTracker ou les partenaires de SeroTracker aucune prise de position quant au statut juridique des pays, territoires, villes ou zones, ou de leurs autorit\xe9s, ni quant au trac\xe9 de leurs fronti\xe8res ou limites. Les traits discontinus form\xe9s d\u2019une succession de points ou de tirets sur les cartes repr\xe9sentent des fronti\xe8res approximatives dont le trac\xe9 peut ne pas avoir fait l\'objet d\'un accord d\xe9finitif.","WhoSerotrackAndPartnersDisclaimer1":" Les appellations employ\xe9es dans la pr\xe9sente publication et la pr\xe9sentation des donn\xe9es qui y figurent n\u2019impliquent de la part de l\u2019OMS aucune prise de position quant au statut juridique des pays, territoires, villes ou zones, ou de leurs autorit\xe9s, ni quant au trac\xe9 de leurs fronti\xe8res ou limites. Les traits discontinus form\xe9s d\u2019une succession de points ou de tirets sur les cartes repr\xe9sentent des fronti\xe8res approximatives dont le trac\xe9 peut ne pas avoir fait l\'objet d\'un accord d\xe9finitif","WhoSerotrackAndPartnersDisclaimer2":"La mention de certaines firmes ou de produits commerciaux dans le mat\xe9riel publi\xe9 sur cette plateforme ne signifie pas que ces firmes et ces produits commerciaux sont agr\xe9\xe9s ou recommand\xe9s par l\u2019OMS, SeroTracker ou les partenaires de SeroTracker de pr\xe9f\xe9rence \xe0 d\u2019autres de nature analogue qui ne sont pas mentionn\xe9s. Sauf erreur ou omission, une majuscule initiale indique qu\u2019il s\u2019agit d\u2019un nom d\xe9pos\xe9. La mention de certains mat\xe9riels dans cette plateforme ne signifie pas que ces mat\xe9riels sont agr\xe9\xe9s ou recommand\xe9s par l\u2019OMS, SeroTracker ou les partenaires de SeroTracker, ni que ces derniers ont v\xe9rifi\xe9 les informations contenues dans ces mat\xe9riels.","WhoSerotrackAndPartnersDisclaimer3":"La plateforme a \xe9t\xe9 cr\xe9\xe9e sans aucune garantie, expresse ou implicite de la part de l\u2019OMS, SeroTracker ou les partenaires de SeroTracker. La responsabilit\xe9 de l\'interpr\xe9tation et de l\'utilisation dudit mat\xe9riel incombe au lecteur. En aucun cas, l\u2019OMS, SeroTracker ou les partenaires de SeroTracker ne sauraient \xeatre tenus responsables des pr\xe9judices subis du fait de son utilisation.","WhoUnity":"L\'OMS-UNITY"}')},335:function(e){e.exports=JSON.parse('{",":",","95%ConfidenceInterval":"95% Konfidenzintervall","95%ConfidenceIntervalTooltip":"Breitere Fehlerbalken weisen auf eine gr\xf6\xdfere Unsicherheit in der aggregierten Seropr\xe4valenzsch\xe4tzung hin.","About":"\xdcber uns","AboutPage":{"AboutSection":{"Covid19ImmunityTaskForce":"COVID-19-Arbeitsgruppe Immunit\xe4t.","GlobalSerologicalKnowledgeHub":"Globaler serologischer Wissenshub","HealthInformatics":"Zentrum f\xfcr Gesundheitsinformatik an der Universit\xe4t Calgary.","HostedAt":"SeroTracker wird auch gehostet beim der","MappingTheExtent":"Die COVID-19-Arbeitsgruppe Immunit\xe4t bildet das Ausma\xdf der SARS-CoV-2-Infektionen in Kanada ab; SeroTracker liefert auch Inhalte f\xfcr ihre","PartOne":"SeroTracker fasst die Ergebnisse von Tausenden von COVID-19-Seropr\xe4valenzstudien weltweit zusammen und bietet eine Datenplattform sowie ein interaktives Dashboard f\xfcr die serologische Surveillance von SARS-CoV-2.","PartTwo":"Best\xe4tigte COVID-19-F\xe4lle sind nur die Spitze des Eisbergs \u2013 die tats\xe4chliche Zahl der SARS-CoV-2-Infektionen wird untersch\xe4tzt, da viele Menschen asymptomatisch infiziert sind oder keinen Zugang zu diagnostischen Tests haben. Im Gegensatz dazu werden bei Seropr\xe4valenzstudien Antik\xf6rper gegen SARS-CoV-2 in der Bev\xf6lkerung gemessen. Da Menschen, bei denen diese Antik\xf6rper vorliegen, zuvor infiziert waren oder geimpft wurden, sind diese Studien f\xfcr das Verst\xe4ndnis des wahren Ausma\xdfes der Pandemie und f\xfcr die Messung der Antik\xf6rperspiegel in der Bev\xf6lkerung von entscheidender Bedeutung.","PublicHealthAgency":"Agentur f\xfcr \xf6ffentliche Gesundheit, Kanada","SupportedBy":"SeroTracker wird unterst\xfctzt von der","ThroughThe":"durch die","UnityStudies":"Seropr\xe4valenzstudien von WHO Unity","WHO1":"SeroTracker arbeitet mit dem/der","WHO2":"zur Visualisierung und Synthese von Ergebnissen aus den","WHO3":"SeroTracker und die Weltgesundheitsorganisation bedanken sich beim Bundesministerium f\xfcr Gesundheit (BMG) f\xfcr die COVID-19-Forschungs- und Entwicklungsmittel zur Unterst\xfctzung dieser Bem\xfchungen.","WorldHealthOrganization":"Weltgesundheitsorganisation"},"ContactSection":{"BulletPointFive":{"PartOne":"Um auf","PartThree":"aufmerksam zu machen, oder auf Studien, die wir noch nicht erfasst haben, f\xfcllen Sie bitte ","PartTwo":"neue Seropr\xe4valenzstudien zu SARS-CoV-2","PartFour":"aus."},"BulletPointOne":{"PartFour":"und Kelly Johnston unter ","PartOne":"Bitte richten Sie alle Anfragen zu SeroTracker (z. B. wenn Sie unsere Bem\xfchungen unterst\xfctzen wollen, mit uns zusammenarbeiten m\xf6chten oder als Journalist*in an einer Berichterstattung \xfcber unsere Ergebnisse interessiert sind) an Rahul Arora unter ","PartThree":"Journalist*innen und Medienvertreter*innen: Bitte kontaktieren Sie Caroline Phaneuf unter ","PartTwo":"und Tingting Yan unter "},"SectionOne":"Wir sind ein interdisziplin\xe4res Team von Forschern und Ingenieuren der Universit\xe4t Oxford, der Universit\xe4t Toronto, der Universit\xe4t Waterloo, der Universit\xe4t Calgary und der Harvard University."},"Headers":{"AboutSeroTracker":"\xdcber SeroTracker","ContactUs":"Kontaktieren Sie uns","OurTeam":"Unser Team"},"SubHeaders":{"Alumni":"Ehemalige","DataCuration":"Team f\xfcr Evidenzsynthese und Datenkuration","DataInfrastructure":"Team Dateninfrastruktur und -analyse","GlobalPartnerships":"Team f\xfcr globale Gesundheitspartnerschaften","DevelopmentTeam":"Entwicklungsteam","ProjectStaff":"Projektmitarbeitende","ScientificAdvisors":"Wissenschaftliche Beraterinnen","TeamLead":"Teamleitung"},"Mapbox":"unterst\xfctzt die Kartierungsinfrastruktur von SeroTracker"},"Accept":"Akzeptieren","AcceptCookies":"Cookies akzeptieren","AccessGithub":"Auf Github zugreifen","AdditionalGraphs":"Zus\xe4tzliche Schaubilder","Age":"Alter","AgeGroup":"Altersgruppe","AgeOptions":{"Adults1864Years":"Erwachsene (18-64)","ChildrenAndYouth017Years":"Kinder und jugendliche (0-17)","Seniors65Years":"Senioren (65+)"},"AggregatedPrevalence":"Aggregierte Pr\xe4valenz","Aggregating":"Aggregieren","AnalysisMethods":{"FirstParagraph":{"FirstSentence":"Die f\xfcr jedes Land und jeden Faktor angegebene Seropr\xe4valenz wird berechnet durch ","SecondSentence":"alle Seropr\xe4valenzsch\xe4tzungen, die den von Ihnen angegebenen Filtern entsprechen."},"SecondParagraph":"Standard-Filter: Landes- bzw. gebietsweite Sch\xe4tzungen in der Allgemeinbev\xf6lkerung und bei Blutspendenden.","ThirdParagraph":"Diese aggregierten Sch\xe4tzungen sollten mit Vorsicht interpretiert werden, insbesondere wenn die Studien, die aggregiert wurden, keine repr\xe4sentativen Stichproben enthielten oder ein hohes Verzerrungspotenzial aufwiesen.","Title":"Analysemethoden","Tooltip":"Die verwendete Aggregationsmethode ist eine mit fixen Effekten und inverser Varianz gewichtete Meta-Analyse der Pr\xe4valenz, wobei die Freeman-Tukey-Transformation mit doppeltem Arkussinus zur Stabilisierung der Varianz verwendet wird. Datens\xe4tze \xfcber dem Stichprobenumfang MIN_DENOMINATOR werden ber\xfccksichtigt."},"Analyze":"Analysieren","AntibodyTarget":"Antik\xf6rper-Target","AntibodyTargetOptions":{"EnvelopeProtein":"H\xfcllprotein","MembraneProtein":"Membranprotein","NR":"NR","NotReported":"Nicht berichtet","Nucleocapsid(N-protein)":"Nukleokapsid (N-Protein)","Spike":"Spike","WholeVirusAntigen":"Vollvirus-Antigen"},"Article":"Artikel","Authors":"Autoren","AuthorAndLeadOrganizationNotReported":"Autor und federf\xfchrende Organisation nicht angegeben","BiblioDigestCard":{"Title":"Wichtige Erkenntnisse von Serotracker","Published":"Ver\xf6ffentlicht:","NewSerosurveys":"Neue serosurveys identifiziert","AFRO":"Afrikanisch","EMRO":"\xd6stliches Mittelmeer","EURO":"Europ\xe4isch","PAHO":"Region Amerikas","SEARO":"S\xfcdostasien","WPRO":"Westpazifik","NonMember":"Nichtmitgliedstaaten","NewSources":"Neue quellen hinzugef\xfcgt"},"BestSeroprevalenceEstimate":"Beste Sch\xe4tzung der Seropr\xe4valenz","BlankUniversity":"NAME Universit\xe4t","ByCountry":"Nach Land","ByPopulation":"Nach Bev\xf6lkerung,","CentreHealthInformatics":"Zentrum f\xfcr Gesundheitsinformatik","ChangeLog":"\xc4nderungsprotokoll","ClearAllFilters":"Alle Filter l\xf6schen","CPPInvestmentBoard":"CPP-Investitionsausschuss","ChangeSettings":"Einstellungen \xe4ndern","CoDirector":"Co-Direktor","ContactUs":"Kontaktieren Sie uns","CookiePolicy":"Cookie-Richtlinie","CookiePolicyBody":"Wir verwenden Cookies, um die Benutzerfreundlichkeit zu verbessern; wir sammeln niemals pers\xf6nliche Daten. Durch die Nutzung unserer Website erkl\xe4ren Sie, dass Sie unsere ","Countries":"L\xe4nder","CountriesIncluded":{"PartOne":"mit","PartTwo":"L\xe4ndern und Regionen"},"CountriesAndAreas":"L\xe4ndern und Regionen","CountryEstimatesExist":"Sch\xe4tzungen der Seropr\xe4valenz","CountryEstimatesNotExist":"Keine Sch\xe4tzungen der Seropr\xe4valenz","CountryOptions":{"England":"England","Iran":"Iran","Scotland":"Schottland","UnitedStates":"Vereinigte Staaten"},"COVIDImmunityTaskForce":"Covid-19-Arbeitsgruppe Immunit\xe4t","Dashboard":"Dashboard","Data":"Daten","DatabaseUptoDateTo":"Datenbank aktuell bis","DataDictionary":"Datenw\xf6rterbuch","DataDictionaryText":{"FirstParagraph":"Weitere Informationen und Zusammenh\xe4nge zu unseren Daten finden Sie in unserer/m","SecondParagraph":"und"},"DataDownload":"Um eine Liste aller Studien in unserer Datenbank und eine Zusammenfassung der gesch\xe4tzten Seropr\xe4valenz herunterzuladen, klicken Sie bitte auf den Link \\"CSV herunterladen\u201c unten rechts auf dieser Seite. Wenn Sie zus\xe4tzliche Daten oder Informationen zu diesen Daten f\xfcr Ihre Analyse ben\xf6tigen, wenden Sie sich bitte an die","DateRange":"Datumsbereich","DateRangeTooltip":"Studien nach dem Enddatum der Stichprobe filtern.","Demographics":"Demografische Daten","DemographicsTooltip":"Filtern Sie nach demografischen Variablen, einschlie\xdflich Bev\xf6lkerungsgruppe, Geschlecht und Altersgruppe ","Details":"Einzelheiten","DisclaimerFooter":"*Die Vertreterinnen und Vertreter von SeroTracker sind auf der SeroTracker-Website aufgef\xfchrt.","DisclaimerList1":"Diese Website und ihr Inhalt, einschlie\xdflich aller Daten, Kartierungen/Mapping und Analysen (\\"Website\u201c) \u2013 Copyright 2020 SeroTracker, alle Rechte vorbehalten \u2013 werden ausschlie\xdflich f\xfcr gemeinn\xfctzige \xf6ffentliche Gesundheits-, Bildungs- und akademische Forschungszwecke bereitgestellt. Wenn Sie einen medizinischen Rat oder eine medizinische Anleitung suchen, sollten Sie sich nicht auf diese Website verlassen.","DisclaimerList2":"Die Nutzung der Website durch Vertreter wirtschaftlicher Interessen bzw. zu Handelszwecken ohne ausdr\xfcckliche schriftliche Genehmigung durch eine/n Vertreter/in* von SeroTracker ist strengstens untersagt. Die Weiterverbreitung der Website oder des der Website zugrundeliegenden aggregierten Datensatzes ohne ausdr\xfcckliche schriftliche Genehmigung eines/r Vertreters/in* von SeroTracker ist ebenfalls strengstens untersagt.","DisclaimerList3":"Wenn Sie Informationen von der Website nutzen oder auf die Website verlinken, geben Sie bitte die SeroTracker-Website der SeroTracker Collaboration als Quelle an.","DisclaimerList4":"Die Website st\xfctzt sich auf \xf6ffentlich verf\xfcgbare Daten aus verschiedenen Quellen, die nicht immer \xfcbereinstimmen. Das SeroTracker-Team und die COVID-19-Arbeitsgruppe Immunit\xe4t lehnen hiermit jegliche Zusicherungen und Gew\xe4hrleistungen in Bezug auf die Website ab, einschlie\xdflich der Genauigkeit, der Gebrauchstauglichkeit, der Zuverl\xe4ssigkeit, der Vollst\xe4ndigkeit und der Nicht-Verletzung der Rechte Dritter.","DisclaimerList5":"Jegliche Nutzung der Namen, Logos, Warenzeichen und/oder Handelsaufmachungen von SeroTracker oder der COVID-19-Arbeitsgruppe Immunit\xe4t auf sachlich falscher Weise oder zu Marketing-, Werbe- oder kommerzielle Zwecke ohne ausdr\xfcckliche schriftliche Genehmigung eines/r Vertreters/in* von SeroTracker ist strengstens verboten.","DisclaimerList6":"Diese Gesch\xe4ftsbedingungen k\xf6nnen sich \xe4ndern. Mit der Nutzung der Website erkl\xe4ren Sie sich mit diesen Gesch\xe4ftsbedingungen sowie mit allen k\xfcnftigen \xc4nderungen einverstanden.","DisclaimerListHeader":"Gesch\xe4ftsbedingungen f\xfcr die Nutzung der Website:,","DropdownQuestions":{"Question1":{"Question":"Woher kommen die Daten von SeroTracker?","Answer":{"Part1":"Wir sammeln alle Seropr\xe4valenzdaten aus ver\xf6ffentlichten, begutachteten Forschungsartikeln, Preprints, Berichten und Medien (unver\xf6ffentlichte graue Literatur). Daten zum Impfstatus und zur Fallzahl werden aus dem","Part2":"gezogen. Die Quellen, die bisher in unser Dashboard eingeflossen sind, finden Sie in der folgenden Tabelle."},"Links":{"Link1":"https://github.com/owid/covid-19-data"},"LinkTexts":{"LinkText1":"OWID GitHub repository. "}},"Question2":{"Question":"Wie sammelt SeroTracker seine Daten?","Answer":"Wir f\xfchren regelm\xe4\xdfige Recherchen in verschiedenen Datenbanken durch, darunter Medline, EMBASE, Web of Science und Europe PMC, sowie gezielte Google-Suchen. Dar\xfcber hinaus kann jeder \xfcber die Schaltfl\xe4che \u201cQuelle einreichen\u201c Quellen einreichen, die wir pr\xfcfen und in unseren Review aufnehmen k\xf6nnen."},"Question3":{"Question":"Wie extrahiert SeroTracker Daten aus ihren Quellen?","Answer":"Wir verf\xfcgen \xfcber ein umfangreiches, in Gesundheitswissenschaften und Epidemiologie geschultes Forschungsteam, das Artikel manuell \xfcberpr\xfcft und Sch\xe4tzungen der Seropr\xe4valenz in AirTable, unserer Datenbankverwaltungssoftware, erfasst. Die Prozesse und Regeln, die wir bei der Datenextraktion befolgen, sind in unserem Studienprotokoll und im AirTable-Datenw\xf6rterbuch zu finden."},"Question4":{"Question":"Wie oft werden die SeroTracker-Daten aktualisiert?","Answer":"Die SeroTracker-Daten werden ungef\xe4hr jede Woche aktualisiert. Unser Team scannt jeden Freitag neue Literatur und die Daten werden im Laufe der folgenden Woche hinzugef\xfcgt."},"Question5":{"Question":"Wie werden die Daten von SeroTracker auf der Karte angezeigt?","Answer":"Die in Airtable eingegebenen Daten durchlaufen automatisch eine Software-Pipeline, die sie bereinigt und zus\xe4tzliche Informationen berechnet (z. B. die geografischen Koordinaten einer Studie). Die Ergebnisse der Pipeline werden dann in einer separaten Datenbank gespeichert, die von serotracker.com abgefragt wird, um die Registerkarte \u201cExplore\u201c zu bedienen.."},"Question6":{"Question":"Kann ich die Daten von SeroTracker f\xfcr meine eigene Analyse herunterladen?","Answer":"Ja, unsere Daten sind quelloffen und k\xf6nnen von jedermann frei genutzt werden. Sie k\xf6nnen unsere vollst\xe4ndige .csv-Datei \xfcber die Schaltfl\xe4che \u201cDownload CSV\u201c (siehe oben) herunterladen. Sie werden zun\xe4chst gebeten, ein Formular auszuf\xfcllen, in dem Sie Ihre Funktion, Ihre Zugeh\xf6rigkeit (falls relevant) und die Art der von Ihnen durchgef\xfchrten Forschungsarbeiten angeben \u2013 so k\xf6nnen wir Datens\xe4tze erstellen, die f\xfcr Sie am n\xfctzlichsten sind."},"Question7":{"Question":"Muss ich ein AirTable-Benutzer sein, um die Daten von SeroTracker zu nutzen?","Answer":"Nein. Obwohl unsere Daten in einer AirTable-Datei dargestellt werden, k\xf6nnen Sie diese problemlos in Excel oder andere Formate exportieren."},"Question8":{"Question":"Wie interpretiere ich die Variablen im Datensatz von SeroTracker?","Answer":"In unserem Datenlexikon (\xfcber die oben erw\xe4hnte Schaltfl\xe4che) finden Sie Erkl\xe4rungen zu unseren Variablen, Datentypen und Beschreibungen sowie einen Einblick in die Art und Weise, wie unsere Daten von unserem Forschungsteam erhoben werden. Sie ist so aufgebaut, dass sie die Interpretation unseres herunterladbaren Datensatzes erleichtert. "},"Question9":{"Question":"Wie haben andere dieSeroTracker-Daten verwendet?","Answer":{"Part1":"Die Daten von SeroTracker werden von vielen Fachleuten des \xf6ffentlichen Gesundheitswesens und von Gesundheitsbeh\xf6rden wie der Weltgesundheitsorganisation und der Agentur f\xfcr \xf6ffentliche Gesundheit, Kanada, verwendet, um nur einige zu nennen. Die Registerkarte \u201cEinblicke/Insights\u201c enth\xe4lt Links zu internen Berichten, von uns erstellten Ver\xf6ffentlichungen sowie zu Berichten \xfcber SeroTracker-Daten und -Arbeiten in den Medien. Unsere neueste ","Part2":"analysiert die weltweite Seropr\xe4valenz von Januar bis Dezember 2020."},"Links":{"Link1":"https://www.medrxiv.org/content/10.1101/2020.11.17.20233460v2"},"LinkTexts":{"LinkText1":"Ver\xf6ffentlichungen"}}},"DownloadAirtable":"Klicken Sie hier, um unsere SARS-CoV-2 Seropr\xe4valenzdaten programmatisch auf Airtable herunterzuladen","DownloadCsv":"CSV herunterladen","DownloadData":"Daten herunterladen","DownloadGithub":"Klicken Sie hier, um unsere SARS-CoV-2 Seropr\xe4valenzdaten programmatisch auf GitHub herunterzuladen","EconomicsTeam":"Team Wirtschaft","EndDate":"Enddatum","English":"Englisch","Estimate":"Sch\xe4tzung","EstimateGrade":"Sch\xe4tzungsebene","EstimateGradeOptions":{"Hyperlocal":"Hyperlokal","Local":"Lokale","National":"Landesweit/Gebietsweit","Regional":"Regionale"},"EstimateRange":"Sch\xe4tzbereich","ExecutiveDirector":"Exekutivdirektor","Explore":"Erkunden/Explore","ExploreBlurb":{"FirstParagraph":"SeroTracker ist eine Dashboard- und Datenplattform f\xfcr SARS-CoV-2-Serosurveys.","SecondParagraph":"Wir f\xfchren einen fortlaufenden systematischen Review durch, um Serosurveys (auf Antik\xf6rpertests basierende Surveillancema\xdfnahmen) auf der ganzen Welt zu verfolgen und die Ergebnisse auf diesem Dashboard sichtbar zu machen.","ThirdParagraph":"Antik\xf6rper gegen SARS-CoV-2 \u2013 das Virus, das COVID-19 verursacht \u2013 weisen auf eine fr\xfchere Infektion oder Impfung hin."},"Filter":"Filter","FilterTooltip":"Filtern Sie den SeroTracker-Datensatz nach geographischen Gegebenheiten, nach Studie, Demografie und Test. Es werden nur Studien ber\xfccksichtigt, die allen aufgef\xfchrten Filtern entsprechen.,","For":"F\xfcr","Footer":{"CiteAs":"Zitieren Sie bitte als:","LastUpdated":"Datenbank aktuell bis","LancetInfDis":"Lancet Inf Dis","Article":"Artikel"},"French":"Fran\xe7ais","FAQ":"FAQ","FrequentlyAskedQuestions":"H\xe4ufig gestellte Fragen","GeneralSerotrackerCommunications":"Allgemeine SeroTracker-Kommunikation","GeneralTerms":"Allgemeine Bedingungen ","Geographies":"Geografien","Geography":"Geographie","GeographyTooltip":"W\xe4hlen Sie die L\xe4nder aus, die Sie interessieren.","Here":"Hier","IncludingParticipants":{"PartOne":"einschlie\xdflich","PartTwo":"Teilnehmenden"},"IndustryMediaTitles":{"UnderstandingVirus":"Das Virus und seine unbeantworteten Fragen verstehen","KnowledgeHub":"Wissenshub, der zur Verfolgung von SARS-CoV-Antik\xf6rperstudien entwickelt wurde","GlobalLaunch":"Weltweiter Start von SeroTracker: ein Hub f\xfcr COVID-19-Antik\xf6rpertests in Zusammenarbeit mit der kanadischen COVID-19-Arbeitsgruppe Immunit\xe4t","StudentsBuild":"Studenten erstellen Online-Dashboard zur Verfolgung von COVID-19-Antik\xf6rperstudien","NewlyLaunched":"Der neu gestartete SeroTracker wird die weltweiten Bem\xfchungen um Antik\xf6rpertests \xfcberwachen","VeteranDoctor":"Was ist, wenn es keinen COVID-19-Impfstoff gibt? Ein erfahrener Arzt der HIV/AIDS-Krise bietet Alternativen","CovidRadar":"Covid-Radar: taxa de subnotifica\xe7\xe3o de casos de covid-19 na Rocinha chega a 62 vezes [Untererfassungsfaktor f\xfcr COVID-19 erreicht 62 in Rocinha].","HowMany":"Wie viele von uns d\xfcrften uns bisher mit dem Coronavirus angesteckt haben?","Lecturership":"Lehrauftrag f\xfcr den CHI-Lab-DPhil-Studenten Rahul Arora","HomeTests":"Billige, t\xe4gliche Tests f\xfcr Zuhause sind der erste Schritt zur Eind\xe4mmung der Pandemie","Webinar":"SeroTracker COVID-19-Reise: Webinar von HIMSS, Ortsverband Kanada","AlumniAndStudents":"Der Serotracker: Ehemalige und gegenw\xe4rtige Studenten entwickeln Instrument zur Verfolgung der Verbreitung von Covid-19","InfectionRate":"Studie \xfcber die weltweite Infektionsrate mit dem Coronavirus: Anzahl der nicht gemeldeten F\xe4lle","McKinseyHealthcare":"McKinsey \xfcber das Gesundheitswesen: Das Jahr 2020 im R\xfcckblick","JouleRecipients":"Joule gibt die Empf\xe4ngerinnen und Empf\xe4nger der Innovationsf\xf6rderung 2020 bekannt","JouleInnovation":"SeroTracker: Empf\xe4ngerin der Joule-Innovationsf\xf6rderung","WhenEnd":"Wann wird die COVID-19-Pandemie enden?","JouleAnnounce":"Joule gibt die Empf\xe4ngerinnen und Empf\xe4nger der Innovationsf\xf6rderung 2020 bekannt","StillVulnerable":"Die Weltbev\xf6lkerung ist immer noch anf\xe4llig f\xfcr COVID-19","NYTIndia":"Wie hoch k\xf6nnte die tats\xe4chliche Covid-Opferzahl in Indien sein?","EconomistDeathToll":"Wie wir die tats\xe4chliche Zahl der Todesopfer der Pandemie gesch\xe4tzt haben","EconomistDeathToll2":"Die wahre Zahl der Todesopfer der Pandemie","InventoryEvidenceSynthesis":"Bestandsaufnahme der Synthese der besten Erkenntnisse"},"IndustryReportTitles":{"AugustReport":"August-Bericht","BloodBank":"SeroTracker Blutbank Seropr\xe4valenz Vorl\xe4ufiger Bericht","JulyReport":"Juli-Bericht","JuneReport":"Juni-Bericht","MayReport":"Mai-Bericht","OctoberReport":"Oktober-Bericht","PreliminaryReport":"Vorl\xe4ufiger Bericht","SeptemberReport":"Bericht September","YearInReview2020":"SeroTracker 2020 Jahresr\xfcckblick","InsuringTheEconomy":"Absicherung der Wirtschaft gegen eine zweite Pandemiewelle"},"ResearchArticleTitles":{"MedRxivNLP":"Eine reale Bewertung der Implementierung der NLP-Technologie in einem abstrakten Screening einer systematischen \xdcberpr\xfcfung","MedRxivMeta":"Globale Epidemiologie der SARS-CoV-2-Infektion: eine systematische \xdcberpr\xfcfung und Metaanalyse standardisierter populationsbasierter Seropr\xe4valenzstudien, Januar 2020 bis Oktober 2021","MedRxivROB":"SeroTracker-ROB: reproduzierbare Entscheidungsregeln zur Risiko-Bias-Bewertung von Seropr\xe4valenzstudien","MedRxivPrivate":"Aufnahme von SARS-CoV-2-Arbeitsplatztestprogrammen, M\xe4rz 2020 bis M\xe4rz 2021","PlosOnePub":"Globale Seropr\xe4valenz von SARS-CoV-2-Antik\xf6rpern: eine systematische \xdcberpr\xfcfung und Meta-Analyse","LancetID":"SeroTracker: ein globales SARS-CoV-2 Seropr\xe4valenz-Dashboard","PrePrint":"Lehren aus einer raschen systematischen \xdcberpr\xfcfung der ersten SARS-CoV-2-Serosurveys"},"BiblioDigestTitles":{"November":"Literatur-Update-Bericht November","LateOctober":"Literatur-Update-Bericht Ende Oktober","October":"Literatur-Update-Bericht Oktober","September":"Literatur-Update-Bericht September","August":"Literatur-Update-Bericht August","July":"Literatur-Update-Bericht Juli","June":"Literatur-Update-Bericht Juni"},"BiblioDigests":"Literatur-Update-Berichte","InitInfoModalText":{"PartOne":"Willkommen auf der SeroTracker-Registerkarte \u201cAnalyze\u201c  Wir f\xfchren eine systematische \xdcberpr\xfcfung von SARS-CoV-2-Serosurveys durch und verwenden die Daten aus unserer \xdcberpr\xfcfung, um dieses Dashboard zu erstellen","PartThree":"Diese aggregierten Sch\xe4tzungen sollten mit Vorsicht interpretiert werden, insbesondere wenn die Studien, die aggregiert wurden, keine repr\xe4sentativen Stichproben enthielten oder ein hohes Verzerrungspotenzial aufwiesen. Sie k\xf6nnen die Quellenliteratur auf der Referenzkarte am Ende dieser Seite eingehend studieren.","PartTwo":"Unser Dashboard aggregiert die Sch\xe4tzungen der Seropr\xe4valenz in jedem Land. Diese aggregierten Sch\xe4tzungen umfassen standardm\xe4\xdfig landes- bzw. gebietsweite Seropr\xe4valenzsch\xe4tzungen in der Allgemeinbev\xf6lkerung oder bei Blutspendenden und schlie\xdfen Sch\xe4tzungen aus, die nur in den Nachrichten ver\xf6ffentlicht wurden"},"Insights":"Einblicke","Isotypes":"Isotypen","IsotypesReported":"Gemeldete Isotypen","IsotypesReportedOptions":{"IgA":"IgA","IgG":"IgG","IgM":"IgM","IgMIgG":"IgM IgG"},"LancetArticle":"Lancet ID","LancetID":"The Lancet Infectious Diseases","LastUpdatedTooltip":"SeroTracker wird st\xe4ndig mit den Ergebnissen neu ver\xf6ffentlichter serologischer Studien aktualisiert. Wir ber\xfccksichtigen neue Studien aus unserer Suche innerhalb von 48 Stunden nach der Ver\xf6ffentlichung","Legalese":"Juristensprache","LocalEstimateRange":"Lokaler Sch\xe4tzbereich","LocalEstimates":"Lokale Sch\xe4tzungen","LocalStudies":"Lokale Studien","LocalStudyDetails":"Details zu lokalen Studien","Location":"Standort","Manufacturers":"Hersteller","ManuscriptAndPreprint":"Manuskript und Vorabdruck","ManuscriptAppendixText":{"FirstParagraph":"vollst\xe4ndige Methoden","SecondParagraph":"(aus dem Anhang zu unserer vollst\xe4ndigen systematischen \xdcberpr\xfcfung und Meta-Analyse von SARS-CoV-2-Serosurveys)"},"Map":"Karte","Media":"Medien ","MediaMentions":"Erw\xe4hnungen in den Medien","MemorialUniversityOfNewfoundland":"Memorial-Universit\xe4t von Neufundland","PrivateSectorReports":"Berichte aus dem Privatsektore","Months":{"January":"Januar","February":"Februar","March":"M\xe4rz","April":"April","May":"Mai","June":"Juni","July":"Juli","August":"August","September":"September","October":"Oktober","November":"November","December":"Dezember"},"N":"N","Name":"Name","NationalEstimateRange":"Landes- bzw. gebietsweite Sch\xe4tzbereich","NationalEstimates":"Landes- bzw. gebietsweite Sch\xe4tzungen","NationalStudies":"Landes- bzw. gebietsweite Studien","NationalStudyDetails":"Landes- bzw. gebietsweite Studiendetails","NoData":"Keine Daten","NoDataAnalyze":{"PartOne":"F\xfcr die von Ihnen angegebenen Filter sind keine Daten verf\xfcgbar","PartTwo":"Bitte versuchen Sie eine andere Filterkombination"},"NotApplicable":"Nicht zutreffend","NotFound":{"PartOne":"Seite nicht gefunden","PartTwo":"Upps! Wir konnten die gesuchte Seite nicht finden! Bitte versuchen Sie es mit einer anderen URL oder besuchen Sie unsere \u201cExplore\u201c-Seite, um wieder auf den richtigen Weg zu kommen.","Button":"\u201cExplore\u201c-Seite besuchen"},"NotReported":"Nicht gemeldet","NumberEstimates":"Anzahl der Sch\xe4tzungen","NumSeroprevalenceEstimates":"Anzahl der Seropr\xe4valenzsch\xe4tzungen","Okay":"Okay, ich verstehe!","OptimisedFunctionality":"F\xfcr eine optimale Funktionalit\xe4t der Website besuchen Sie uns bitte auf einem Desktop-Ger\xe4t.","OurData":"Unsere Daten","OurDataText":{"PointOne":"erfasst alle Studien, die \xfcber Pr\xe4valenzsch\xe4tzungen berichten","PointTwo":"beschreibt Studien, die noch keine Seropr\xe4valenzsch\xe4tzungen vorgelegt haben","Text":"Die nachstehende Tabelle beschreibt unsere Ergebnisse, einschlie\xdflich detaillierter Informationen zu jeder Studie, jeder Pr\xe4valenzsch\xe4tzung sowie zum damit verbundenen Verzerrungspotenzial."},"OurProtocol":"Unser Protokoll","OverallRiskOfBias":"Gesamt Risk of bias (Verzerrungsrisiko) ","Paper":"Papier","PaperText":"Unser erstes Manuskript, in dem die Erkenntnisse aus den Serosurveys bis zum 1. Mai beschrieben werden, finden Sie unter","PaperTextTwo":"Weitere Informationen \xfcber unser Dashboard finden Sie unter","Partnerships":"Partnerschaften","PartnershipsList":{"Canada":"Kanada (CITF)"},"PartnershipsPageTitle":{"Canada":"Kanadische Covid-19-Arbeitsgruppe Immunit\xe4t"},"PartnershipsPageDescription":{"Canada":{"PartOne":"SeroTracker wird von der Agentur f\xfcr \xf6ffentliche Gesundheit, Kanada, \xfcber die COVID-19-Arbeitsgruppe Immunit\xe4t (CITF) finanziell unterst\xfctzt. Die CITF hat viele hochkar\xe4tige serologische Untersuchungen und andere immunit\xe4tsbezogene Forschungsarbeiten finanziert, \xfcber die Sie","PartTwo":"auf seiner Website mehr erfahren k\xf6nnen.","PartThree":"Sie bieten auch modellierte Sch\xe4tzungen der Seropr\xe4valenz aufgrund von Infektionen in der kanadischen Bev\xf6lkerung","PartFour":"die Sie hier finden k\xf6nnen."}},"PartnershipsView":{"MapNote1":"Die Karte zeigt die Seropr\xe4valenzsch\xe4tzungen f\xfcr alle geografisch basierten Sch\xe4tzungen (einschlie\xdflich der gemeldeten Teilsch\xe4tzungen, z. B. regionale Sch\xe4tzungen auf Provinzebene, die in einer landesweiten Studie gemeldet wurden). Die Pins sind um den Mittelpunkt ihrer geografischen Lage(n) angeordnet.","MapNote2":"Die Anzahl der F\xe4lle und Todesf\xe4lle (in der Mitte der Stichprobe der Studie) wurde auf nationaler Ebene von ourworldindata.org \xfcbernommen (Unterquelle: coronavirus.jhu.edu)"},"Per100":" pro 100","PlannedSerosurveys":"Geplante Serosurveys","Population":"Bev\xf6lkerung","PopulationGroup":"Bev\xf6lkerungsgruppe","DateRangeTo":"bis","PopulationGroupOptions":{"All":"Alle","BloodDonors":"Blutspendende","Children":"Kinder","CommunityResident":"Einwohnerinnen und Einwohner der Gemeinde","FactoryWorker":"Fabrikarbeiterinnen und Fabrikarbeiter","FirstResponders":"Ersthelferinnen und Ersthelfer","GeneralPopulation":"Allgemeine Bev\xf6lkerung","HealthCareWorkers":"Fachkr\xe4fte im Gesundheitswesen","HotelStaffMember":"Hotelangestellte/r","IndustrySpecificEmployees":"Branchenspezifische Mitarbeiterinnen und Mitarbeiter","NonCovidHospitalizedPatients":"Nicht-COVID-Patientinnen und -Patienten im Krankenhaus","NonCovidPatientsInHealthCareSettings":"Nicht-COVID-Patientinnen und -Patienten in der Gesundheitsversorgung","PregnantOrParturientWomen":"Schwangere oder geb\xe4rende Frauen","RelativeOfHealthCareWorker":"Angeh\xf6rige/r einer medizinischen Fachkraft","ResidualSera":"Restliche Seren","Students":"Studentinnen und Studenten","Unspecified":"Nicht spezifiziert"},"Populations":"Bev\xf6lkerungen","PositiveCases":"Positive F\xe4lle","Prevalence":"Pr\xe4valenz","PrevalenceEstimateDetails":"Details zur Pr\xe4valenzsch\xe4tzung","PrivacyPolicy":"Datenschutzrichtlinie","Publication":"Ver\xf6ffentlichung","PublicationDescriptions":{"Publications":"Erfahren Sie mehr \xfcber den Einfluss von SeroTracker in Forschungsartikeln Zusammenfassungen und Medienberichten","ResearchArticles":"Peer-Review- und Pre-Print-Forschungspapiere, die vom SeroTracker-Team ver\xf6ffentlicht wurden","LiteratureUpdateReports":"Monatliche \xdcbersichten und Updates zu Trends in der Literatur \xfcber Serosurveys und zu den von der WHO bereitgestellten Metriken","GeneralSerotrackerCommunications":"Updates und Einblicke aus dem gesamten SeroTracker-Team","MediaMentions":"Weltweite Medienver\xf6ffentlichungen, die SeroTracker vorstellen","PrivateSectorReports":"Berichte \xfcber die COVID-19 screening und Testpraktiken im privaten Sektor Kanadas im Jahr 2020"},"Publications":"Ver\xf6ffentlichung","Published":"Ver\xf6ffentlicht","DataTable":"Referenzentabelle","RegionalEstimateRange":"Regionaler Sch\xe4tzbereich","RegionalEstimates":"Regionale Sch\xe4tzungen","RegionalStudies":"Regionale Studien","RegionalStudyDetails":"Details zu regionalen Studien","RegulatoryApproval":"Beh\xf6rdliche Genehmigung","Report":"Bericht","ReportsAndArticles":"Berichte und Artikel","ResearchArticles":"Forschungsartikel","RiskOfBias":"risiko der Voreingenommenheit","RiskOfBiasOptions":{"High":"Hoch","Low":"Niedrig","Moderate":"M\xe4\xdfig","Unclear":"Unklar"},"SampleSize":"Stichprobengr\xf6\xdfe","Sampling":"Probenahme","SamplingEndDate":"Enddatum der Probenahme","SamplingDates":"Daten der Probenahme","SamplingMethod":"Stichprobenverfahren","SchoolName":{"Cumming":"Cumming School of Medicine","Schulich":"Schulich School of Engineering"},"ScientificLead":"Wissenschaftliche/r Leiter/in","SelectDate":"Datum ausw\xe4hlen","Sensitivity":"Empfindlichkeit","SeroPrevalenceByCountry":"Aggregierte Sch\xe4tzungen der Seropr\xe4valenz in verschiedenen L\xe4ndern","Seroprevalence":"Seropr\xe4valenz","SeroprevalenceBy":"Seropr\xe4valenz nach","SeroprevalenceScale":"Seropr\xe4valenz-Skala","SeroprevalenceScaleTooltip":"Erstellt aus der Logit-Transformation des Maximalwertes zur Bestimmung der \'Bins\'","SeroprevalenceStudies":"Seropr\xe4valenzstudien","SeroprevalenceTooltip":{"FirstParagraph":"Pr\xe4valenz von Antik\xf6rpern gegen SARS-CoV-2 aggregiert gem\xe4\xdf den von Ihnen gew\xe4hlten Filtern.","SecondParagraph":"NB: Dies sollte nicht als repr\xe4sentative Sch\xe4tzung der Seropr\xe4valenz in der betreffenden Region interpretiert werden, insbesondere nicht wenn die aggregierten Studien verzerrte Stichproben aufweisen.","ThirdParagraph":"Pooling-Technik: mit festen Effekten und inverser Varianz gewichtete Aggregation von Datens\xe4tzen mit einem Stichprobenumfang \xfcber dem MIN_DENOMINATOR"},"Serosurveys":"Serosurveys","SerosurveysReportingPrevalence":"Serosurveys, die eine Pr\xe4valenz melden","SeroprevalenceEstimatesInRegion":"Seropr\xe4valenzsch\xe4tzungen in Kanada nach geografischem Gebiet","SeroTrackerTeam":"SeroTracker-Team","Settings":"Einstellungen","Sex":"Geschlecht","SexOptions":{"Female":"Weiblich","Male":"M\xe4nnlich","Other":"Andere"},"Source":"Quelle","SourceType":"Quellenart","SourceTypeOptions":{"JournalArticlePeerReviewed":"Zeitschriftenartikel (peer-reviewed)","InstitutionalReport":"Institutioneller Bericht","NewsAndMedia":"Nachrichten und Medien","Preprint":"Preprint","Publication":"Ver\xf6ffentlichungen"},"Specificity":"Spezifit\xe4t","StartDate":"Startdatum","Status":"Status","StudiesPerPage":"Studien pro Seite","Study":"Studie","StudyDetailsAuthorString":{"LeadOrg":"Vom/Nach FIRST_AUTHOR bei LEAD_ORG","NoLeadOrg":"Vom/Nach FIRST_AUTHOR"},"StudyDetailsPublishString":{"NoPublishDate":"Ver\xf6ffentlicht vom PUBLISHER ","NoPublisher":"Ver\xf6ffentlicht am PUBLISH_DATE ","PublisherAndDate":"Ver\xf6ffentlicht am PUBLISH_DATE von PUBLISHER"},"StudyInformation":"Informationen zur Studie","StudyInformationTooltip":{"FirstParagraph":"Filtern Sie nach Studiendetails, einschlie\xdflich der Art der Quelle (Ver\xf6ffentlichung, Preprint, Nachrichten oder Bericht), nach dem Status der Studie (laufend, abgeschlossen) sowie nach der Orientierung an das WHO-Unity-Protokoll.","SecondParagraph":{"PartOne":"Verzerrungspotenzial:","PartTwo":"spiegelt das Ausma\xdf wider, in dem die tats\xe4chliche Pr\xe4valenz von der gesch\xe4tzten Pr\xe4valenz abweichen kann. Gesch\xe4tzt von SeroTracker-Reviewerinnen und Reviewer auf der Grundlage des kritischen Bewertungstools f\xfcr Pr\xe4valenzsch\xe4tzungen aus dem Joanna Briggs Institute"},"ThirdParagraph":{"PartOne":"WHO-Unity-Protokoll:","PartTwo":"Die WHO hat mehrere standardisierte generische Protokolle f\xfcr robuste Untersuchungen auf COVID-19 entwickelt:","PartThree":"die Unity-Studien.","PartFour":"SeroTracker arbeitet mit der Weltgesundheitsorganisation zusammen, um Ergebnisse aus den WHO Unity Seropr\xe4valenzstudien zu visualisieren und zusammenzufassen. SeroTracker und die Weltgesundheitsorganisation bedanken sich beim deutschen Bundesministerium f\xfcr Gesundheit (BMG) f\xfcr die COVID-19-Forschungs- und -Entwicklungsmittel zur Unterst\xfctzung dieser Bem\xfchungen."}},"StudyName":"Name der Studie","StudyPins":"Studienpins anzeigen","StudySize":"Gr\xf6\xdfe der Studie","StudyStatus":"Status der Studie","StudyStatusOptions":{"Completed":"Abgeschlossen","Ongoing":"Laufend"},"StudyType":"Studienart","SublocalEstimateRange":"Sublokaler Sch\xe4tzbereich","SublocalEstimates":"Sublokale Sch\xe4tzungen","SublocalStudyDetails":"Details zu sublokalen Studien","SubmitSource":"Quelle einreichen","Summary":"Zusammenfassung","SummaryStatistics":"Zusammenfassende Statistik","Team":"Unser Team","TeamLead":"Teamleiter","TemporaryMaintenance":"Vor\xfcbergehende Wartung","TemporaryMaintenanceDescription":"Wir sind wegen geplanter Wartungsarbeiten au\xdfer Betrieb, der Dienst wird in K\xfcrze wieder aufgenommen.","TermsOfUse":"Nutzungsbedingungen","TestDetails":"Test-Details","TestInformation":"Test-Informationen","TestInformationTooltip":"Filtern Sie nach Testdetails, einschlie\xdflich Assay-Typ und Antik\xf6rper-Isotyp.","TestsAdministered":"Durchgef\xfchrte Antik\xf6rpertests","TestType":"Testtyp","TestTypeOptions":{"Neutralization":"Neutralisierungs","Clia":"Neutralisationstest CLIA","Elisa":"ELISA","Lfia":"LFIA","Other":"Andere"},"TestUsed":"Verwendeter Test","ThisForm":"dieses Formular","Today":"Heute","TotalEstimates":"Sch\xe4tzungen insgesamt","TotalTests":"Tests insgesamt","UnityBanner":{"Currently":"Derzeit sind nur","ProtocolLink":"Seroepidemiologisches Protokoll der WHO Unity","ViewDatabase":"ausgerichtete Studien werden angezeigt. Um unsere vollst\xe4ndige Datenbank zu sehen, deaktivieren Sie bitte das Kontrollk\xe4stchen","WHOUnityFilter":"WHO-Unity Protokoll konforme Studien","Filter":"Filter"},"UnityStudiesOnly":"WHO-Unity Protokoll konforme Studien","UnityStudiesOnlyLong":"Nur Studien im Rahmen der WHO-Unity anzeigen","UniversityOf":"Universit\xe4t NAME","UseOfData":"Die Verwendung dieser Daten unterliegt den SeroTracker-Bestimmungen","Vaccinations":"Impfungen","VaccineRolloutStatus":"Verf\xfcgbarkeit des Impfstoffs w\xe4hrend der Studie","VaccinationPolicyLow":"Impfstoffe nicht verf\xfcgbar","VaccinationPolicyMed":"F\xfcr bestimmte Gruppen verf\xfcgbare Impfstoffe","VaccinationPolicyHigh":"Impfstoffe f\xfcr breite Bev\xf6lkerungsschichten verf\xfcgbar","ViewPartnership":"Ansicht Partnerschaft","ViewFile":"Datei ansehen","ViewHere":"Hier ansehen","Welcome":"Willkommen bei SeroTracker","WhatWeDoText":{"FirstParagraph":"Bei SeroTracker sammeln wir Daten und Informationen \xfcber SARS-CoV-2-Seropr\xe4valenzstudien, indem wir einen systematischen Review und eine Meta-Analyse von ver\xf6ffentlichten und unver\xf6ffentlichten Daten zur Seropr\xe4valenz durchf\xfchren. Die Daten werden f\xfcr den Hauptsch\xe4tzer jeder Quelle und f\xfcr bestimmte relevante Untergruppen extrahiert. Die vollst\xe4ndigen Methoden finden Sie in unserem Studienprotokoll.","SecondParagraph":"Auf unserem Dashboard stellen wir Daten f\xfcr die Fach- und breite \xd6ffentlichkeit zur Verf\xfcgung. Wir bem\xfchen uns, unser Dashboard w\xf6chentlich zu aktualisieren. Weitere Informationen, die \xfcber die folgende \xfcberblicksartige Zusammenfassung hinausgehen, finden Sie in unserem Studienprotokoll und in den erg\xe4nzenden Methoden f\xfcr eine detaillierte Erl\xe4uterung unserer Forschungsprozesse."},"WhoDisclaimerSmall":"Die verwendeten Bezeichnungen und die Darstellung des auf dieser Plattform verf\xfcgbaren Materials bedeuten nicht, dass die WHO irgendeine Meinung \xfcber den rechtlichen Status eines Landes, eines Gebiets, einer Stadt oder eines Gebiets oder seiner Beh\xf6rden oder \xfcber den Verlauf seiner Grenzen zum Ausdruck bringt. Die gepunkteten und gestrichelten Linien auf den Karten stellen ungef\xe4hre Grenzlinien dar, \xfcber die eventuell noch kein vollst\xe4ndiges Einvernehmen besteht.","WhoDisclaimer":"Haftungsausschluss: Die verwendeten Bezeichnungen und die Darstellung des auf dieser Plattform verf\xfcgbaren Materials bedeuten nicht, dass die WHO irgendeine Meinung \xfcber den rechtlichen Status eines Landes, eines Gebiets, einer Stadt oder eines Bereichs oder seiner Beh\xf6rden oder \xfcber den Verlauf seiner Grenzen zum Ausdruck bringt. Die gepunkteten und gestrichelten Linien auf den Karten stellen ungef\xe4hre Grenzlinien dar, \xfcber die eventuell noch kein vollst\xe4ndiges Einvernehmen besteht. Die Erw\xe4hnung bestimmter Unternehmen oder Produkte bestimmter Hersteller in den auf dieser Plattform verf\xfcgbaren Materialien bedeutet nicht, dass diese von der WHO bef\xfcrwortet oder empfohlen werden und anderen, nicht erw\xe4hnten Produkten \xe4hnlicher Art vorgezogen werden. Vorbehaltlich von Irrt\xfcmern und Auslassungen sind die Namen der gesch\xfctzten Produkte durch gro\xdfe Anfangsbuchstaben gekennzeichnet. Die Auflistung von Materialien auf dieser Plattform bedeutet nicht, dass die WHO diese Ver\xf6ffentlichungen oder Websites bef\xfcrwortet oder empfiehlt oder die darin enthaltenen Inhalte \xfcberpr\xfcft hat. Die Plattform wurde ohne jegliche Garantie, weder ausdr\xfccklich noch stillschweigend, von der WHO erstellt. Die Verantwortung f\xfcr die Auslegung und Nutzung der auf dieser Plattform verf\xfcgbaren Ver\xf6ffentlichungen und Materialien liegt beim Leser. Die WHO haftet in keinem Fall f\xfcr Sch\xe4den, die sich aus der Nutzung dieser Website ergeben.","WhoSerotrackAndPartnersDisclaimerSmall":"Die verwendeten Bezeichnungen und die Darstellung des auf dieser Plattform verf\xfcgbaren Materials bedeuten nicht, dass die WHO, SeroTracker oder die Partner von SeroTracker irgendeine Meinung \xfcber den rechtlichen Status eines Landes, eines Gebiets, einer Stadt oder eines Gebiets oder seiner Beh\xf6rden oder \xfcber den Verlauf seiner Grenzen zum Ausdruck bringen. Die gepunkteten und gestrichelten Linien auf den Karten stellen ungef\xe4hre Grenzlinien dar, \xfcber die eventuell noch kein vollst\xe4ndiges Einvernehmen besteht.","WhoSerotrackAndPartnersDisclaimer1":"Die verwendeten Bezeichnungen und die Darstellung des auf dieser Plattform verf\xfcgbaren Materials bedeuten nicht, dass die WHO, SeroTracker oder die Partner von SeroTracker irgendeine Meinung \xfcber den rechtlichen Status eines Landes, eines Gebiets, einer Stadt oder eines Gebiets oder seiner Beh\xf6rden oder \xfcber den Verlauf seiner Grenzen zum Ausdruck bringen. Die gepunkteten und gestrichelten Linien auf den Karten stellen ungef\xe4hre Grenzlinien dar, \xfcber die eventuell noch kein vollst\xe4ndiges Einvernehmen besteht.","WhoSerotrackAndPartnersDisclaimer2":"Die Erw\xe4hnung bestimmter Unternehmen oder Produkte bestimmter Hersteller in den auf dieser Plattform verf\xfcgbaren Materialien bedeutet nicht, dass diese von der WHO, SeroTracker oder den SeroTracker-Partnern bef\xfcrwortet oder empfohlen werden und anderen, nicht erw\xe4hnten Produkten \xe4hnlicher Art vorgezogen werden. Vorbehaltlich von Irrt\xfcmern und Auslassungen sind die Namen der gesch\xfctzten Produkte durch gro\xdfe Anfangsbuchstaben gekennzeichnet. Die Auflistung von Materialien auf dieser Plattform bedeutet nicht, dass die WHO, SeroTracker oder die Partner von SeroTracker diese Ver\xf6ffentlichungen oder Websites bef\xfcrwortet oder empfiehlt oder die darin enthaltenen Inhalte \xfcberpr\xfcft hat.","WhoSerotrackAndPartnersDisclaimer3":"Die Plattform wurde ohne jegliche Garantie, weder ausdr\xfccklich noch stillschweigend, von der WHO, SeroTracker oder den SeroTracker-Partnern erstellt. Die Verantwortung f\xfcr die Auslegung und Nutzung der auf dieser Plattform verf\xfcgbaren Ver\xf6ffentlichungen und Materialien liegt beim Leser. In keinem Fall sind die WHO, SeroTracker oder die Partner von SeroTracker f\xfcr Sch\xe4den haftbar, die aus der Nutzung dieser Website entstehen.","WhoUnity":"WHO-Einheit"}')},338:function(e,t,a){e.exports=a.p+"static/media/WHO-FR-C-H.e509206a.png"},339:function(e,t,a){e.exports=a.p+"static/media/public-health-agency.a1b9e73c.svg"},340:function(e,t,a){e.exports=a.p+"static/media/University-Of-Calgary-Logo.ce61287b.png"},341:function(e,t){e.exports="data:image/png;base64,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"},344:function(e,t,a){e.exports=a.p+"static/media/BrokenAb.a9aeed43.gif"},359:function(e,t,a){e.exports=a.p+"static/media/airtable-icon.72f20372.svg"},370:function(e,t,a){e.exports=a.p+"static/media/YearInReview2020.fd7fe07a.png"},371:function(e,t,a){e.exports=a.p+"static/media/IndustryUpdatePre_2020.a93736ac.png"},372:function(e,t,a){e.exports=a.p+"static/media/SeroTrackerBloodBank_July_2020.669b184d.png"},373:function(e,t,a){e.exports=a.p+"static/media/LancetIDArticle.9c54a7db.png"},374:function(e,t,a){e.exports=a.p+"static/media/InsuringTheEconomy.14c5681c.png"},375:function(e,t,a){e.exports=a.p+"static/media/PlosOnePub.69693f7a.png"},376:function(e,t,a){e.exports=a.p+"static/media/3622.1582633003.73b9602c.png"},377:function(e,t,a){e.exports=a.p+"static/media/Bloomberg_Logo.3ee92577.jpg"},378:function(e,t,a){e.exports=a.p+"static/media/chi_logo_89px.8628d1b7.png"},379:function(e,t,a){e.exports=a.p+"static/media/cision_logo.62e4fbc9.svg"},380:function(e,t,a){e.exports=a.p+"static/media/CITF-logo-BIL-700.4149acbd.png"},381:function(e,t){e.exports="data:image/png;base64,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"},382:function(e,t,a){e.exports=a.p+"static/media/Forbes-logo.c6a3b406.png"},383:function(e,t,a){e.exports=a.p+"static/media/HIMSSlogo_Hfullcolor_RGB.fdc4df40.png"},384:function(e,t,a){e.exports=a.p+"static/media/JournalQuebec_Logo2013-.58cfe948.png"},385:function(e,t,a){e.exports=a.p+"static/media/marcia news.18b7513f.png"},386:function(e,t,a){e.exports=a.p+"static/media/mars.f902dbfa.jpg"},387:function(e,t,a){e.exports=a.p+"static/media/mcgill-university-logo-png-transparent-cropped.46394929.png"},388:function(e,t,a){e.exports=a.p+"static/media/New-York-Times-Logo8x6_0.48a0e045.png"},389:function(e,t,a){e.exports=a.p+"static/media/oxford.18734b66.jpg"},390:function(e,t,a){e.exports=a.p+"static/media/UCalgary.1fe9c1ca.svg"},391:function(e,t,a){e.exports=a.p+"static/media/waterloo.31e73eb2.png"},392:function(e,t,a){e.exports=a.p+"static/media/covidend-global-logo.40d97435.png"},395:function(e,t,a){e.exports=a.p+"static/media/SerotrackerLogo.157d7250.svg"},408:function(e,t,a){e.exports=a(688)},414:function(e,t,a){},423:function(e,t,a){},523:function(e,t,a){},553:function(e,t,a){},594:function(e,t,a){},603:function(e,t,a){},604:function(e,t,a){},605:function(e,t,a){},606:function(e,t,a){},660:function(e,t,a){},661:function(e,t,a){},686:function(e,t,a){},687:function(e,t,a){},688:function(e,t,a){"use strict";a.r(t);var n,r,i,s,o,l=a(0),c=a.n(l),u=a(59),d=a.n(u),m=a(19),p=a.n(m),h=a(27),g=a(11),f=a(31),b=(a(414),a(227)),v=a(60),y=a(52),S=a(28),E=a(82),k={en:"https://public.tableau.com/views/SeroTrackerAnalyzeEN/GlobalAnalyze?:language=en-US&:display_count=n&:origin=viz_share_link",fr:"https://public.tableau.com/views/SeroTrackerAnalyseFR/GlobalAnalyse?:language=en-US&publish=yes&:display_count=n&:origin=viz_share_link",de:"https://public.tableau.com/views/SeroTrackerAnalyseDE/GlobalAnalyse?:language=de-DE&publish=yes&:display_count=n&:origin=viz_share_link"},A="Explore",w="Analyze",T="Data",P="Publications",O="About",N=(n={},Object(E.a)(n,A,{Map:"Map"}),Object(E.a)(n,w,{ByCountry:"ByCountry",ByPopulation:"ByPopulation",AdditionalGraphs:"AdditionalGraphs"}),Object(E.a)(n,T,{DataDictionary:"DataDictionary",ChangeLog:"ChangeLog",SubmitSource:"SubmitSource",DownloadCsv:"DownloadCsv",AccessGithub:"AccessGithub",FAQ:"FAQ",DataTable:"DataTable"}),Object(E.a)(n,P,{ResearchArticles:"ResearchArticles",GeneralSerotrackerCommunications:"GeneralSerotrackerCommunications",BiblioDigests:"BiblioDigests",PrivateSectorReports:"PrivateSectorReports",MediaMentions:"MediaMentions"}),Object(E.a)(n,O,{ContactUs:"ContactUs",Team:"Team"}),n);!function(e){e.french="fr",e.english="en",e.german="de"}(r||(r={})),function(e){e.explore="explore"}(i||(i={})),function(e){e.country="country",e.population_group="population_group",e.sex="sex",e.age="age",e.test_type="test_type",e.source_type="source_type",e.overall_risk_of_bias="overall_risk_of_bias",e.isotypes_reported="isotypes_reported"}(s||(s={})),function(e){e.airtable="",e.github="github"}(o||(o={}));var D=a(119),C=a(330),x=a(331),R=a(332),I=a(333),L=a(334),M=a(335),z=a(113),j=a.n(z),F=function(e){return j.a.upperFirst(j.a.camelCase(e))},U=a(699),W=a(700),B=a(701),V=r.english,H=function(e){if(e){var t=e.getZoom();return 80/Math.pow(2,t)}return 0},G=function(e){return"/".concat(V,"/").concat(e)};D.registerLocale(C),D.registerLocale(x),D.registerLocale(R);var _={en:I,fr:L,de:M},q=function(e,t,a){var n=D.getAlpha2Code(e,"en"),r=D.getName(n,t);return r||(Y(a,[F(e)])||e)},K=function e(t,a,n){var r=t[a[n]];return n+1===a.length?r:e(r,a,n+1)},Q=r.english,J=function(e){!function(e){V=e}(e),Q=e};function Y(e){var t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:null,a=arguments.length>2&&void 0!==arguments[2]?arguments[2]:null,n=arguments.length>3&&void 0!==arguments[3]?arguments[3]:null,r=_[Q];try{var i=r[e];return i?(t&&(i=K(i,t,0)),a&&Object.keys(a).forEach((function(e){var t=a[e],n=new RegExp(e,"g");i=i.replace(n,"".concat(t))})),n&&n[0]&&(i=" "+i),n&&n[1]&&(i+=" "),i):t?t[t.length-1]:e}catch(s){return"No translation for string ".concat(e)}}function Z(e){return new Intl.DateTimeFormat(Q,{year:"numeric",month:"short",day:"numeric"}).format(new Date(e))}a(71);var X=a(118),$=a(15),ee=Object(l.createContext)({}),te=new Date(2019,1,1,1),ae=new Date;function ne(){return{source_type:[],test_type:[],country:[],population_group:[],sex:[],age:[],overall_risk_of_bias:[],isotypes_reported:[],antibody_target:[],publish_date:[te,ae],estimate_grade:[],unity_aligned_only:!1}}var re={chartAggregationFactor:s.country,explore:{filters:ne(),records:[],estimateGradePrevalences:[],isLoading:!1,legendLayers:{National:!0,Regional:!0,Local:!0}},allFilterOptions:ne(),calendarStartDates:{minDate:te,maxDate:ae},language:r.english,updatedAt:"",showCookieBanner:!1,pulsateUnityFilter:!1},ie=function(e,t){switch(t.type){case"CLOSE_COOKIE_BANNER":return Object($.a)(Object($.a)({},e),{},{showCookieBanner:!1});case"OPEN_COOKIE_BANNER":return Object($.a)(Object($.a)({},e),{},{showCookieBanner:!0});case"UPDATE_ESTIMATE_PREVALENCES":var a=t.payload,n=a.pageStateEnum,r=a.estimateGradePrevalences,i=Object($.a)({},e);return i[n].estimateGradePrevalences=r,i;case"SELECT_LANGUAGE":return Object($.a)(Object($.a)({},e),{},{language:t.payload});case"GET_ALL_FILTER_OPTIONS":return Object($.a)(Object($.a)({},e),{},{allFilterOptions:t.payload});case"GET_AIRTABLE_RECORDS":var s=t.payload,o=s.pageStateEnum,l=s.records,c=Object($.a)({},e);return c[o].records=l,c;case"UPDATED_AT":return Object($.a)(Object($.a)({},e),{},{updatedAt:t.payload});case"UPDATE_FILTER":var u=t.payload,d=u.pageStateEnum,m=u.filterType,p=u.filterValue,h=Object($.a)({},e);return h[d].filters[m]=p,h;case"UPDATE_ALL_FILTERS":var g=t.payload,f=g.pageStateEnum,b=g.newFilters,v=Object($.a)({},e);return v[f].filters=b,v;case"CLEAR_ALL_FILTERS":var y=t.payload.pageStateEnum,S=Object($.a)({},e);return S[y].filters=ne(),S;case"MAX_MIN_DATES":var E=t.payload,k=E.minDate,A=E.maxDate;return Object($.a)(Object($.a)({},e),{},{calendarStartDates:{minDate:k,maxDate:A}});case"CHANGE_LOADING":var w=t.payload,T=w.pageStateEnum,P=w.isLoading,O=Object($.a)({},e);return O[T].isLoading=P,O;case"UPDATE_AGGREGATION_FACTOR":return Object($.a)(Object($.a)({},e),{},{chartAggregationFactor:t.payload});case"TOGGLE_NATIONAL_PIN_LAYER":return Object($.a)(Object($.a)({},e),{},{explore:Object($.a)(Object($.a)({},e.explore),{},{legendLayers:Object($.a)(Object($.a)({},e.explore.legendLayers),{},{National:!e.explore.legendLayers.National})})});case"TOGGLE_REGIONAL_PIN_LAYER":return Object($.a)(Object($.a)({},e),{},{explore:Object($.a)(Object($.a)({},e.explore),{},{legendLayers:Object($.a)(Object($.a)({},e.explore.legendLayers),{},{Regional:!e.explore.legendLayers.Regional})})});case"TOGGLE_LOCAL_PIN_LAYER":return Object($.a)(Object($.a)({},e),{},{explore:Object($.a)(Object($.a)({},e.explore),{},{legendLayers:Object($.a)(Object($.a)({},e.explore.legendLayers),{},{Local:!e.explore.legendLayers.Local})})});case"SET_UNITY_FILTER_PULSATE":return Object($.a)(Object($.a)({},e),{},{pulsateUnityFilter:t.payload});default:return e}},se=function(e){var t=Object(l.useReducer)(ie,re),a=Object(g.a)(t,2),n=a[0],r=a[1];return c.a.createElement(ee.Provider,{value:[n,r]},e.children)},oe=function(e){X.a.set({page:e.pathname}),X.a.pageview(e.pathname)},le=function(e){localStorage.getItem("acceptedCookies")&&X.a.event(e)},ce=function(e){var t=ne();if(!j.a.isEqual(e,t)){var a="";Object.keys(e).sort().forEach((function(n){var r=e[n];Array.isArray(r)?j.a.isEqual(r,t[n])||(a+="".concat(n.toString()," - ").concat(r.sort(),";")):!0===r&&(a+="".concat(n.toString(),";"))})),le({category:"Filter",action:"selection",label:a})}},ue=function(){le({category:"WHO Unity Filter",action:"checked",label:""})},de=function(e){var t=e.children,a=Object(f.g)();return Object(l.useEffect)((function(){return oe(a.location),a.listen(oe)}),[a,!1]),t},me=a(22),pe=a(226),he=a(714),ge=a(92),fe=a(225),be=a.n(fe),ve=a(338),ye=a.n(ve),Se=function(e){var t=Object(l.useContext)(ee),a=Object(g.a)(t,1)[0],n=Object(l.useState)(void 0),i=Object(g.a)(n,2),s=i[0],o=i[1];return Object(l.useEffect)((function(){switch(a.language){case r.english:o(be.a);break;case r.french:o(ye.a);break;default:o(be.a)}}),[a.language]),c.a.createElement("img",{src:s,className:null===e||void 0===e?void 0:e.className,alt:"World Health Organization",height:e.height})},Ee=a(339),ke=a.n(Ee),Ae=a(340),we=a.n(Ae),Te=a(341),Pe=a.n(Te),Oe=(a(423),function(){var e=Object(l.useContext)(ee),t=Object(g.a)(e,1)[0].updatedAt;return Object(S.useMediaQuery)({maxDeviceWidth:1200})?De(t):Ne(t)}),Ne=function(e){return c.a.createElement("footer",{className:"container-fluid mx-0 footer"},c.a.createElement("div",{className:"footer__visible-section row justify-content-between d-flex align-items-center text-center"},c.a.createElement("div",{className:"col-2"},c.a.createElement(Ce,{updatedAt:e})),c.a.createElement("div",{className:"col-2"},c.a.createElement(xe,null))),c.a.createElement("div",{className:"row justify-content-center mt-3"},c.a.createElement("div",{className:"col-8"},c.a.createElement("div",{className:"row"},c.a.createElement(Le,null)))),c.a.createElement("div",{className:"row justify-content-center mt-5"},c.a.createElement("div",{className:"col-8"},c.a.createElement("div",{className:"footer__sponsers-pill my-2"},c.a.createElement(Ie,null)),c.a.createElement(Re,null))),c.a.createElement("div",{className:"row justify-content-center py-5 text-center"},c.a.createElement(me.a,{className:"footer__link px-1",to:G("PrivacyPolicy")},Y("PrivacyPolicy")),"|",c.a.createElement(me.a,{className:"footer__link px-1",to:G("CookiePolicy")},Y("CookiePolicy")),"|",c.a.createElement(me.a,{className:"footer__link px-1",to:G("TermsOfUse")},Y("TermsOfUse"))))},De=function(e){return c.a.createElement("footer",{className:"container-fluid mx-0 footer"},c.a.createElement("div",{className:"footer__visible-section row d-flex p-2"},c.a.createElement(Ce,{updatedAt:e}),c.a.createElement(xe,null)),c.a.createElement("div",{className:"row justify-content-center mt-5"},c.a.createElement("div",{className:"col-10 "},c.a.createElement(Me,null))),c.a.createElement("div",{className:"row justify-content-center mt-5"},c.a.createElement("div",{className:"col-8"},c.a.createElement("div",{className:"footer__sponsers-pill row"},c.a.createElement(Ie,null)),c.a.createElement(Re,null))),c.a.createElement("div",{className:"row justify-content-center mt-5 pb-5 text-center"},c.a.createElement("div",null,c.a.createElement(me.a,{className:"footer__link px-1",to:G("PrivacyPolicy")},Y("PrivacyPolicy"))),"|",c.a.createElement("div",null,c.a.createElement(me.a,{className:"footer__link px-1",to:G("CookiePolicy")},Y("CookiePolicy"))),"|",c.a.createElement("div",null,c.a.createElement(me.a,{className:"footer__link px-1",to:G("TermsOfUse")},Y("TermsOfUse")))))},Ce=function(e){var t=e.updatedAt;return t?c.a.createElement("span",{className:"pr-2"},Y("Footer",["LastUpdated"]),": ",c.a.createElement("b",{className:"updated-at-bold"},Z(t))):null},xe=function(){return c.a.createElement("span",{className:"text-right"},Y("Footer",["CiteAs"]),c.a.createElement("a",{href:"https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30631-9/fulltext#%20",target:"__blank",rel:"noopener noreferrer",className:"cite-link"},c.a.createElement("i",null,Y("Footer",["LancetInfDis"]))," ",Y("Footer",["Article"])))},Re=function(){return c.a.createElement("small",{className:"whoDisclaimer"},Y("WhoSerotrackAndPartnersDisclaimerSmall"))},Ie=function(){return c.a.createElement("div",{className:"d-flex justify-content-around row"},c.a.createElement("a",{href:"https://www.covid19immunitytaskforce.ca/",target:"__blank",rel:"noopener noreferrer",className:"footer__image-wrapper col-lg-auto justify-content-center"},c.a.createElement("img",{src:"https://www.covid19immunitytaskforce.ca/wp-content/themes/pena-lite-child/CITF_logo_ENG.svg",className:"footer__image d-flex",alt:"COVID-19 Immunity Task Force Logo"})),c.a.createElement("a",{href:"https://cumming.ucalgary.ca/centres/centre-health-informatics",target:"__blank",rel:"noopener noreferrer",className:"footer__image-wrapper col-lg-auto justify-content-center"},c.a.createElement("img",{src:we.a,className:"footer__image d-flex",alt:"Centre for Health Informatics"})),c.a.createElement("a",{href:"https://www.canada.ca/en/public-health.html/",target:"__blank",rel:"noopener noreferrer",className:"footer__image-wrapper col-lg-auto justify-content-center"},c.a.createElement("img",{src:ke.a,className:"footer__image d-flex",alt:"Public Health Agency Logo"})),c.a.createElement("a",{href:"https://www.who.int/",target:"__blank",rel:"noopener noreferrer",className:"footer__image-wrapper col-lg-auto justify-content-center"},c.a.createElement(Se,{className:"footer__image d-flex"})),c.a.createElement("a",{href:"https://joulecma.ca/",target:"__blank",rel:"noopener noreferrer",className:"footer__image-wrapper col-lg-auto justify-content-center"},c.a.createElement("img",{src:Pe.a,className:"footer__image d-flex",alt:"CMA Joule"})))},Le=function(){return c.a.createElement(c.a.Fragment,null,Object.keys(N).map((function(e){return c.a.createElement("div",{className:"col mx-2"},c.a.createElement("h3",{className:"row"},Y(e)),Object.keys(N[e]).map((function(t){return c.a.createElement(pe.a,{to:"".concat(G(e),"#").concat(t),className:"row mt-3 footer__link"},Y(t))})))})))},Me=function(){var e=Object(l.useState)(0),t=Object(g.a)(e,2),a=t[0],n=t[1];return c.a.createElement(he.a,{fluid:!0,styled:!0,className:"footer-accordion"},Object.keys(N).map((function(e,t){return c.a.createElement(c.a.Fragment,null,c.a.createElement(he.a.Title,{className:"footer accordion__title footer__link",active:a===t,index:t,onClick:function(){return n(t)}},c.a.createElement(ge.a,{name:"dropdown"}),Y(e)),c.a.createElement(he.a.Content,{active:a===t},Object.keys(N[e]).map((function(t){return c.a.createElement(pe.a,{to:"".concat(G(e),"#").concat(t),className:"row mt-3 footer__link"},Y(t))}))))})))};function ze(){var e=Object(S.useMediaQuery)({maxWidth:1200}),t=function(e,t){le({category:"Social Media Link",action:"click",label:"".concat(e," - ").concat(t)})},a=function(e){le({category:"About Page Link",action:"click",label:e})};function n(e,a){var n=arguments.length>2&&void 0!==arguments[2]?arguments[2]:null,r=arguments.length>3&&void 0!==arguments[3]?arguments[3]:null,i=arguments.length>4&&void 0!==arguments[4]?arguments[4]:null;return c.a.createElement("div",null,c.a.createElement("b",null,e),c.a.createElement("br",null),a.map((function(e){return c.a.createElement("div",{key:e},e,c.a.createElement("br",null))})),n?c.a.createElement("a",{href:n,onClick:function(){return t("LinkedIn",e)},target:"_blank",rel:"noopener noreferrer"},c.a.createElement(y.a,{icon:b.a,className:"mr-2 linked-in"})):null,i?c.a.createElement("a",{href:i,onClick:function(){return t("Twitter",e)},target:"_blank",rel:"noopener noreferrer"},c.a.createElement(y.a,{icon:b.b,className:"mr-2 twitter"})):null,r?c.a.createElement("a",{href:"mailto:".concat(r),onClick:function(){return t("Email",e)}},c.a.createElement(y.a,{icon:v.a,className:"mr-2 email"})):null)}return c.a.createElement("div",{className:"page col-12"},c.a.createElement("div",{className:e?"pb-2 static-mobile":"static-content pb-2"},c.a.createElement("h1",null,Y("AboutPage",["Headers","AboutSeroTracker"])),c.a.createElement("p",null,c.a.createElement("b",null,Y("AboutPage",["AboutSection","PartOne"])),Y("AboutPage",["AboutSection","PartTwo"],null,[!0,!1])),c.a.createElement(Ie,null),c.a.createElement("p",null,Y("AboutPage",["AboutSection","SupportedBy"]),c.a.createElement("a",{target:"_blank",rel:"noreferrer noopener",onClick:function(){return a("Public Health Agency")},href:"https://www.canada.ca/en/public-health.html"},Y("AboutPage",["AboutSection","PublicHealthAgency"],null,[!0,!0])),Y("AboutPage",["AboutSection","ThroughThe"]),c.a.createElement("a",{target:"_blank",rel:"noreferrer noopener",onClick:function(){return a("ITF Website")},href:"https://www.covid19immunitytaskforce.ca/"},Y("AboutPage",["AboutSection","Covid19ImmunityTaskForce"],null,[!0,!0])),Y("AboutPage",["AboutSection","HostedAt"]),c.a.createElement("a",{onClick:function(){return a("Centre for Health Informatics")},href:"https://cumming.ucalgary.ca/centres/centre-health-informatics",target:"_blank",rel:"noreferrer noopener"},Y("AboutPage",["AboutSection","HealthInformatics"],null,[!0,!0]))),c.a.createElement("p",null,Y("AboutPage",["AboutSection","WHO1"]),c.a.createElement("a",{onClick:function(){return a("WorldHealthOrganization")},href:"https://www.who.int/",target:"_blank",rel:"noreferrer noopener"},Y("AboutPage",["AboutSection","WorldHealthOrganization"],null,[!0,!0])),Y("AboutPage",["AboutSection","WHO2"]),c.a.createElement("a",{target:"_blank",rel:"noreferrer noopener",onClick:function(){return a("UnityStudies")},href:"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/early-investigations"},Y("AboutPage",["AboutSection","UnityStudies"],null,[!0,!1])),Y("AboutPage",["AboutSection","WHO3"],null,[!0,!0])),c.a.createElement("p",null,c.a.createElement("a",{onClick:function(){return a("Mapbox")},href:"https://www.mapbox.com/",target:"_blank",rel:"noreferrer noopener"},"Mapbox")," ",Y("AboutPage",["Mapbox"])),c.a.createElement("h2",{id:N.About.ContactUs},Y("AboutPage",["Headers","ContactUs"])),c.a.createElement("div",null,c.a.createElement("p",null,Y("AboutPage",["ContactSection","BulletPointOne","PartOne"],null,[!0,!0]),c.a.createElement("a",{target:"_blank",rel:"noreferrer noopener",href:"mailto:rahul.arora@balliol.ox.ac.uk"},"rahul.arora@balliol.ox.ac.uk"),Y("AboutPage",["ContactSection","BulletPointOne","PartTwo"],null,[!0,!0]),c.a.createElement("a",{target:"_blank",rel:"noreferrer noopener",href:"mailto:tingting.yan@mail.utoronto.ca"},"tingting.yan@mail.utoronto.ca"),".",Y("AboutPage",["ContactSection","BulletPointOne","PartThree"],null,[!0,!0]),c.a.createElement("a",{target:"_blank",rel:"noreferrer noopener",href:"mailto:media@covid19immunitytaskforce.ca"},"media@covid19immunitytaskforce.ca"),Y("AboutPage",["ContactSection","BulletPointOne","PartFour"],null,[!0,!0]),c.a.createElement("a",{target:"_blank",rel:"noreferrer noopener",href:"mailto:kelly.johnston2@ucalgary.ca"},"kelly.johnston2@ucalgary.ca"),"."),c.a.createElement("p",null,Y("AboutPage",["ContactSection","BulletPointFive","PartOne"]),c.a.createElement("b",null,Y("AboutPage",["ContactSection","BulletPointFive","PartTwo"],null,[!0,!1])),Y("AboutPage",["ContactSection","BulletPointFive","PartThree"],null,[!0,!0]),c.a.createElement("a",{onClick:function(){return a("Form Open")},rel:"noopener noreferrer",target:"_blank",href:"https://forms.gle/XWHQ7QPjQnzQMXSz8"},Y("ThisForm")),Y("AboutPage",["ContactSection","BulletPointFive","PartFour"],null,[!0,!0]))),c.a.createElement("h1",{id:N.About.Team},Y("AboutPage",["Headers","OurTeam"])),c.a.createElement("h2",{className:"team-name-text"},Y("AboutPage",["SubHeaders","TeamLead"])),c.a.createElement("div",{className:"bio-grid-container"},n("Rahul Arora",[Y("UniversityOf",null,{NAME:"Oxford"}),Y("UniversityOf",null,{NAME:"Calgary"})],"https://www.linkedin.com/in/rahularorayyc/","rahularoradfs@gmail.com"),n("Tingting Yan",[Y("UniversityOf",null,{NAME:"Toronto"})],"https://www.linkedin.com/in/tingting-yan/","","https://twitter.com/TingtingYan_")),c.a.createElement("h2",{className:"team-name-text"},Y("AboutPage",["SubHeaders","DataCuration"])),c.a.createElement("div",{className:"bio-grid-container"},n("Anabel Selemon",[Y("UniversityOf",null,{NAME:"Calgary"})],null,"anabel.selemon@ucalgary.ca"),n("Caseng Zhang",[Y("BlankUniversity",null,{NAME:"McMaster"})],"www.linkedin.com/in/caseng","zhangcaseng@gmail.com"),n("Claire Donnici",[Y("UniversityOf",null,{NAME:"Calgary"})],null,"claire.donnici@ucalgary.ca","https://twitter.com/ClaireDonnici"),n("Dayoung Kim",[Y("UniversityOf",null,{NAME:"Calgary"})],"https://www.linkedin.com/in/dayoung-kim-448425198/","dayoung.kim1@ucalgary.ca"),n("Emma Loeschnik",[Y("BlankUniversity",null,{NAME:"Western"}),Y("BlankUniversity",null,{NAME:"Brock"})],"https://www.linkedin.com/in/emma-loeschnik-97bb48220","eloeschn@uwo.ca","https://twitter.com/emma_loeschnik"),n("Kim No\xebl",[Y("BlankUniversity",null,{NAME:"McGill"})],"https://www.linkedin.com/in/kim-noel-aa27821b8","kim.noel@mail.mcgill.ca"),n("Mercedes Yanes",[Y("BlankUniversity",null,{NAME:"McGill"}),"Universidad Autonoma de San Luis Potosi"],"https://www.linkedin.com/in/mercedes-yanes-lane-64b25a19b","mercedes.yaneslane@mcgill.ca",null),n("Natalie Duarte",[Y("UniversityOf",null,{NAME:"Toronto"})],null,"natalieaduarte@gmail.com"),n("Natasha Ilincic",[Y("UniversityOf",null,{NAME:"Toronto"}),Y("UniversityOf",null,{NAME:"Guelph"})],"https://www.linkedin.com/in/natasha-ilincic/","natasha.ilincic@gmail.com"),n("Niklas Bobrovitz ",[Y("UniversityOf",null,{NAME:"Oxford"}),Y("UniversityOf",null,{NAME:"Toronto"})],"https://www.linkedin.com/in/nik-bobrovitz-19a117179/","niklas.bobrovitz@mail.utoronto.ca","https://twitter.com/nikbobrovitz"),n("Sara Perlman-Arrow",[Y("BlankUniversity",null,{NAME:"McGill"})],"https://www.linkedin.com/in/sara-perlman-arrow-5075421b6/","sara.perlman-arrow@mail.mcgill.ca")),c.a.createElement("h2",{className:"team-name-text"},Y("AboutPage",["SubHeaders","DataInfrastructure"])),c.a.createElement("div",{className:"bio-grid-container"},n("Christian Cao",[Y("UniversityOf",null,{NAME:"Calgary"})],"https://ca.linkedin.com/in/christian-cao-275b78190","ccao.canada@gmail.com"),n("Gabriel Deveaux",[Y("MemorialUniversityOfNewfoundland")],"https://www.linkedin.com/in/grdeveaux/","grdeveaux@mun.ca"),n("Harriet Ware",[Y("UniversityOf",null,{NAME:"Toronto"}),Y("BlankUniversity",null,{NAME:"Queen's"})],null,"ware.harriet@gmail.com"),n("Judy Chen",[Y("BlankUniversity",null,{NAME:"McGill"})],null,"judy.chen@mail.mcgill.ca")),c.a.createElement("h2",{className:"team-name-text"},Y("AboutPage",["SubHeaders","GlobalPartnerships"])),c.a.createElement("div",{className:"bio-grid-container"},n("Harriet Ware",[Y("UniversityOf",null,{NAME:"Toronto"}),Y("BlankUniversity",null,{NAME:"Queen's"})],null,"ware.harriet@gmail.com"),n("Mair\xe9ad Whelan",[Y("UniversityOf",null,{NAME:"Oxford"}),Y("UniversityOf",null,{NAME:"Calgary"})],"https://www.linkedin.com/in/mairead-whelan","mairead.whelan@ucalgary.ca","https://twitter.com/Mairead_GWhelan"),n("Xiaomeng Ma",[Y("UniversityOf",null,{NAME:"Toronto"})],"https://www.linkedin.com/in/xiaomeng-simone-ma-6a8156b9/","xiaomeng.ma@mail.utoronto.ca"),n("Zihan Li",[Y("UniversityOf",null,{NAME:"Waterloo"})],"https://www.linkedin.com/in/zihanli/","zihan.li@uwaterloo.ca","https://twitter.com/emma_loeschnik")),c.a.createElement("h2",{className:"team-name-text"},Y("AboutPage",["SubHeaders","DevelopmentTeam"])),c.a.createElement("div",{className:"bio-grid-container"},n("Austin Atmaja",[Y("UniversityOf",null,{NAME:"Waterloo"})],"https://www.linkedin.com/in/austinatmaja","atatmaja@uwaterloo.ca","https://twitter.com/atatmaja_"),n("Flora Guo",[Y("UniversityOf",null,{NAME:"Waterloo"})],"https://www.linkedin.com/in/floraguolr/","floraguolr@gmail.com"),n("Himanshu Ranka",[Y("BlankUniversity",null,{NAME:"McGill"})],"https://www.linkedin.com/in/himanshu-ranka-635a02181/","himanshu.ranka@mail.mcgill.ca"),n("Simona Rocco",[Y("UniversityOf",null,{NAME:"Waterloo"})],"https://www.linkedin.com/in/simona-rocco/","serocco@uwaterloo.ca")),c.a.createElement("h2",{className:"team-name-text"},Y("AboutPage",["SubHeaders","Alumni"])),c.a.createElement("div",{className:"bio-grid-container"},n("Abel Joseph",[Y("UniversityOf",null,{NAME:"Waterloo"})],"https://www.linkedin.com/in/abel-joseph/","abel.joseph@uwaterloo.ca"),n("Abhinav Pillai",[Y("UniversityOf",null,{NAME:"Calgary"})],null,"abhinav.arunpillai@ucalgary.ca"),n("Brett Dziedzic",[Y("UniversityOf",null,{NAME:"Lethbridge"})],"https://www.linkedin.com/in/brett-dziedzic/","brettdziedzic@gmail.com"),n("Emily Boucher",[Y("SchoolName",["Cumming"]),Y("UniversityOf",null,{NAME:"Calgary"})],null,"emily.boucher@ucalgary.ca"),n("Ewan May",[Y("SchoolName",["Schulich"]),Y("UniversityOf",null,{NAME:"Calgary"})],"https://www.linkedin.com/in/ewan-may","ewan.may@ucalgary.ca"),n("Hannah Rahim",[Y("UniversityOf",null,{NAME:"Calgary"})],"https://www.linkedin.com/in/hannah-rahim/","hannahrahim2@gmail.com","https://twitter.com/Hannah_Rahim1"),n("Jordan Van Wyk",[Y("UniversityOf",null,{NAME:"Waterloo"})],"https://www.linkedin.com/in/jordanvanwyk/","jordanvanwyk@outlook.com","https://twitter.com/jordanvw_"),n("Lucas Penny",[Y("UniversityOf",null,{NAME:"Toronto"})],"https://www.linkedin.com/in/lucaspenny/","lucas.penny@mail.utoronto.ca","https://twitter.com/lucasjpenny"),n("Michael Liu",[Y("UniversityOf",null,{NAME:"Oxford"}),Y("BlankUniversity",null,{NAME:"Harvard"})],"https://www.linkedin.com/in/michael-liu-8728249a/","liu.michael222@gmail.com","https://twitter.com/mliu_canada"),n("Mitchell Segal",[Y("UniversityOf",null,{NAME:"Toronto"})],null,"mitchell.segal@mail.utoronto.ca"),n("Nathan Duarte",[Y("BlankUniversity",null,{NAME:"McGill"}),Y("UniversityOf",null,{NAME:"Waterloo"})],"https://www.linkedin.com/in/duartenathan/","nathanduarte1@gmail.com","https://twitter.com/niduarte_canada"),n("Noel Loo",[Y("UniversityOf",null,{NAME:"Cambridge"})],null,"noel.loo.188@gmail.com"),n("Prannoy Lal",[Y("UniversityOf",null,{NAME:"Waterloo"})],"https://www.linkedin.com/in/prannoylal/","p4lal@uwaterloo.ca"),n("Sean D'Mello",[Y("UniversityOf",null,{NAME:"Waterloo"})],"https://www.linkedin.com/in/dmellosean/","sean.dmello@uwaterloo.ca","https://twitter.com/SeanDMello1")),c.a.createElement("h2",{className:"team-name-text"},Y("AboutPage",["SubHeaders","ScientificAdvisors"])),c.a.createElement("div",{className:"bio-grid-container"},n("Tim Evans",[Y("BlankUniversity",null,{NAME:"McGill"}),Y("COVIDImmunityTaskForce")]),n("Tyler Williamson",[Y("CentreHealthInformatics"),Y("UniversityOf",null,{NAME:"Calgary"})]),n("Matthew Cheng",[Y("COVIDImmunityTaskForce"),Y("BlankUniversity",null,{NAME:"McGill"})]),n("David Naylor",[Y("COVIDImmunityTaskForce"),Y("UniversityOf",null,{NAME:"Toronto"})]),n("David Buckeridge",[Y("COVIDImmunityTaskForce"),Y("BlankUniversity",null,{NAME:"McGill"})]),n("Bruce Mazer",[Y("COVIDImmunityTaskForce"),Y("BlankUniversity",null,{NAME:"McGill"})]),n("Jesse Papenburg",[Y("COVIDImmunityTaskForce"),Y("BlankUniversity",null,{NAME:"McGill"})]),n("Catherine Hankins",[Y("COVIDImmunityTaskForce"),Y("BlankUniversity",null,{NAME:"McGill"})])),c.a.createElement("h2",{className:"team-name-text"},Y("AboutPage",["SubHeaders","ProjectStaff"])),c.a.createElement("div",{className:"bio-grid-container mb-5"},n("Erin O'Connor",[Y("CentreHealthInformatics"),Y("UniversityOf",null,{NAME:"Calgary"})]),n("Catherine Eastwood",[Y("CentreHealthInformatics"),Y("UniversityOf",null,{NAME:"Calgary"})]))))}var je=a(693),Fe=a(344),Ue=a.n(Fe);function We(){Object(S.useMediaQuery)({maxWidth:1200});var e=Object(f.g)(),t=Object(l.useContext)(ee),a=Object(g.a)(t,2),n=a[0].language;a[1];return c.a.createElement("div",{className:"page col-12"},c.a.createElement("div",{className:"center-container"},c.a.createElement("img",{src:Ue.a,height:"30%",alt:""}),c.a.createElement("p",{className:"not-found-subheader"},Y("NotFound",["PartOne"])),c.a.createElement("p",null,Y("NotFound",["PartTwo"])),c.a.createElement(je.a,{className:"not-found-button",onClick:function(){return e.push("/".concat(n,"/Explore"))}},Y("NotFound",["Button"]))))}function Be(){var e=Object(S.useMediaQuery)({maxDeviceWidth:1200});return Object(l.useEffect)((function(){var e=document.createElement("script");return e.text="(function(d, s, id) { var js, tjs = d.getElementsByTagName(s)[0]; if (d.getElementById(id)) return; js = d.createElement(s); js.id = id; js.src = 'https://app.termly.io/embed-policy.min.js'; tjs.parentNode.insertBefore(js, tjs); }(document, 'script', 'termly-jssdk'));",document.body.appendChild(e),function(){document.body.removeChild(e)}}),[]),c.a.createElement("div",{className:e?"policy-div-mobile":"policy-div-desktop"},c.a.createElement("iframe",{title:"CookiePolicy",className:e?"policy-frame-mobile":"policy-frame-desktop",src:"https://app.termly.io/embed/terms-of-use/4cfb8f90-983a-40b4-bea2-2cdd373f14b5"}))}var Ve=a(708),He=a(707),Ge=a(346),_e=a(80),qe=a.n(_e),Ke=a(76),Qe=a(77),Je=a(690),Ye=a(692),Ze="/data_provider/records",Xe=function(){function e(){Object(Ke.a)(this,e)}return Object(Qe.a)(e,[{key:"httpGet",value:function(){var e=Object(h.a)(p.a.mark((function e(t,a){var n,r,i,s;return p.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return n=t,a&&(n="https://iit-backend.com"+n),e.next=4,fetch(n);case 4:if(200===(r=e.sent).status){e.next=11;break}return i=r.json(),console.error(i),e.abrupt("return");case 11:return e.next=13,r.json();case 13:return s=e.sent,e.abrupt("return",s);case 15:case"end":return e.stop()}}),e)})));return function(t,a){return e.apply(this,arguments)}}()},{key:"httpPost",value:function(){var e=Object(h.a)(p.a.mark((function e(t,a){var n,r,i,s;return p.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return n="https://iit-backend.com"+(n=t),e.next=4,fetch(n,{method:"POST",headers:{"Content-Type":"application/json"},body:JSON.stringify(a)});case 4:if(200===(r=e.sent).status){e.next=11;break}return i=r.json(),console.error(i),e.abrupt("return");case 11:return e.next=13,r.json();case 13:return s=e.sent,e.abrupt("return",s);case 15:case"end":return e.stop()}}),e)})));return function(t,a){return e.apply(this,arguments)}}()},{key:"getStyles",value:function(){var e=Object(h.a)(p.a.mark((function e(t){var a,n,r;return p.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return e.next=2,fetch(t);case 2:if(200===(a=e.sent).status){e.next=9;break}return n=a.json(),console.error(n),e.abrupt("return");case 9:return e.next=11,a.json();case 11:return r=e.sent,e.abrupt("return",r);case 13:case"end":return e.stop()}}),e)})));return function(t){return e.apply(this,arguments)}}()},{key:"getRecordDetails",value:function(){var e=Object(h.a)(p.a.mark((function e(t){var a,n;return p.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return e.next=2,this.httpGet("".concat("/data_provider/record_details","/").concat(t),!0);case 2:if(a=e.sent){e.next=5;break}return e.abrupt("return",null);case 5:return n=a,e.abrupt("return",n);case 7:case"end":return e.stop()}}),e,this)})));return function(t){return e.apply(this,arguments)}}()},{key:"getAllFilterOptions",value:function(){var e=Object(h.a)(p.a.mark((function e(){var t,a,n,r,i;return p.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return e.next=2,this.httpGet("/data_provider/filter_options",!0);case 2:return t=e.sent,(a=t).isotypes_reported=["IgG","IgA","IgM"],n=Object(Je.default)(Object(Ye.default)(t.updated_at),"yyyy/MM/dd"),r=Object(Ye.default)(t.max_publication_end_date),i=Object(Ye.default)(t.min_publication_end_date),delete a.min_date,delete a.max_date,e.abrupt("return",{options:a,updatedAt:n,maxDate:r,minDate:i});case 11:case"end":return e.stop()}}),e,this)})));return function(){return e.apply(this,arguments)}}()},{key:"preparePostBody",value:function(e){var t=Object($.a)({},e),a=e.publish_date,n=e.unity_aligned_only,r=function(e){var t=Object(U.a)(new Date),a=Object(U.a)(Object(W.a)(new Date(t),{years:-2}));if(e){var n=Array.from(e);1===Object(B.a)(n[0],n[1])&&n.reverse(),t=n[1]?Object(U.a)(n[1]):t,a=n[0]?Object(U.a)(n[0]):a}return[a,t]}(a),i=Object(g.a)(r,2),s=i[0],o=i[1];return delete t.publish_date,delete t.unity_aligned_only,{filters:t,sampling_start_date:s,sampling_end_date:o,unity_aligned_only:n,estimates_subgroup:"primary_estimates"}}},{key:"getExploreData",value:function(){var e=Object(h.a)(p.a.mark((function e(t){var a,n,r,i,s,o=arguments;return p.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return a=o.length>1&&void 0!==o[1]&&o[1],n=this.preparePostBody(t),a&&(n.columns=["source_id","estimate_grade","pin_latitude","pin_longitude"]),e.next=5,this.httpPost(Ze,n);case 5:if((r=e.sent)&&r.records&&r.country_seroprev_summary){e.next=8;break}return e.abrupt("return",{records:[],estimateGradePrevalences:[]});case 8:return i=r.records.map((function(e){return e})),s=this.formatEstimateGradePrevalences(r),e.abrupt("return",{records:i,estimateGradePrevalences:s});case 11:case"end":return e.stop()}}),e,this)})));return function(t){return e.apply(this,arguments)}}()},{key:"formatEstimateGradePrevalences",value:function(e){return e.country_seroprev_summary.map((function(e){var t=e.seroprevalence_estimate_summary;return{numberOfStudies:e.n_estimates,testsAdministered:e.n_tests_administered,geographicalName:e.country,alpha3Code:e.country_iso3,localEstimate:{maxEstimate:t.Local.max_estimate,minEstimate:t.Local.min_estimate,numEstimates:t.Local.n_estimates},nationalEstimate:{maxEstimate:t.National.max_estimate,minEstimate:t.National.min_estimate,numEstimates:t.National.n_estimates},regionalEstimate:{maxEstimate:t.Regional.max_estimate,minEstimate:t.Regional.min_estimate,numEstimates:t.Regional.n_estimates},sublocalEstimate:{maxEstimate:t.Sublocal.max_estimate,minEstimate:t.Sublocal.min_estimate,numEstimates:t.Sublocal.n_estimates}}}))}},{key:"getCountryPartnershipData",value:function(){var e=Object(h.a)(p.a.mark((function e(t){var a,n,r,i;return p.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return a={filters:t,include_subgeography_estimates:!0,estimates_subgroup:"primary_estimates"},e.next=3,this.httpPost(Ze,a);case 3:if((n=e.sent)&&n.records&&n.country_seroprev_summary){e.next=6;break}return e.abrupt("return",{records:[],estimateGradePrevalences:[]});case 6:return r=n.records.map((function(e){return e})),i=this.formatEstimateGradePrevalences(n),e.abrupt("return",{records:r,estimateGradePrevalences:i});case 9:case"end":return e.stop()}}),e,this)})));return function(t){return e.apply(this,arguments)}}()}]),e}(),$e={National:{Color:"#094180",Size:11},Regional:{Color:"#F19E66",Size:9},Local:{Color:"#E15759",Size:6},Sublocal:{Color:"#E15759",Size:5},Default:{Color:"#FFFFFF",Size:0}},et={IsHighlighted:{Color:"#b0c8d4"},HasData:{Color:"#97b1bd",Opacity:.5},Disputed:{Color:"#E1E1E1",Opacity:1},Shaded:{Color:"#707070"},Default:{Color:"#FFFFFF",Opacity:0}},tt="https://tiles.arcgis.com/tiles/5T5nSi527N4F7luB/arcgis/rest/services/WHO_Polygon_Basemap_no_labels/VectorTileServer",at="https://tiles.arcgis.com/tiles/5T5nSi527N4F7luB/arcgis/rest/services/Countries/VectorTileServer",nt={center:[10,30],zoom:2,minZoom:2,maxZoom:14,attributionControl:!1,scrollZoom:!1},rt={Studies:{"circle-color":["match",["get","estimate_grade"],"National",$e.National.Color,"Regional",$e.Regional.Color,"Local",$e.Local.Color,"Sublocal",$e.Sublocal.Color,$e.Default.Color],"circle-radius":["match",["get","estimate_grade"],"National",$e.National.Size,"Regional",$e.Regional.Size,"Local",$e.Local.Size,"Sublocal",$e.Sublocal.Size,$e.Default.Size],"circle-stroke-color":["case",["boolean",["feature-state","isSelected"],!1],"black","white"],"circle-stroke-width":3,"circle-stroke-opacity":["case",["boolean",["feature-state","hover"],!1],1,["case",["boolean",["feature-state","isSelected"],!1],1,0]],"circle-opacity":["case",["boolean",["feature-state","isBlurred"],!1],.2,.6]},Countries:{"fill-color":["case",["boolean",["feature-state","isHighlighted"],!0],et.IsHighlighted.Color,["boolean",["feature-state","hasData"],!0],et.HasData.Color,et.Default.Color],"fill-opacity":["case",["boolean",["feature-state","hasData"],!1],et.HasData.Opacity,et.Default.Opacity]}};function it(e){return st.apply(this,arguments)}function st(){return(st=Object(h.a)(p.a.mark((function e(t){var a,n,r;return p.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return a=t+"/resources/styles/root.json",n=new Xe,e.next=4,n.getStyles(a);case 4:return(r=e.sent).sprite=t+"/resources/sprites/sprite",r.glyphs=t+"/resources/fonts/{fontstack}/{range}.pbf",r.sources.esri={type:"vector",tiles:[t+"/tile/{z}/{y}/{x}.pbf"],maxzoom:23},e.abrupt("return",r);case 9:case"end":return e.stop()}}),e)})))).apply(this,arguments)}function ot(e){return lt.apply(this,arguments)}function lt(){return(lt=Object(h.a)(p.a.mark((function e(t){var a,n,r;return p.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return e.next=2,it(t);case 2:return a=e.sent,n=a.sources.esri,"Countries"===(r=a.layers[0]).id&&(n.promoteId={Countries:"CODE"},r.paint=rt.Countries),e.abrupt("return",a);case 7:case"end":return e.stop()}}),e)})))).apply(this,arguments)}var ct=a(173),ut=a.n(ct),dt=a(702);function mt(e,t){return c.a.createElement("div",{className:"d-flex justify-content-between mb-2"},c.a.createElement("div",{className:"country-popup-heading"},e),c.a.createElement("div",{className:"country-popup-text"},t))}var pt=function(e,t,a){var n=null===e||void 0===e?void 0:e.state;if(n.testsAdministered){var r=[],i=function(e,t){return void 0!==e&&0!==e.numEstimates?r.push({Region:e,Name:t}):null};return i(n.nationalEstimate,Y("NationalEstimates")),i(n.regionalEstimate,Y("RegionalEstimates")),i(n.localEstimate,Y("LocalEstimates")),i(n.sublocalEstimate,Y("SublocalEstimates")),c.a.createElement("div",{className:"country-popup-content p-4"},c.a.createElement("div",{className:"country-popup-title"},q(n.geographicalName,t,"CountryOptions")),c.a.createElement(dt.a,null),mt(Y("TestsAdministered"),c.a.createElement("b",null,null===n||void 0===n?void 0:n.testsAdministered)),mt(Y("NumSeroprevalenceEstimates"),c.a.createElement("b",null,null===n||void 0===n?void 0:n.numberOfStudies)),r.map((function(e){return function(e,t){var a="".concat((100*e.minEstimate).toFixed(2),"%"),n="".concat((100*e.maxEstimate).toFixed(2),"%"),r=a===n?a:"".concat(a," - ").concat(n);return c.a.createElement("div",{key:Math.random()},c.a.createElement("div",{key:Math.random(),className:"country-popup-header pt-1 mb-2"},t),mt(Y("EstimateRange"),c.a.createElement("b",null,r)),mt(Y("NumberEstimates"),c.a.createElement("b",null,e.numEstimates)))}(e.Region,e.Name)})),a?c.a.createElement(je.a,{className:"not-found-button mt-2",onClick:function(){a()}},Y("ViewPartnership")):"")}return c.a.createElement("div",{className:"country-popup-content"},c.a.createElement("div",{className:"country-popup-title"},q(n.geographicalName,t,"CountryOptions")),c.a.createElement("div",{className:"col-12 p-0 flex country-popup-text"},Y("NoData")))},ht=[{iso3:"CAN",routeName:"Canada",tableauKey:"CanadianTableau",tableauUrl:{en:"https://public.tableau.com/views/CanadaEN/Canadiancharts?:language=en-US&publish=yes&:display_count=n&:origin=viz_share_link",fr:"https://public.tableau.com/views/CanadaFR/Canadiancharts?:language=en-US&:display_count=n&:origin=viz_share_link"},mapboxMapOptions:{bounds:[[-148,39],[-50,75]]}}];function gt(e,t){e.getSource("Countries")&&function(e,t){e.removeFeatureState({source:"Countries",sourceLayer:"Countries"}),t.forEach((function(t){if(t&&t.testsAdministered&&t.alpha3Code){var a=ht.find((function(e){return e.iso3===t.alpha3Code}));e.setFeatureState({source:"Countries",sourceLayer:"Countries",id:t.alpha3Code},{hasData:!0,isHighlighted:!1,testsAdministered:t.testsAdministered,geographicalName:t.geographicalName,numberOfStudies:t.numberOfStudies,localEstimate:t.localEstimate,nationalEstimate:t.nationalEstimate,regionalEstimate:t.regionalEstimate,sublocalEstimate:t.sublocalEstimate,partnershipConfig:a})}}))}(e,t)}var ft=function(e,t){var a=t.estimateGradePrevalences,n=t.countryFocus,r=Object(l.useContext)(ee),i=Object(g.a)(r,1)[0],s=Object(l.useState)(void 0),o=Object(g.a)(s,2),c=o[0],u=o[1],d=Object(l.useState)(!1),m=Object(g.a)(d,2),p=m[0],h=m[1],b=Object(f.g)();Object(l.useEffect)((function(){e&&a&&p&&gt(e,a)}),[e,a,n,p]),Object(l.useEffect)((function(){e&&(e.getSource("Countries")?h(!0):e.on("styledata",(function(){return h(!0)})))}),[e]),Object(l.useEffect)((function(){e&&e.on("click","Countries",(function(t){if(0===e.queryRenderedFeatures(t.point).filter((function(e){return"study-pins"===e.source})).length){var a=t.features[0],n=H(e);new qe.a.Popup({offset:25,className:"pin-popup"}).setMaxWidth("370px").setHTML(ut.a.renderToString(pt(a,i.language))).setLngLat(t.lngLat).addTo(e),e.flyTo({center:[t.lngLat.lng,t.lngLat.lat-n],curve:.5,speed:.5}),le({category:"Country popup",action:"open",label:t.features[0].id})}}))}),[e,i.language,b]),Object(l.useEffect)((function(){e&&(e.on("mousemove","Countries",(function(t){t.features&&t.features.length>0&&t.features[0].state.hasData&&(void 0!==c&&e.setFeatureState({source:"Countries",sourceLayer:"Countries",id:c},{isHighlighted:!1}),u(t.features[0].id),e.setFeatureState({source:"Countries",sourceLayer:"Countries",id:t.features[0].id},{isHighlighted:!0}))})),e.on("mouseleave","Countries",(function(){void 0!==c&&e.setFeatureState({source:"Countries",sourceLayer:"Countries",id:c},{isHighlighted:!1}),u(void 0)})))}),[e,c])};function bt(e,t){return c.a.createElement("div",{className:"d-flex justify-content-between mb-2"},c.a.createElement("div",{className:"popup-heading"},e),c.a.createElement("div",{className:"popup-text"},t))}function vt(e,t){var a=t,n=e.find((function(e){return e.english===t}));n&&(a=n[{en:"english",fr:"french",de:"german"}[Q]]);return a}function yt(e,t){var a,n;return c.a.createElement("div",{className:"popup-content pt-2"},c.a.createElement("div",{className:"popup-section"},c.a.createElement("div",{className:"popup-title"},Y("".concat(e.estimate_grade,"StudyDetails"))),c.a.createElement("div",{className:"popup-subtitle"},e.url?c.a.createElement("a",{href:e.url,target:"_blank",rel:"noopener noreferrer"},e.source_name):e.source_name)),c.a.createElement("div",{className:"popup-seroprev-level popup-section"},c.a.createElement("div",{className:"popup-heading"},Y("BestSeroprevalenceEstimate"),": ",c.a.createElement("b",null," ",e.serum_pos_prevalence?"".concat((100*e.serum_pos_prevalence).toFixed(1),"%"):"N/A")),c.a.createElement("div",{className:"popup-text"},e.sampling_start_date&&e.sampling_end_date&&c.a.createElement(c.a.Fragment,null,"".concat(Z(e.sampling_start_date)," ").concat(Y("DateRangeTo")," ").concat(Z(e.sampling_end_date))))),c.a.createElement("div",{className:"popup-section"},bt(Y("PopulationGroup"),e.population_group?vt(t,e.population_group):Y("NotReported")),bt(Y("Location"),function(e,t,a){if(!a)return Y("Not Reported");function n(e){return e&&0!==e.length?"string"===typeof e?e.trim()+", ":e.map((function(e){return e.trim()})).join(", ")+", ":""}return""+n(e)+n(t)+a}(e.city,e.state,e.country)),bt(Y("SampleSize"),null===(a=e.denominator_value)||void 0===a?void 0:a.toString().replace(/\B(?=(\d{3})+(?!\d))/g,Y(","))),bt(Y("AntibodyTarget"),e.antibody_target&&e.antibody_target.length>0?function(e){if("string"==typeof e)return Y("AntibodyTargetOptions",[e.replace(/\s/g,"")]);return e.reduce((function(e,t){return e+Y("AntibodyTargetOptions",[t.replace(/\s/g,"")])+", "}),"").slice(0,-2)}(e.antibody_target):"N/A"),bt(Y("PositiveCases"),e.cases_per_hundred?e.cases_per_hundred.toFixed(1)+Y("Per100"):"N/A"),bt(Y("Vaccinations"),e.full_vaccinations_per_hundred?e.full_vaccinations_per_hundred.toFixed(1)+Y("Per100"):"N/A")),(n="".concat(e.overall_risk_of_bias),c.a.createElement("div",{className:"popup-risk-tag popup-risk-"+n},Y("RiskOfBiasOptions",[n])," ",Y("RiskOfBias"))))}var St=function(e){var t=Object(l.useRef)();return Object(l.useEffect)((function(){t.current=e})),t.current};var Et=function(e,t){e.querySourceFeatures("study-pins",{sourceLayer:"study-pins"}).forEach((function(a){var n=!(t===(null===a||void 0===a?void 0:a.id)||void 0===t);a&&a.id&&e.setFeatureState({source:"study-pins",id:a.id},{isBlurred:n,hover:!1})}))},kt=function(e,t){var a=t.records,n=Object(l.useContext)(ee),r=Object(g.a)(n,1)[0],i=Object(l.useState)(new Xe),s=Object(g.a)(i,1)[0],o=Object(l.useState)(void 0),c=Object(g.a)(o,2),u=c[0],d=c[1],m=St(u),p=Object(l.useState)(void 0),h=Object(g.a)(p,2),f=h[0],b=h[1],v=St(f);Object(l.useEffect)((function(){if(e){var t=function(e){return{type:"geojson",promoteId:"source_id",data:{type:"FeatureCollection",features:function(e){return e.flatMap((function(e){var t;return e.pin_latitude||e.pin_longitude?{type:"Feature",properties:{estimate_grade:e.estimate_grade,source_id:null!==(t=e.source_id)&&void 0!==t?t:void 0},geometry:{type:"Point",coordinates:[e.pin_longitude,e.pin_latitude]}}:[]}))}(e)}}}(a);if(void 0===e.getLayer("study-pins"))e.addSource("study-pins",t),e.addLayer({id:"study-pins",type:"circle",source:"study-pins",paint:rt.Studies});else e.getSource("study-pins").setData(t.data)}}),[e,a]),Object(l.useEffect)((function(){e&&(null===e||void 0===e||e.setFilter("study-pins",["match",["get","estimate_grade"],"National",r.explore.legendLayers.National,"Regional",r.explore.legendLayers.Regional,"Local",r.explore.legendLayers.Local,"Sublocal",r.explore.legendLayers.Local,!1]))}),[e,r.explore.legendLayers]),Object(l.useEffect)((function(){if(e){var t=void 0;e.on("click","study-pins",(function(a){void 0!==t&&t.remove();var n=a.features[0].properties.source_id,i=H(e);s.getRecordDetails(n).then((function(s){null!==s&&(d(n),Et(e,n),t=new qe.a.Popup({offset:5,className:"pin-popup"}).setLngLat(a.lngLat).setMaxWidth("480px").setHTML(ut.a.renderToString(yt(s,r.allFilterOptions.population_group))).addTo(e),e.flyTo({center:[a.lngLat.lng,a.lngLat.lat-i],curve:.5,speed:.5}),le({category:"Study pin popup",action:"open",label:"".concat(n," - ").concat(s.source_name)}),t.on("close",(function(){d(void 0),Et(e)})))}))})),e.on("mouseenter","study-pins",(function(){e.getCanvas().style.cursor="pointer"})),e.on("mouseleave","study-pins",(function(){e.getCanvas().style.cursor=""})),e.on("mousemove","study-pins",(function(e){b(e.features[0].properties.source_id)}))}}),[e,s]),Object(l.useEffect)((function(){e&&f&&!u&&(e.setFeatureState({source:"study-pins",id:f},{hover:!0}),e.setFeatureState({source:"study-pins",id:v},{hover:!1}))}),[e,f]),Object(l.useEffect)((function(){e&&(m&&e.setFeatureState({source:"study-pins",id:m},{isSelected:!1}),u&&e.setFeatureState({source:"study-pins",id:u},{isSelected:!0}))}),[e,u,m])},At=a(139),wt=a.n(At);a(523),a(524);function Tt(e,t){ot(at).then((function(a){!function(e,t){var a=null===e||void 0===e?void 0:e.layers[0]["source-layer"];if(t.addSource(a,e.sources.esri),"Countries"===a){var n=null===e||void 0===e?void 0:e.layers[0];n.source=a,t.addLayer(n)}else e.layers.forEach((function(e){"DISPUTED_AREAS"!==e.source&&"DISPUTED_BORDERS"!==e.source&&(e.source=a,t.addLayer(e))}))}(a,e);var n=e.getStyle();if(n&&n.layers){var r,i=Object(Ge.a)(n.layers);try{for(i.s();!(r=i.n()).done;){var s=r.value;"DISPUTED_AREAS"===s["source-layer"]&&(e.moveLayer("Countries",s.id),e.on("mouseenter",s.id,(function(e){t({type:"HIDE_COUNTRY_HOVER"})})),e.on("mouseleave",s.id,(function(e){t({type:"SHOW_COUNTRY_HOVER"})})))}}catch(o){i.e(o)}finally{i.f()}}}))}wt.a.workerClass=a(525).default,wt.a.accessToken="pk.eyJ1Ijoic2Vyb3RyYWNrZXIiLCJhIjoiY2twdW5xb3N4MDJjeTJ1cWduMXZicHE5bCJ9.b9qA_yhR12XUs-vMLxPfFA";var Pt=function(e){var t=e.mapConfig,a=e.countriesConfig,n=e.studyPinsConfig,r=Object(l.useRef)(null),i=Object(l.useContext)(ee),s=Object(g.a)(i,2),o=(s[0],s[1]),u=Object(l.useState)(void 0),d=Object(g.a)(u,2),m=d[0],f=d[1];return Object(l.useEffect)((function(){return Object(h.a)(p.a.mark((function e(){var a,n,i;return p.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return e.next=2,ot(tt);case 2:a=e.sent,n=Object($.a)(Object($.a)(Object($.a)({},{container:r.current,style:a}),nt),t),(i=new wt.a.Map(n).addControl(new wt.a.NavigationControl)).on("load",(function(){Tt(i,o),f(i)}));case 6:case"end":return e.stop()}}),e)})))(),function(){return null===m||void 0===m?void 0:m.remove()}}),[]),ft(m,a),kt(m,n),c.a.createElement("div",{className:"w-100 h-100 overflow-hidden",ref:function(e){return r.current=e}})},Ot=a(717),Nt=a(718),Dt=a(716),Ct=a(710),xt=function(){var e=Object(h.a)(p.a.mark((function e(t,a,n,r,i){var s;return p.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:t({type:"UPDATE_FILTER",payload:{filterType:n,filterValue:r,pageStateEnum:i}}),(s=Object.assign({},a))[n]=r,ce(s),It(t,s,i);case 5:case"end":return e.stop()}}),e)})));return function(t,a,n,r,i){return e.apply(this,arguments)}}(),Rt=function(){var e=Object(h.a)(p.a.mark((function e(t,a){return p.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:t({type:"CLEAR_ALL_FILTERS",payload:{pageStateEnum:a}}),It(t,ne(),a);case 2:case"end":return e.stop()}}),e)})));return function(t,a){return e.apply(this,arguments)}}(),It=function(){var e=Object(h.a)(p.a.mark((function e(t,a,n){var r,i,s,o;return p.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return r=new Xe,t({type:"CHANGE_LOADING",payload:{pageStateEnum:n,isLoading:!0}}),e.next=4,r.getExploreData(a,!0);case 4:i=e.sent,s=i.records,o=i.estimateGradePrevalences,t({type:"GET_AIRTABLE_RECORDS",payload:{pageStateEnum:n,records:s}}),t({type:"UPDATE_ESTIMATE_PREVALENCES",payload:{pageStateEnum:n,estimateGradePrevalences:o}}),t({type:"CHANGE_LOADING",payload:{pageStateEnum:n,isLoading:!1}});case 10:case"end":return e.stop()}}),e)})));return function(t,a,n){return e.apply(this,arguments)}}(),Lt=a(715);function Mt(e){var t=e.color,a=e.size,n=e.tooltip,r=e.tooltipHeader,i=e.offset,s=e.position,o=e.popupSize,l=void 0===o?"small":o;return c.a.createElement("div",{className:"px-2"},c.a.createElement(Lt.a,{key:Math.random(),offset:i,position:s,size:l,hoverable:!0,onOpen:function(){le({category:"Tooltip",action:"opening",label:r||"Unknown tooltip"})},popperModifiers:{preventOverflow:{boundariesElement:"window"}},trigger:c.a.createElement(y.a,{icon:v.c,color:t,size:a})},r&&c.a.createElement(Lt.a.Header,{className:"flex left"},r),c.a.createElement(Lt.a.Content,{className:"flex left"},n)))}a(310);function zt(e){var t=e.header_text,a=e.tooltip_text,n=e.tooltip_header;return c.a.createElement("div",{className:"pb-2 flex"},c.a.createElement("div",{className:"filter-section-header"},t),a&&c.a.createElement("div",{className:"tooltip-vert-adj"},c.a.createElement(Mt,{offset:10,position:"bottom right",color:"#455a64",tooltipHeader:n||t,popupSize:"small",size:"sm",tooltip:a})))}var jt=a(120),Ft=a.n(jt),Ut=a(705),Wt=a(176),Bt=a(712),Vt=a(713),Ht=a(140),Gt=a(112),_t=a(111),qt=l.Component,Kt=l.Fragment,Qt=function(e){Object(Gt.a)(a,e);var t=Object(_t.a)(a);function a(){var e;Object(Ke.a)(this,a);for(var n=arguments.length,r=new Array(n),i=0;i<n;i++)r[i]=arguments[i];return(e=t.call.apply(t,[this].concat(r))).state={mouseOver:!1},e.onMouseEnter=function(){e.setState({mouseOver:!0})},e.onMouseLeave=function(){e.setState({mouseOver:!1})},e}return Object(Qe.a)(a,[{key:"render",value:function(){var e=this.props,t=Object(g.a)(e.domain,2),a=t[0],n=t[1],r=e.handle,i=r.id,s=r.value,o=r.percent,c=e.isActive,u=e.disabled,d=e.getHandleProps,m=this.state.mouseOver;return l.createElement(Kt,null,!m&&!c||u?null:l.createElement("div",{className:"active-handle-style",style:{left:"".concat(o,"%")}},l.createElement("div",{className:"tooltip"},l.createElement("span",{className:"tooltiptext"},"Value: ",s))),l.createElement("div",Object.assign({role:"slider","aria-valuemin":a,"aria-valuemax":n,"aria-valuenow":s,className:"handle-style",style:{left:"".concat(o,"%"),backgroundColor:u?"#666":"#f1f5f7"}},d(i,{onMouseEnter:this.onMouseEnter,onMouseLeave:this.onMouseLeave}))))}}]),a}(qt);function Jt(e){var t=e.source,a=e.target,n=e.getTrackProps,r=e.disabled,i=void 0!==r&&r;return l.createElement("div",Object.assign({className:"track-style",style:{backgroundColor:i?"#999":"#455a6a",left:"".concat(t.percent,"%"),width:"".concat(a.percent-t.percent,"%")}},n()))}Qt.defaultProps={disabled:!1};var Yt=l.Component,Zt=l.Fragment,Xt=function(e){Object(Gt.a)(a,e);var t=Object(_t.a)(a);function a(){var e;Object(Ke.a)(this,a);for(var n=arguments.length,r=new Array(n),i=0;i<n;i++)r[i]=arguments[i];return(e=t.call.apply(t,[this].concat(r))).state={value:null,percent:null},e.onMouseEnter=function(){document.addEventListener("mousemove",e.onMouseMove)},e.onMouseLeave=function(){e.setState({value:null,percent:null}),document.removeEventListener("mousemove",e.onMouseMove)},e.onMouseMove=function(t){var a=e.props,n=a.activeHandleID,r=a.getEventData;n?e.setState({value:null,percent:null}):e.setState(r(t))},e}return Object(Qe.a)(a,[{key:"render",value:function(){var e=this.state,t=e.value,a=e.percent,n=this.props,r=n.activeHandleID,i=n.getRailProps;return l.createElement(Zt,null,!r&&t?l.createElement("div",{className:"handle-style",style:{left:"".concat(a,"%")}},l.createElement("div",{className:"tooltip"},l.createElement("span",{className:"tooltiptext"},"Value: ",t))):null,l.createElement("div",Object.assign({className:"rail-style"},i({onMouseEnter:this.onMouseEnter,onMouseLeave:this.onMouseLeave}))),l.createElement("div",{className:"rail-center-style"}))}}]),a}(Yt);Xt.defaultProps={disabled:!1};var $t={position:"relative",width:"80%",margin:"5% 10%"};function ea(e){var t=e.minPossibleValue,a=e.maxPossibleValue,n=e.minDate,r=e.values,i=e.onMouseUp,s=e.onSliderMove,o=Object(l.useState)([t,a]),c=Object(g.a)(o,2),u=c[0],d=c[1],m=[t,a];Object(l.useEffect)((function(){d(r)}),[r]);var p=function(e){return new Date(n.getTime()+864e5*e)},h=function(e){return e.getFullYear()+"/"+(e.getMonth()+1)+"/"+e.getDate()};return l.createElement("div",{style:{height:10,width:"100%"}},l.createElement(Ht.c,{mode:1,step:1,domain:m,rootStyle:$t,onUpdate:function(e){d(e.concat()),s(u)},onChange:function(e){e[0]===r[0]?i(!1,p(e.concat()[1])):i(!0,p(e.concat()[0]))},values:r},l.createElement(Ht.b,null,(function(e){return l.createElement(Xt,e)})),l.createElement(Ht.a,null,(function(e){var t=e.handles,a=e.activeHandleID,n=e.getHandleProps;return l.createElement("div",{className:"slider-handles"},t.map((function(e){return l.createElement(Qt,{key:e.id,handle:e,domain:m,isActive:e.id===a,getHandleProps:n})})))})),l.createElement(Ht.d,{left:!1,right:!1},(function(e){var t=e.tracks,a=e.getTrackProps;return l.createElement("div",{className:"slider-tracks"},t.map((function(e){var t=e.id,n=e.source,r=e.target;return l.createElement(Jt,{key:t,source:n,target:r,getTrackProps:a})})))}))),l.createElement("div",{className:"pt-4 d-flex justify-content-between"},l.createElement("div",null,h(p(u[0]))),l.createElement("div",null,h(p(u[1])))))}a(553);function ta(e){var t=e.page,a=Object(l.useContext)(ee),n=Object(g.a)(a,2),r=n[0],i=n[1],s=r[t].filters,o=r.calendarStartDates.minDate,u=r.calendarStartDates.maxDate,d=Object(l.useState)((u.getTime()-o.getTime())/864e5),m=Object(g.a)(d,2),p=m[0],h=m[1],f=Array.from(s.publish_date),b=Object(g.a)(f,2),v=b[0],y=b[1],S=function(e){return(e.getTime()-o.getTime())/864e5},E=function(e){return new Date(o.getTime()+864e5*e)},k=Object(l.useState)([S(v),S(y)]),A=Object(g.a)(k,2),w=A[0],T=A[1];Object(l.useEffect)((function(){Object(jt.registerLocale)("en",Wt.a),Object(jt.registerLocale)("fr",Bt.a),Object(jt.registerLocale)("de",Vt.a)}),[]),Object(l.useEffect)((function(){var e=Array.from(s.publish_date),t=Object(g.a)(e,2),a=t[0],n=t[1];T([S(a),S(n)])}),[s.publish_date]),Object(l.useEffect)((function(){h(S(u))}),[u,o]);var P=function(e,a){var n;e?(n=[a,E(w[1])],T([S(a),w[1]])):(n=[E(w[0]),a],T([w[0],S(a)])),xt(i,s,"publish_date",n,t)},O=function(e){var t=e.value,a=e.onClick;e.text;return c.a.createElement("div",{className:"col-12 p-0 flex input-seperate"},c.a.createElement(Ut.a,{className:"col-12 p-0 cursor",value:t,fluid:!0,type:"text",placeholder:Y("SelectDate"),onClick:a}))};return c.a.createElement("div",{className:"row justify-content-center"},c.a.createElement("div",{className:"col-10 col align-items-center p-0"},c.a.createElement("div",{className:"pb-1"},c.a.createElement("div",null,c.a.createElement(zt,{header_text:Y("DateRange"),tooltip_text:Y("DateRangeTooltip")})),c.a.createElement(ea,{maxPossibleValue:p,minPossibleValue:0,onMouseUp:P,onSliderMove:function(e){T(e)},values:w,minDate:o}),c.a.createElement("div",{className:"space-between mt-3 mb-3"},c.a.createElement(Ft.a,{selected:E(w[0]),onChange:function(){},onSelect:function(e){return P(!0,e)},dateFormatCalendar:"MMMM yyyy ",dateFormat:"yyyy/MM/dd",minDate:o,maxDate:E(w[1]),showYearDropdown:!0,yearDropdownItemNumber:5,scrollableYearDropdown:!0,showMonthDropdown:!0,locale:r.language,customInput:c.a.createElement(O,{value:E(w[0]),onClick:onclick}),withPortal:!0,closeOnScroll:!0,shouldCloseOnSelect:!1,dropdownMode:"select",todayButton:Y("Today")}),c.a.createElement(Ft.a,{selected:E(w[1]),onChange:function(){},onSelect:function(e){return P(!1,e)},dateFormat:"yyyy/MM/dd",dateFormatCalendar:"MMM yyyy",minDate:E(w[0]),maxDate:u,showYearDropdown:!0,yearDropdownItemNumber:5,scrollableYearDropdown:!0,showMonthDropdown:!0,locale:r.language,customInput:c.a.createElement(O,{value:E(w[1]),onClick:onclick}),withPortal:!0,closeOnScroll:!0,shouldCloseOnSelect:!1,dropdownMode:"select",todayButton:"Today"})))))}a(594);function aa(e){var t,a,n,i,s=e.page,o=Object(l.useContext)(ee),u=Object(g.a)(o,2),d=u[0],m=u[1],f=d[s].filters,b=function(e,t){if(e){var a=[],n=F(t.toString()),i="".concat(n,"Options");switch(t){case"country":e.forEach((function(e){a.push({key:e,text:q(e,d.language,i),value:e})}));break;case"population_group":e.forEach((function(e){e=e;var t="";d.language===r.english?t=e.english:d.language===r.french?t=e.french:d.language===r.german&&(t=e.german),a.push({key:t,text:t,value:t})}));break;default:e.forEach((function(e){var t=Y(i,[F(e)]),n=Y(i,[e.replace(/ /g,"")]),r=n||t?t||n:e;a.push({key:e,text:r,value:e})}))}return a}},v=function(e,t){xt(m,f,t,e,s)},y=function(){var e=Object(h.a)(p.a.mark((function e(){return p.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:Rt(m,s);case 1:case"end":return e.stop()}}),e)})));return function(){return e.apply(this,arguments)}}(),S=function(e,t){return c.a.createElement("div",{className:"pb-3"},c.a.createElement(Ct.a,{text:t,fluid:!0,multiple:!0,search:!0,clearable:!0,selection:!0,options:b(d.allFilterOptions[e],e),onChange:function(t,a){v(a.value,e)},value:f[e],defaultValue:f[e]}))};return c.a.createElement("div",{className:"col-12 p-0"},c.a.createElement("div",{className:"py-3 center flex"},c.a.createElement("h3",null,Y("Filter")),c.a.createElement("div",{className:"tooltip-vert-adj"},c.a.createElement(Mt,{offset:10,position:"bottom right",color:"#455a64",tooltipHeader:Y("Filter"),popupSize:"small",size:"sm",tooltip:Y("FilterTooltip")}))),c.a.createElement("div",{className:"row justify-content-center"},c.a.createElement("div",{className:"col-10 col align-items-center p-0"},c.a.createElement("div",{className:"pb-1"},c.a.createElement("div",null,c.a.createElement(zt,{header_text:Y("StudyInformation"),tooltip_text:c.a.createElement("div",null,c.a.createElement("p",null,Y("StudyInformationTooltip",["FirstParagraph"])),c.a.createElement("p",null,c.a.createElement("b",null,Y("StudyInformationTooltip",["SecondParagraph","PartOne"],null,[!1,!0])),Y("StudyInformationTooltip",["SecondParagraph","PartTwo"])),c.a.createElement("p",null,c.a.createElement("b",null,Y("StudyInformationTooltip",["ThirdParagraph","PartOne"],null,[!1,!0])),Y("StudyInformationTooltip",["ThirdParagraph","PartTwo"],null,[!1,!0]),c.a.createElement("a",{href:"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/early-investigations",target:"_blank",rel:"noopener noreferrer"},Y("StudyInformationTooltip",["ThirdParagraph","PartThree"],null,[!1,!0])),Y("StudyInformationTooltip",["ThirdParagraph","PartFour"])))})),c.a.createElement("div",null,(t="unity_aligned_only",a=Y("UnityStudiesOnly"),n=Y("UnityStudiesOnlyLong"),i="https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/early-investigations",c.a.createElement("div",{title:n||a,className:"checkbox-item pb-3 ",id:"National",onClick:function(e){"unity_aligned_only"===t&&f[t]&&ue(),v(!f[t],t)}},c.a.createElement("input",{className:"ui checkbox "+(d.pulsateUnityFilter?"pulse":""),type:"checkbox",onClick:function(){m({type:"SET_UNITY_FILTER_PULSATE",payload:!1})},checked:f[t],readOnly:!0}),c.a.createElement("label",null,c.a.createElement("a",{href:i,target:"_blank",rel:"noopener noreferrer"},a))))),c.a.createElement("div",null,S("source_type",Y("SourceType"))),c.a.createElement("div",null,S("overall_risk_of_bias",Y("OverallRiskOfBias")))),c.a.createElement("div",{className:"pb-1"},c.a.createElement("div",null,c.a.createElement(zt,{header_text:Y("Demographics"),tooltip_text:Y("DemographicsTooltip")})),c.a.createElement("div",null,S("population_group",Y("PopulationGroup"))),c.a.createElement("div",null,S("sex",Y("Sex"))),c.a.createElement("div",null,S("age",Y("Age")))),c.a.createElement("div",{className:"pb-1"},c.a.createElement("div",null,c.a.createElement(zt,{header_text:Y("TestInformation"),tooltip_text:Y("TestInformationTooltip")})),c.a.createElement("div",null,S("test_type",Y("TestType"))),c.a.createElement("div",null,S("isotypes_reported",Y("IsotypesReported"))),c.a.createElement("div",null,S("antibody_target",Y("AntibodyTarget")))))),c.a.createElement(ta,{page:s}),c.a.createElement("div",{className:"row justify-content-center"},c.a.createElement("div",{className:"col-10 col align-items-center p-0"},c.a.createElement("div",{className:"pb-3"},c.a.createElement(je.a,{className:"clear-filters-btn",size:"medium",onClick:y}," ",Y("ClearAllFilters"))))))}a(603);var na=a(706);function ra(e){var t=e.hideLayers,a=Object(l.useContext)(ee),n=Object(g.a)(a,2),r=n[0],i=n[1],s=function(e){switch(e.currentTarget.id){case"National":return i({type:"TOGGLE_NATIONAL_PIN_LAYER"});case"Regional":return i({type:"TOGGLE_REGIONAL_PIN_LAYER"});case"Local":return i({type:"TOGGLE_LOCAL_PIN_LAYER"})}};return c.a.createElement("div",{className:"flex legend-container",key:Math.random()},c.a.createElement("div",{className:"legend-item",id:"National",onClick:s},c.a.createElement("i",{className:"circleBase legend-icon",style:{background:$e.National.Color}}),c.a.createElement("label",{className:"legend-label"},Y("NationalStudies")),c.a.createElement(na.a,{className:"legend-checkbox",checked:r.explore.legendLayers.National})),c.a.createElement("div",{className:"legend-item",id:"Regional",onClick:s},c.a.createElement("i",{className:"circleBase legend-icon",style:{background:$e.Regional.Color}}),c.a.createElement("label",{className:"legend-label"},Y("RegionalStudies")),c.a.createElement(na.a,{className:"legend-checkbox",checked:r.explore.legendLayers.Regional})),c.a.createElement("div",{className:"legend-item mb-1",id:"Local",onClick:s},c.a.createElement("i",{className:"circleBase legend-icon",style:{background:$e.Local.Color}}),c.a.createElement("label",{className:"legend-label"},Y("LocalStudies")),c.a.createElement(na.a,{className:"legend-checkbox",checked:r.explore.legendLayers.Local})),t?null:c.a.createElement(c.a.Fragment,null,c.a.createElement("div",{className:"legend-item"},c.a.createElement("i",{className:"block legend-icon",style:{background:et.HasData.Color,outlineWidth:1,outlineStyle:"solid"}}),c.a.createElement("label",null,Y("CountryEstimatesExist"))),c.a.createElement("div",{className:"legend-item"},c.a.createElement("i",{className:"block legend-icon",style:{background:et.Default.Color,outlineWidth:1,outlineStyle:"solid"}}),c.a.createElement("label",null,Y("CountryEstimatesNotExist"))),c.a.createElement("div",{className:"legend-item"},c.a.createElement("i",{className:"block legend-icon",style:{background:et.Disputed.Color,outlineWidth:1,outlineStyle:"solid"}}),c.a.createElement("label",null,Y("NotApplicable")))))}a(604);function ia(e){var t=e.page,a=Object(l.useContext)(ee),n=Object(g.a)(a,1)[0],r=Object(l.useState)(0),i=Object(g.a)(r,2),s=i[0],o=i[1],u=Object(l.useState)(0),d=Object(g.a)(u,2),m=d[0],f=d[1],b=Object(l.useState)(0),v=Object(g.a)(b,2),y=v[0],S=v[1],E=n[t];return Object(l.useEffect)((function(){(function(){var e=Object(h.a)(p.a.mark((function e(){return p.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:o(E.estimateGradePrevalences.length),S(E.estimateGradePrevalences.map((function(e){return e.testsAdministered})).reduce((function(e,t){return e+t}),0)),f(E.estimateGradePrevalences.map((function(e){return e.numberOfStudies})).reduce((function(e,t){return e+t}),0));case 3:case"end":return e.stop()}}),e)})));return function(){return e.apply(this,arguments)}})()()}),[E.estimateGradePrevalences]),c.a.createElement("div",{className:"col-12 p-0 stats-container"},c.a.createElement("h3",{className:"mt-3 mb-2 center"},Y("SummaryStatistics")),c.a.createElement("div",{className:"flex middle py-2"},c.a.createElement("div",{className:"secondary-statistic"},m),c.a.createElement("div",{className:"secondary-statistic-title px-1 center"},Y("SeroprevalenceStudies"))),c.a.createElement("div",{className:"flex middle py-2"},c.a.createElement("div",{className:"secondary-statistic-title px-1 center"},Y("CountriesIncluded",["PartOne"])),c.a.createElement("div",{className:"secondary-statistic"},s),c.a.createElement("div",{className:"secondary-statistic-title px-1 center"},Y("CountriesIncluded",["PartTwo"]))),c.a.createElement("div",{className:"flex middle py-2"},c.a.createElement("div",{className:"secondary-statistic-title center px-1"},Y("IncludingParticipants",["PartOne"])),c.a.createElement("div",{className:"secondary-statistic center"},y.toLocaleString()),c.a.createElement("div",{className:"secondary-statistic-title px-1 center "},Y("IncludingParticipants",["PartTwo"]))),c.a.createElement("br",null))}var sa=a(359),oa=a.n(sa);function la(e){var t=Object(l.useState)(!1),a=Object(g.a)(t,2),n=a[0],r=a[1],i=e.buttonLabelKey,s=e.downloadLink,u=e.formLink,d=e.iconName,m=e.popupText;Object(l.useEffect)((function(){localStorage.getItem("DownloadFormCompleted")&&r(!0)}),[]);var f=function(){var e=Object(h.a)(p.a.mark((function e(){return p.a.wrap((function(e){for(;;)switch(e.prev=e.next){case 0:return le({category:"Data Link Click",action:"click",label:i}),localStorage.setItem("DownloadFormCompleted","true"),e.next=4,new Promise((function(e){setTimeout(e,18e4)}));case 4:r(!0);case 5:case"end":return e.stop()}}),e)})));return function(){return e.apply(this,arguments)}}(),b=function(){return n?s:u};return d===o.airtable?c.a.createElement(Lt.a,{popperModifiers:{preventOverflow:{boundariesElement:"window"}},content:Y(m),size:"small",style:{textAlign:"left"},position:"top left",trigger:c.a.createElement(je.a,{key:i,size:"large",iconName:d,className:"download-data-btn mb-2",id:e.id},c.a.createElement("a",{onClick:function(){return f()},target:"_blank",rel:"noopener noreferrer",href:b(),className:"d-flex align-items-center"},c.a.createElement("span",{className:"button-text"}," ",Y(i)),c.a.createElement("img",{className:"ml-3",src:oa.a,alt:"airtable-logo",width:"24",height:"24"})))}):c.a.createElement(Lt.a,{popperModifiers:{preventOverflow:{boundariesElement:"window"}},id:e.id,size:"small",style:{textAlign:"left"},content:Y(m),position:"top left",trigger:c.a.createElement(je.a,{id:e.id,key:i,size:"large",iconName:d,className:"download-data-btn mb-2"},c.a.createElement("a",{onClick:function(){return f()},target:"_blank",rel:"noopener noreferrer",href:b(),className:"d-flex align-items-center"},c.a.createElement("span",{className:"button-text"}," ",Y(i)),c.a.createElement(ge.a,{name:d,size:"large",className:"ml-3"})))})}a(605);function ca(e){var t=e.page,a={buttonLabelKey:"DownloadCsv",downloadLink:"https://airtable.com/shraXWPJ9Yu7ybowM/tbljN2mhRVfSlZv2d?backgroundColor=blue&viewControls=on",formLink:"https://docs.google.com/forms/d/e/1FAIpQLSdGd_wlq8YSyVPs2AOi1VfvxuLzxA8Ye5I3HkQwW_9yrumsCg/viewform",iconName:o.airtable,popupText:"DownloadAirtable"},n={buttonLabelKey:"AccessGithub",downloadLink:"https://github.com/serotracker/sars-cov-2-data",formLink:"https://docs.google.com/forms/d/e/1FAIpQLSdGd_wlq8YSyVPs2AOi1VfvxuLzxA8Ye5I3HkQwW_9yrumsCg/viewform",iconName:o.github,popupText:"DownloadGithub"};return c.a.createElement("div",{className:"sidebar-container flex left-sidebar"},c.a.createElement(ia,{page:t}),c.a.createElement(dt.a,null),c.a.createElement("div",null,c.a.createElement("p",null,Y("ExploreBlurb",["FirstParagraph"])),"\n",c.a.createElement("p",null,Y("ExploreBlurb",["SecondParagraph"])),"\n",c.a.createElement("p",null,Y("ExploreBlurb",["ThirdParagraph"]))),c.a.createElement("div",{className:"d-flex justify-content-center mt-3"},c.a.createElement("span",{style:{margin:"0"}},c.a.createElement(la,a))),c.a.createElement("div",{className:"d-flex justify-content-center mt-1"},c.a.createElement("span",{style:{margin:"0"},id:N.Explore.AccessGithub},c.a.createElement(la,n))))}a(606);function ua(){var e=Object(l.useState)(!1),t=Object(g.a)(e,2),a=t[0],n=t[1],r=Object(l.useState)(!1),s=Object(g.a)(r,2),o=s[0],u=s[1],d=Object(l.useState)(!1),m=Object(g.a)(d,2),p=m[0],h=m[1],f=Object(l.useContext)(ee),b=Object(g.a)(f,1)[0],S=function(){var e=arguments.length>0&&void 0!==arguments[0]&&arguments[0],t=arguments.length>1&&void 0!==arguments[1]&&arguments[1],a=arguments.length>2&&void 0!==arguments[2]&&arguments[2];n(e),u(t),h(a)};return Object(l.useEffect)((function(){n(b.pulsateUnityFilter)}),[b.pulsateUnityFilter]),c.a.createElement("div",{className:"fill flex explore",style:{height:"100%"}},c.a.createElement(Ot.a.Pushable,{as:Nt.a,className:"fill flex"},c.a.createElement(Ot.a,{as:Dt.a,animation:"overlay",icon:"labeled",className:"col-10 p-0",vertical:!0,direction:"left",visible:a,width:"wide"},c.a.createElement(aa,{page:i.explore}),c.a.createElement(y.a,{icon:v.d,onClick:function(){return S()},className:"icon",color:"#455a64",style:{fontWeight:300,position:"absolute",zIndex:3e3,top:10,right:20},size:"lg"})),c.a.createElement(Ot.a,{as:Dt.a,animation:"overlay",icon:"labeled",className:"col-10 p-0",vertical:!0,direction:"left",visible:o,width:"wide"},c.a.createElement(y.a,{icon:v.d,onClick:function(){return S()},className:"icon",color:"#455a64",style:{fontWeight:300,position:"absolute",zIndex:3e3,top:10,right:20},size:"lg"}),c.a.createElement(ca,{page:i.explore})),c.a.createElement(Ot.a,{as:Dt.a,animation:"overlay",icon:"labeled",className:"col-10 p-0",vertical:!0,visible:p,width:"wide"},c.a.createElement(y.a,{icon:v.d,onClick:function(){return S()},className:"icon",color:"#455a64",style:{fontWeight:300,position:"absolute",zIndex:3e3,top:10,right:20},size:"lg"}),c.a.createElement("div",{className:"m-3 mt-5"},c.a.createElement(ra,null))),c.a.createElement(Ot.a.Pusher,{className:"fill flex"},c.a.createElement(Pt,{countriesConfig:{estimateGradePrevalences:b.explore.estimateGradePrevalences},studyPinsConfig:{records:b.explore.records}}),c.a.createElement("div",{className:"sidebar__info-btn"},c.a.createElement(ge.a,{name:"filter",size:"large",className:"ml-1 mt-1",onClick:function(){return S(!a,!1,!1)}})),c.a.createElement("div",{className:"sidebar__filter-btn"},c.a.createElement(ge.a,{name:"question circle",size:"large",className:"ml-1 mt-1",onClick:function(){return S(!1,!o,!1)}})),c.a.createElement("div",{className:"sidebar__map-btn"},c.a.createElement(ge.a,{name:"map",size:"large",className:"ml-1 mt-1",onClick:function(){return S(!1,!1,!a)}})))))}a(313);function da(e){var t=e.isOpen;e.headerText;return c.a.createElement(Ve.a,{className:"maintenance-modal",closeOnEscape:!1,closeOnDimmerClick:!1,open:t},c.a.createElement(Ve.a.Header,null,Y("TemporaryMaintenance")),c.a.createElement(Ve.a.Content,null,c.a.createElement("p",null,Y("TemporaryMaintenanceDescription"))))}function ma(e){var t=e.initialFilters,a=Object(S.useMediaQuery)({maxDeviceWidth:1200}),n=Object(l.useContext)(ee),r=Object(g.a)(n,2),s=r[0],o=r[1],u=Object(l.useState)(!1),d=Object(g.a)(u,2),m=d[0],p=d[1],h=Object(l.useState)(a),f=Object(g.a)(h,2),b=f[0],v=f[1];return Object(l.useEffect)((function(){t&&(p(!0),o({type:"UPDATE_ALL_FILTERS",payload:{newFilters:t,pageStateEnum:i.explore}}),ce(t),t.unity_aligned_only&&ue()),It(o,s.explore.filters,i.explore)}),[]),c.a.createElement(c.a.Fragment,null,c.a.createElement(Ve.a,{onClose:function(){v(!1)},open:b,size:"mini",closeOnEscape:!0,closeOnDimmerClick:!0},c.a.createElement(Ve.a.Header,{className:"flex justify-content-center text-center"},Y("Welcome")),c.a.createElement(Ve.a.Content,{className:"text-center"},Y("OptimisedFunctionality")),c.a.createElement(Ve.a.Actions,{className:"flex justify-content-center"},c.a.createElement(je.a,{onClick:function(){return v(!1)},style:{backgroundColor:"#094180",color:"#FFFFFF"}},Y("Okay")))),c.a.createElement("div",{className:"fill flex dashboard"},a?c.a.createElement("div",{className:"flex w-100"},m&&c.a.createElement("div",{className:"px-4 flex center-item justify-content-between w-100",style:{backgroundColor:"#E8EBEF",height:"150px"}},c.a.createElement("div",{style:{width:"80%"}},Y("UnityBanner",["Currently"]),c.a.createElement("a",{href:"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/early-investigations",target:"_blank",rel:"noopener noreferrer"},Y("UnityBanner",["ProtocolLink"]))," ",Y("UnityBanner",["ViewDatabase"])," ",c.a.createElement("span",{className:"link",onClick:function(){o({type:"SET_UNITY_FILTER_PULSATE",payload:!0})}}," ",Y("UnityBanner",["WHOUnityFilter"])," "),Y("UnityBanner",["Filter"])),c.a.createElement(ge.a,{link:!0,onClick:function(){p(!1)},name:"close"})),c.a.createElement(ua,null)):c.a.createElement(c.a.Fragment,null,m&&c.a.createElement("div",{className:"px-4 flex center-item justify-content-between w-100 visible",style:{backgroundColor:"#E8EBEF",height:"50px"}},c.a.createElement("div",{style:{width:"80%"}},Y("UnityBanner",["Currently"]),c.a.createElement("a",{href:"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/early-investigations",target:"_blank",rel:"noopener noreferrer"},Y("UnityBanner",["ProtocolLink"]))," ",Y("UnityBanner",["ViewDatabase"])," ",c.a.createElement("span",{className:"link",onClick:function(){o({type:"SET_UNITY_FILTER_PULSATE",payload:!0})}}," ",Y("UnityBanner",["WHOUnityFilter"])," "),Y("UnityBanner",["Filter"])),c.a.createElement(ge.a,{link:!0,onClick:function(){p(!1)},name:"close"})),c.a.createElement("div",{className:"flex h-100 w-100"},c.a.createElement("div",{className:"col-2 p-0 flex"},c.a.createElement(ca,{page:i.explore})),c.a.createElement("div",{className:"col-8 p-0 flex",id:N.Explore.Map},c.a.createElement(He.a,{indeterminate:!0,active:s.explore.isLoading}),c.a.createElement("div",{className:"info flex legend center-item"},c.a.createElement(ra,null)),c.a.createElement(Pt,{countriesConfig:{estimateGradePrevalences:s.explore.estimateGradePrevalences},studyPinsConfig:{records:s.explore.records}})),c.a.createElement("div",{className:"col-2 p-0 flex sidebar-container"},c.a.createElement(aa,{page:i.explore}))))),c.a.createElement(da,{isOpen:!1,headerText:"Explore"}))}function pa(){var e=[{label:"OurProtocol",link:"https://docs.google.com/document/d/1NYpszkr-u__aZspFDFa_fa4VBzjAAAAxNxM1rZ1txWU/edit"},{label:"DataDictionary",link:"https://airtable.com/shr9XzggGpYFqMdJF/tblIdx2b6ZOLevdJr",id:N.Data.DataDictionary},{label:"ChangeLog",link:"https://airtable.com/shrxpAlF6v0LeRYkA",id:N.Data.ChangeLog},{label:"SubmitSource",link:"https://docs.google.com/forms/d/e/1FAIpQLSdvNJReektutfMT-5bOTjfnvaY_pMAy8mImpQBAW-3v7_B2Bg/viewform",id:N.Data.SubmitSource}].map((function(e,t){return c.a.createElement(je.a,{key:t,color:"blue",size:"large",className:"mb-2 mr-2",id:null===e||void 0===e?void 0:e.id},c.a.createElement("a",{onClick:function(){return t=e.label,void le({category:"Data Link Click",action:"click",label:t});var t},target:"_blank",rel:"noopener noreferrer",href:e.link},c.a.createElement("p",{className:"button-text"}," ",Y(e.label))))})),t={id:N.Data.DownloadCsv,buttonLabelKey:"DownloadCsv",downloadLink:"https://airtable.com/shraXWPJ9Yu7ybowM/tbljN2mhRVfSlZv2d?backgroundColor=blue&viewControls=on",formLink:"https://docs.google.com/forms/d/e/1FAIpQLSdGd_wlq8YSyVPs2AOi1VfvxuLzxA8Ye5I3HkQwW_9yrumsCg/viewform",iconName:o.airtable,popupText:"DownloadAirtable"},a={id:N.Data.AccessGithub,buttonLabelKey:"AccessGithub",downloadLink:"https://github.com/serotracker/sars-cov-2-data",formLink:"https://docs.google.com/forms/d/e/1FAIpQLSdGd_wlq8YSyVPs2AOi1VfvxuLzxA8Ye5I3HkQwW_9yrumsCg/viewform",iconName:o.github,popupText:"DownloadGithub"};return c.a.createElement("div",null,e,c.a.createElement("span",null,c.a.createElement("span",{className:"mr-2"},c.a.createElement(la,t)),c.a.createElement("span",{className:"mr-2"},c.a.createElement(la,a))))}function ha(){var e=Object(l.useState)(-1),t=Object(g.a)(e,2),a=t[0],n=t[1],r=function(e,t){var r=t.index,i=t.titleText,s=a===r?-1:r;n(s),-1!=s&&le({category:"Data FAQ",action:"open",label:i})},i=Object.entries(function(e){var t=_[Q];try{return t[e]}catch(a){return{error:"No translation object for string ".concat(e)}}}("DropdownQuestions")).map((function(e,t){return c.a.createElement(he.a,{key:t,fluid:!0,styled:!0},c.a.createElement(he.a.Title,{active:a===t,index:t,onClick:r,className:"accordion-title"},c.a.createElement(ge.a,{name:"dropdown"})," ",e[1].Question),c.a.createElement(he.a.Content,{active:a===t},e[1].Links?c.a.createElement("div",null,Object.entries(e[1].Answer).map((function(t,a){var n,r;return c.a.createElement("p",{className:"no-space"}," ",t[1]," ",c.a.createElement("a",{href:null===(n=e[1].Links)||void 0===n?void 0:n["Link".concat(a+1)],target:"_blank",rel:"noopener noreferrer"},null===(r=e[1].LinkTexts)||void 0===r?void 0:r["LinkText".concat(a+1)]))}))):c.a.createElement("p",null,e[1].Answer)))}));return c.a.createElement("div",null,i)}function ga(){var e=Object(S.useMediaQuery)({maxDeviceWidth:1200});return c.a.createElement(c.a.Fragment,null,c.a.createElement("div",{className:"col-12 page pb-5"},c.a.createElement("div",{className:e?"static-mobile py-2":"static-content py-2"},c.a.createElement("div",{className:e?"pt-3":"pt-0"},c.a.createElement("h1",null,Y("OurData")),c.a.createElement("p",null,Y("WhatWeDoText",["FirstParagraph"])),c.a.createElement("p",null,Y("WhatWeDoText",["SecondParagraph"])),c.a.createElement(pa,null)),c.a.createElement("div",{className:e?"pt-3":"pt-0",id:N.Data.FAQ},c.a.createElement("h1",null,Y("FrequentlyAskedQuestions")),c.a.createElement(ha,null)),c.a.createElement("div",{className:e?"pb-3 pt-3":"pt-0 pb-0",id:N.Data.DataTable},c.a.createElement("h1",null,Y("DataTable")),c.a.createElement("p",null,c.a.createElement("span",null,Y("UseOfData",null,null,[!1,!0])),c.a.createElement(me.a,{to:"/TermsOfUse"},Y("TermsOfUse")),"."),c.a.createElement(Nt.a,null,c.a.createElement("iframe",{title:"Data Table",className:"iframe-style",src:e?"https://airtable.com/embed/shrtuN7F8x4bdkdDA?backgroundColor=cyan&layout=card&viewControls=on":"https://airtable.com/embed/shrtuN7F8x4bdkdDA?backgroundColor=cyan&viewControls=on"}))))),c.a.createElement(da,{isOpen:!1,headerText:"Data"}))}var fa=a(711);function ba(e){return c.a.createElement("div",{className:"py-4 px-2 flex justify-content-center"},c.a.createElement(fa.a,{className:"publications-card"},e.img&&c.a.createElement(fa.a.Content,null,c.a.createElement("div",{className:"flex center-item publications-card-image mb-2"},c.a.createElement("img",{src:e.img,alt:"",className:"fit publications-card-image"}),c.a.createElement("a",{href:e.url,target:"_blank",rel:"noopener noreferrer",className:"overlay flex publication-link"},c.a.createElement("div",{className:"publications-card-image-overlay flex fill center-item column"},c.a.createElement("div",null,Y("ViewFile")),c.a.createElement("div",{className:"flex center-item"},c.a.createElement(y.a,{icon:v.b,className:"icon",color:"white",size:"lg"})))))),c.a.createElement(fa.a.Content,null,c.a.createElement("div",{className:"publications-card-title m-0"},c.a.createElement("a",{href:e.url,target:"_blank",rel:"noopener noreferrer",className:"publication-link"},e.italicize?c.a.createElement("i",null,e.italicize,"\xa0"):null,Y(e.titleKey1,e.titleKey2))),e.date&&c.a.createElement("div",{className:"publications-card-date"},Z(e.date+"T00:00:00")))))}a(660);function va(e){return c.a.createElement("div",{className:"py-4 px-2 flex justify-content-center"},c.a.createElement(fa.a,{className:"biblio-digest-card"},c.a.createElement(fa.a.Content,{className:"my-2 mx-4"},c.a.createElement("h4",{className:"biblio-digest-card-title pb-4"},c.a.createElement("a",{href:e.url,target:"_blank",rel:"noopener noreferrer",className:"publication-link"},Y("BiblioDigestCard",["Title"])," ",Z(e.screeningStartDate+"T00:00:00")," - ",Z(e.screeningEndDate+"T00:00:00"))),c.a.createElement("div",{className:"pb-3"},c.a.createElement("div",{className:"biblio-digest-card-text"},Y("BiblioDigestCard",["Published"])," ",Z(e.publishDate+"T00:00:00"))),c.a.createElement("div",{className:"biblio-digest-card-row pb-2"},c.a.createElement("div",{className:"biblio-digest-card-text-bold"},Y("BiblioDigestCard",["NewSerosurveys"])),c.a.createElement("div",{className:"biblio-digest-card-text-bold"},e.serosurveysTotal)),c.a.createElement("div",{className:"biblio-digest-card-row pl-3"},c.a.createElement("div",{className:"biblio-digest-card-text"},Y("BiblioDigestCard",["AFRO"])),c.a.createElement("div",{className:"biblio-digest-card-text"},e.serosurveysAFRO)),c.a.createElement("div",{className:"biblio-digest-card-row pl-3"},c.a.createElement("div",{className:"biblio-digest-card-text"},Y("BiblioDigestCard",["EMRO"])),c.a.createElement("div",{className:"biblio-digest-card-text"},e.serosurveysEMRO)),c.a.createElement("div",{className:"biblio-digest-card-row pl-3"},c.a.createElement("div",{className:"biblio-digest-card-text"},Y("BiblioDigestCard",["EURO"])),c.a.createElement("div",{className:"biblio-digest-card-text"},e.serosurveysEURO)),c.a.createElement("div",{className:"biblio-digest-card-row pl-3"},c.a.createElement("div",{className:"biblio-digest-card-text"},Y("BiblioDigestCard",["PAHO"])),c.a.createElement("div",{className:"biblio-digest-card-text"},e.serosurveysPAHO)),c.a.createElement("div",{className:"biblio-digest-card-row pl-3"},c.a.createElement("div",{className:"biblio-digest-card-text"},Y("BiblioDigestCard",["SEARO"])),c.a.createElement("div",{className:"biblio-digest-card-text"},e.serosurveysSEARO)),c.a.createElement("div",{className:"biblio-digest-card-row pl-3"},c.a.createElement("div",{className:"biblio-digest-card-text"},Y("BiblioDigestCard",["WPRO"])),c.a.createElement("div",{className:"biblio-digest-card-text"},e.serosurveysWPRO)),c.a.createElement("div",{className:"biblio-digest-card-row pl-3"},c.a.createElement("div",{className:"biblio-digest-card-text"},Y("BiblioDigestCard",["NonMember"])),c.a.createElement("div",{className:"biblio-digest-card-text"},e.serosurveysNonMember)),e.sourcesAdded&&c.a.createElement("div",{className:"biblio-digest-card-row pt-2"},c.a.createElement("div",{className:"biblio-digest-card-text-bold"},Y("BiblioDigestCard",["NewSources"])),c.a.createElement("div",{className:"biblio-digest-card-text-bold"},e.sourcesAdded)))))}var ya=a(370),Sa=a.n(ya),Ea=a(371),ka=a.n(Ea),Aa=a(372),wa=a.n(Aa),Ta=a(121),Pa=a.n(Ta),Oa=a(373),Na=a.n(Oa),Da=a(374),Ca=a.n(Da),xa=a(375),Ra=a.n(xa),Ia=a(232),La=a.n(Ia),Ma=a(376),za=a.n(Ma),ja=a(377),Fa=a.n(ja),Ua=a(378),Wa=a.n(Ua),Ba=a(379),Va=a.n(Ba),Ha=a(380),Ga=a.n(Ha),_a=a(381),qa=a.n(_a),Ka=a(382),Qa=a.n(Ka),Ja=a(383),Ya=a.n(Ja),Za=a(233),Xa=a.n(Za),$a=a(384),en=a.n($a),tn=a(385),an=a.n(tn),nn=a(386),rn=a.n(nn),sn=a(387),on=a.n(sn),ln=a(234),cn=a.n(ln),un=a(388),dn=a.n(un),mn=a(389),pn=a.n(mn),hn=a(390),gn=a.n(hn),fn=a(391),bn=a.n(fn),vn=a(392),yn=a.n(vn),Sn=[{date:"2021-01-15",img:Sa.a,titleKey1:"IndustryReportTitles",titleKey2:["YearInReview2020"],url:"https://drive.google.com/file/d/14u0GroEadFQ__Gdvoe104HI-y0LWDwSu/view?usp=sharing"},{date:"2020-08-20",img:Ca.a,titleKey1:"IndustryReportTitles",titleKey2:["InsuringTheEconomy"],url:"https://drive.google.com/file/d/1kEl6xv54yPGoDXZoPq9h2q4SqYnL2OU-/view?usp=sharing"},{date:"2020-07-22",img:wa.a,titleKey1:"IndustryReportTitles",titleKey2:["BloodBank"],url:"https://drive.google.com/file/d/1It2CzAwEfTcQ1zIC6z2fO7i7XEfmWfom/view?usp=sharing"},{date:"2020-05-19",img:ka.a,titleKey1:"IndustryReportTitles",titleKey2:["PreliminaryReport"],url:"https://drive.google.com/file/d/1I1gY1lZndwp4_eUqoZviU8L2_izmkmQP/view?usp=sharing"}],En=[{date:"2022-02-25",img:Pa.a,titleKey1:"ResearchArticleTitles",titleKey2:["MedRxivNLP"],publicationName:"medRxiv",authors:"Sara Perlman-Arrow, Noel Loo, Niklas Bobrovitz et al.",url:"https://www.medrxiv.org/content/10.1101/2022.02.24.22268947v1"},{date:"2021-12-15",img:Pa.a,titleKey1:"ResearchArticleTitles",titleKey2:["MedRxivMeta"],publicationName:"medRxiv",authors:"Isabel Bergeri, Mairead Whelan, Harriet Ware et al.",url:"https://www.medrxiv.org/content/10.1101/2021.12.14.21267791v1"},{date:"2021-11-21",img:Pa.a,titleKey1:"ResearchArticleTitles",titleKey2:["MedRxivROB"],publicationName:"medRxiv",authors:"Niklas Bobrovitz, Kim No\xebl, Zihan Li et al.",url:"https://www.medrxiv.org/content/10.1101/2021.11.17.21266471v1"},{date:"2021-07-03",img:Pa.a,titleKey1:"ResearchArticleTitles",titleKey2:["MedRxivPrivate"],publicationName:"medRxiv",authors:"Nathan Duarte, Sean D'Mello, Nathalie A Duarte et al.",url:"https://www.medrxiv.org/content/10.1101/2021.06.29.21259730v1"},{date:"2021-06-23",img:Ra.a,titleKey1:"ResearchArticleTitles",titleKey2:["PlosOnePub"],publicationName:"Plos One",authors:"Niklas Bobrovitz, Rahul Krishan Arora, Christian Cao et al.",url:"https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0252617"},{date:"2020-08-14",img:Na.a,titleKey1:"ResearchArticleTitles",titleKey2:["LancetID"],publicationName:"The Lancet: Infectious Diseases",authors:"Rahul K Arora, Abel Joseph, Jordan Van Wyk et al.",url:"https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30631-9/fulltext#%20"},{date:"2020-05-14",img:Pa.a,titleKey1:"ResearchArticleTitles",titleKey2:["PrePrint"],publicationName:"medRxiv",authors:"Niklas Bobrovitz, Rahul Krishan Arora, Tingting Yan et al.",url:"https://www.medrxiv.org/content/10.1101/2020.05.10.20097451v1"}],kn=[{date:"2021-06-25",titleKey1:"IndustryMediaTitles",titleKey2:["StillVulnerable"],publicationName:"Le Journal de Quebec",img:en.a,authors:"",url:"https://www.journaldequebec.com/2021/06/25/la-population-mondiale-toujours-vulnerable-a-la-covid-19"},{date:"2021-05-25",titleKey1:"IndustryMediaTitles",titleKey2:["NYTIndia"],publicationName:"The New York Times",authors:"",url:"https://www.nytimes.com/interactive/2021/05/25/world/asia/india-covid-death-estimates.html",img:dn.a},{date:"2021-05-13",titleKey1:"IndustryMediaTitles",titleKey2:["EconomistDeathToll"],publicationName:"The Economist",authors:"",url:"https://www.economist.com/graphic-detail/2021/05/13/how-we-estimated-the-true-death-toll-of-the-pandemic",img:La.a},{date:"2021-01-23",titleKey1:"IndustryMediaTitles",titleKey2:["JouleAnnounce"],publicationName:"Cision",authors:"",url:"https://www.newswire.ca/news-releases/joule-announces-2020-innovation-grant-recipients-867798355.html",img:Va.a},{date:"2021-01-20",titleKey1:"IndustryMediaTitles",titleKey2:["WhenEnd"],publicationName:"McKinsey & Company",authors:"",url:"https://www.mckinsey.com/industries/healthcare-systems-and-services/our-insights/when-will-the-covid-19-pandemic-end",img:cn.a},{date:"2021-01-15",titleKey1:"IndustryMediaTitles",titleKey2:["JouleInnovation"],publicationName:"AMC Joule",authors:"",url:"https://joulecma.ca/innovate/grants/serotracker ",img:Xa.a},{date:"2021-01-14",titleKey1:"IndustryMediaTitles",titleKey2:["JouleRecipients"],publicationName:"Markets Insider",authors:"",url:"https://markets.businessinsider.com/amp/news/joule-announces-2020-innovation-grant-recipients-1029968953",img:Xa.a},{date:"2021-01-01",titleKey1:"IndustryMediaTitles",titleKey2:["McKinseyHealthcare"],publicationName:"McKinsey & Company",authors:"",url:"https://www.mckinsey.com/~/media/McKinsey/Industries/Healthcare%20Systems%20and%20Services/Our%20Insights/McKinsey%20on%20Healthcare%202020%20Year%20in%20Review/McKinsey-on-Healthcare-2020-Year-in-Review.pdf",img:cn.a},{date:"2020-11-24",titleKey1:"IndustryMediaTitles",titleKey2:["InfectionRate"],publicationName:"taz",authors:"",url:"https://taz.de/Studie-zu-globaler-Corona-Infektionsrate/!5730030/",img:qa.a},{date:"2020-11-23",titleKey1:"IndustryMediaTitles",titleKey2:["AlumniAndStudents"],publicationName:"University of Calgary",authors:"",url:"https://cumming.ucalgary.ca/news/serotracker",img:gn.a},{date:"2020-11-10",titleKey1:"IndustryMediaTitles",titleKey2:["Webinar"],publicationName:"HIMSS",authors:"",url:"http://www.himsschapter.org/event/serotracker-covid-19-journey-himss-canadian-prairies-chapter-webinar",img:Ya.a},{date:"2020-08-17",titleKey1:"IndustryMediaTitles",titleKey2:["HomeTests"],publicationName:"Forbes",authors:"",url:"https://www.forbes.com/sites/williamhaseltine/2020/08/17/cheap-daily-home-tests-are-the-first-step-to-containing-the-pandemic/?sh=677d47d14ad4",img:Qa.a},{date:"2020-08-03",titleKey1:"IndustryMediaTitles",titleKey2:["Lecturership"],publicationName:"Computational Health Informatics",authors:"",url:"https://eng.ox.ac.uk/chi/news/adjunct-lecturership-for-rahul/",img:Wa.a},{date:"2020-07-22",titleKey1:"IndustryMediaTitles",titleKey2:["HowMany"],publicationName:"NewScientist",authors:"",url:"https://www.newscientist.com/article/mg24632873-000-how-many-of-us-are-likely-to-have-caught-the-coronavirus-so-far/",img:za.a},{date:"2020-07-07",titleKey1:"IndustryMediaTitles",titleKey2:["CovidRadar"],publicationName:"M1 Marica News",authors:"",url:"https://m1newstv.com/subnotificacao-no-brasil-e-na-rocinha-e-a-media-mundial/",img:an.a},{date:"2020-06-11",titleKey1:"IndustryMediaTitles",titleKey2:["VeteranDoctor"],publicationName:"MaRS",authors:"",url:"https://www.marsdd.com/magazine/what-if-there-is-no-covid-19-vaccine/",img:rn.a},{date:"2020-06-02",titleKey1:"IndustryMediaTitles",titleKey2:["NewlyLaunched"],publicationName:"McGill Publications",authors:"",url:"https://publications.mcgill.ca/medenews/2020/06/16/newly-launched-serotracker-will-monitor-global-antibody-testing-efforts/",img:on.a},{date:"2020-06-02",titleKey1:"IndustryMediaTitles",titleKey2:["StudentsBuild"],publicationName:"University of Waterloo",authors:"",url:"https://uwaterloo.ca/stories/engineering-students/students-build-online-dashboard-track-covid-19-antibody",img:bn.a},{date:"2020-05-28",titleKey1:"IndustryMediaTitles",titleKey2:["GlobalLaunch"],publicationName:"Covid-19 Immunity Task Force",authors:"",url:"https://www.covid19immunitytaskforce.ca/global-launch-of-serotracker-a-covid-19-antibody-testing-hub-in-partnership-with-canadas-covid-19-immunity-task-force/",img:Ga.a},{date:"2020-05-24",titleKey1:"IndustryMediaTitles",titleKey2:["KnowledgeHub"],publicationName:"University of Oxford",authors:"",url:"https://www.research.ox.ac.uk/Article/2020-05-28-knowledge-hub-developed-to-track-sars-cov-antibody-studies",img:pn.a},{date:"2020-05-23",titleKey1:"IndustryMediaTitles",titleKey2:["UnderstandingVirus"],publicationName:"Bloomberg",authors:"",url:"https://www.bloomberg.com/news/articles/2020-05-06/understanding-the-virus-and-its-unanswered-questions-quicktake",img:Fa.a},{date:"2022-01-12",titleKey1:"IndustryMediaTitles",titleKey2:["EconomistDeathToll2"],publicationName:"The Economist",authors:"",url:"https://www.economist.com/graphic-detail/coronavirus-excess-deaths-estimates",img:La.a},{date:"2021-06-29",titleKey1:"IndustryMediaTitles",titleKey2:["InventoryEvidenceSynthesis"],publicationName:"COVID-END",authors:"",url:"https://www.mcmasterforum.org/networks/covid-end/resources-to-support-decision-makers/Inventory-of-best-evidence-syntheses/public-health-measures",img:yn.a}],An=[{url:"https://drive.google.com/file/d/1h7RpDI_EWi2qu2KTjErME03jlhY1hS5Y/view?usp=sharing",sourcesAdded:128,serosurveysTotal:310,serosurveysAFRO:29,serosurveysEMRO:4,serosurveysEURO:185,serosurveysPAHO:58,serosurveysSEARO:21,serosurveysWPRO:13,serosurveysNonMember:0,publishDate:"2022-03-10",screeningStartDate:"2022-02-05",screeningEndDate:"2022-03-04"},{url:"https://drive.google.com/file/d/1PME1WFA-ItYAzzuPfGNSvLvJyKXQAezl/view?usp=sharing",sourcesAdded:98,serosurveysTotal:160,serosurveysAFRO:20,serosurveysEMRO:3,serosurveysEURO:66,serosurveysPAHO:36,serosurveysSEARO:14,serosurveysWPRO:20,serosurveysNonMember:1,publishDate:"2022-02-11",screeningStartDate:"2022-01-08",screeningEndDate:"2022-02-04"},{url:"https://drive.google.com/file/d/1J51-liWMXACBdMgl2Yqc_litXSIukkBQ/view?usp=sharing",sourcesAdded:65,serosurveysTotal:102,serosurveysAFRO:6,serosurveysEMRO:2,serosurveysEURO:49,serosurveysPAHO:24,serosurveysSEARO:15,serosurveysWPRO:6,serosurveysNonMember:0,publishDate:"2022-01-14",screeningStartDate:"2021-12-11",screeningEndDate:"2022-01-07"},{url:"https://drive.google.com/file/d/1ibebgdbG5C-k0whOJfjeEuECrybmHlQ2/view?usp=sharing",sourcesAdded:85,serosurveysTotal:176,serosurveysAFRO:37,serosurveysEMRO:5,serosurveysEURO:67,serosurveysPAHO:40,serosurveysSEARO:11,serosurveysWPRO:15,serosurveysNonMember:1,publishDate:"2021-12-17",screeningStartDate:"2021-11-20",screeningEndDate:"2021-12-10"},{url:"https://drive.google.com/file/d/1v1Tzyatwzg-1v7f0H6qO1JGfL9Hk3_jN/view?usp=sharing",sourcesAdded:133,serosurveysTotal:269,serosurveysAFRO:14,serosurveysEMRO:10,serosurveysEURO:153,serosurveysPAHO:55,serosurveysSEARO:24,serosurveysWPRO:13,serosurveysNonMember:0,publishDate:"2021-11-26",screeningStartDate:"2021-10-23",screeningEndDate:"2021-11-09"},{url:"https://drive.google.com/file/d/1Fy-fQS0fVzMPW75ZpWQRLZoU1EVYdeaF/view?usp=sharing",sourcesAdded:171,serosurveysTotal:263,serosurveysAFRO:18,serosurveysEMRO:24,serosurveysEURO:134,serosurveysPAHO:66,serosurveysSEARO:11,serosurveysWPRO:10,serosurveysNonMember:0,publishDate:"2021-10-29",screeningStartDate:"2021-09-25",screeningEndDate:"2021-10-22"},{url:"https://drive.google.com/file/d/12u72w5ZpgNV1JykEasxVD1QYWi3F9mV4/view?usp=sharing",sourcesAdded:117,serosurveysTotal:289,serosurveysAFRO:6,serosurveysEMRO:8,serosurveysEURO:136,serosurveysPAHO:117,serosurveysSEARO:18,serosurveysWPRO:4,serosurveysNonMember:0,publishDate:"2021-10-01",screeningStartDate:"2021-08-28",screeningEndDate:"2021-09-24"},{url:"https://drive.google.com/file/d/16Bi6Si2Ph0wwCSkDR15l-gNYzB91aOei/view?usp=sharing",serosurveysTotal:147,serosurveysAFRO:2,serosurveysEMRO:11,serosurveysEURO:53,serosurveysPAHO:63,serosurveysSEARO:14,serosurveysWPRO:4,serosurveysNonMember:0,publishDate:"2021-09-03",screeningStartDate:"2021-07-31",screeningEndDate:"2021-08-27"},{url:"https://drive.google.com/file/d/1c7OWeVdGwL2Hix-RIHs8y-EZHdKGv8kV/view?usp=sharing",serosurveysTotal:271,serosurveysAFRO:98,serosurveysEMRO:7,serosurveysEURO:94,serosurveysPAHO:46,serosurveysSEARO:12,serosurveysWPRO:14,serosurveysNonMember:0,publishDate:"2021-08-06",screeningStartDate:"2021-07-03",screeningEndDate:"2021-07-30"},{url:"https://drive.google.com/file/d/1u6mix47HTUwSLraj4eMcD1rvGj7N7Z4g/view?usp=sharing",serosurveysTotal:214,serosurveysAFRO:51,serosurveysEMRO:7,serosurveysEURO:71,serosurveysPAHO:44,serosurveysSEARO:21,serosurveysWPRO:20,serosurveysNonMember:0,publishDate:"2021-07-09",screeningStartDate:"2021-06-05",screeningEndDate:"2021-07-02"},{url:"https://drive.google.com/file/d/1qxAa3xnqEQzFwsph75wI4_zBj84iJ2FZ/view?usp=sharing",serosurveysTotal:162,serosurveysAFRO:17,serosurveysEMRO:3,serosurveysEURO:72,serosurveysPAHO:51,serosurveysSEARO:11,serosurveysWPRO:8,serosurveysNonMember:0,publishDate:"2021-06-10",screeningStartDate:"2021-04-25",screeningEndDate:"2021-06-04"}],wn=[{titleKey1:"IndustryReportTitles",titleKey2:["OctoberReport"],collection:"A Pillai, N Duarte, M Rocco.",authors:"N Duarte, R Arora.",date:"2020",url:"https://drive.google.com/file/d/1aCgxzxv9J5Zvh4EVyI5REmSVgWLQ_Ip3/view?usp=sharing"},{titleKey1:"IndustryReportTitles",titleKey2:["SeptemberReport"],collection:"A Pillai, N Duarte, M Rocco.",authors:"N Duarte, R Arora.",date:"2020",url:"https://drive.google.com/file/d/1CjMcs7UZzu4_E_QFJVYZdv0QhyfoNMAe/view?usp=sharing"},{titleKey1:"IndustryReportTitles",titleKey2:["AugustReport"],collection:"A Pillai, N Duarte, M Rocco.",authors:"N Duarte, J Chen, R Arora.",date:"2020",url:"https://drive.google.com/file/d/1m7BlfUKCYs32_D1jnFUEQHPr3Qjg5Eyt/view?usp=sharing"},{titleKey1:"IndustryReportTitles",titleKey2:["JulyReport"],collection:"A Pillai, N Duarte, M Rocco.",authors:"Jamie Chen, N Duarte, R Arora.",date:"2020",url:"https://drive.google.com/file/d/1Rx3i_Sy01suu-ZZYV7LRpo2KEclbXCNN/view?usp=sharing"},{titleKey1:"IndustryReportTitles",titleKey2:["JuneReport"],collection:"A Pillai, N Duarte, M Rocco.",authors:"J Chen, N Duarte, R Arora.",date:"2020",url:"https://drive.google.com/file/d/1HO--VWYdyEqd5Dc3xcZBwERXWDBjCfxN/view"},{titleKey1:"IndustryReportTitles",titleKey2:["MayReport"],collection:"by S Rocco, N Duarte, M Rocco, J Van Wyk.",authors:"N Duarte, A Pillai.",date:"2020",url:"https://drive.google.com/file/d/16pCR-zh1UiWjQFhTDxW_2adSGuq0pCgz/view?usp=sharing"}],Tn=(a(661),a(709));function Pn(e){return c.a.createElement("div",{className:"py-2"},c.a.createElement(Tn.a,{className:"publication-item"},c.a.createElement(Tn.a.Content,null,c.a.createElement(Tn.a.Meta,{className:"text-default"},e.publicationName&&e.publicationName),c.a.createElement(Tn.a.Header,null,c.a.createElement("h4",{className:"m-0"},c.a.createElement("a",{href:e.url,target:"_blank",rel:"noopener noreferrer",className:"publication-link"},e.italicize?c.a.createElement("i",null,e.italicize,"\xa0"):null,Y(e.titleKey1,e.titleKey2)))),c.a.createElement(Tn.a.Meta,null,e.date&&c.a.createElement("div",{className:"text-small"},Z(e.date+"T00:00:00")),c.a.createElement("div",{className:"text-small"},e.authors?Y("Authors: ")+e.authors:"")))))}var On=a(394),Nn=a.n(On);function Dn(e){return c.a.createElement("div",{className:"py-4 px-2 flex justify-content-center"},c.a.createElement(fa.a,{className:"private-reports-card"},c.a.createElement(fa.a.Content,null,c.a.createElement("div",{className:"publications-card-title m-0 mb-2"},c.a.createElement("a",{href:e.url,target:"_blank",rel:"noopener noreferrer",className:"publication-link"},e.italicize?c.a.createElement("i",null,e.italicize,"\xa0"):null,Y(e.titleKey1,e.titleKey2))),c.a.createElement(fa.a.Meta,{className:"text-small mb-1"},e.date),c.a.createElement(fa.a.Description,{className:"text-small mb-1"},"Authored by: ",e.authors),c.a.createElement(fa.a.Description,{className:"text-small mb-1"},"Collected by: ",e.collection))))}function Cn(){var e=Object(S.useMediaQuery)({maxDeviceWidth:1200});return c.a.createElement("div",{className:"col-12 page pb-4"},c.a.createElement("div",{className:e?"pb-2 policy-container static-content w-100":"policy-container static-content"},c.a.createElement("h1",{className:"col-12 p-0 fit"},Y("Publications")),c.a.createElement("p",null,Y("PublicationDescriptions",["Publications"])),c.a.createElement("div",{className:"publication-menu",style:{flexDirection:e?"column":"row"}},c.a.createElement("p",{className:e?"publication-menu-item":"pl-0 publication-menu-item"},c.a.createElement("a",{className:"publication-link",href:"#"+N.Publications.ResearchArticles},Y("ResearchArticles"))),c.a.createElement("p",{className:"publication-menu-item"},c.a.createElement("a",{className:"publication-link",href:"#"+N.Publications.GeneralSerotrackerCommunications},Y("GeneralSerotrackerCommunications"))),c.a.createElement("p",{className:"publication-menu-item"},c.a.createElement("a",{className:"publication-link",href:"#"+N.Publications.BiblioDigests},Y("BiblioDigests"))),c.a.createElement("p",{className:"publication-menu-item"},c.a.createElement("a",{className:"publication-link",href:"#"+N.Publications.PrivateSectorReports},Y("PrivateSectorReports"))),c.a.createElement("p",{className:"publication-menu-item"},c.a.createElement("a",{className:"publication-link",href:"#"+N.Publications.MediaMentions},Y("MediaMentions")))),c.a.createElement("hr",{style:{borderTop:"2px solid #bbb",width:"100%"}}),c.a.createElement("h2",{id:N.Publications.ResearchArticles},Y("ResearchArticles")),c.a.createElement("p",null,Y("PublicationDescriptions",["ResearchArticles"])),xn(En),c.a.createElement("h2",{id:N.Publications.GeneralSerotrackerCommunications},Y("GeneralSerotrackerCommunications")),c.a.createElement("p",null,Y("PublicationDescriptions",["GeneralSerotrackerCommunications"])),xn(Sn),c.a.createElement("h2",{id:N.Publications.BiblioDigests},Y("BiblioDigests")),c.a.createElement("p",null,Y("PublicationDescriptions",["LiteratureUpdateReports"])),Rn("BiblioDigest",2),c.a.createElement("h2",{id:N.Publications.PrivateSectorReports},Y("PrivateSectorReports")),c.a.createElement("p",null,Y("PublicationDescriptions",["PrivateSectorReports"])),Rn("PrivateReports",3),c.a.createElement("h2",{id:N.Publications.MediaMentions},Y("MediaMentions")),c.a.createElement("p",null,Y("PublicationDescriptions",["MediaMentions"])),Rn("Media",3)))}var xn=function(e){return e.map((function(e){return c.a.createElement(Pn,e)}))},Rn=function(e,t){return c.a.createElement("div",{className:"publications-slider-container pb-4"},c.a.createElement(Nn.a,function(e){return{dots:!0,infinite:!0,arrows:!0,speed:500,slidesToShow:e,slidesToScroll:e,responsive:[{breakpoint:1048,settings:{slidesToShow:2,slidesToScroll:2,infinite:!0,dots:!0}},{breakpoint:480,settings:{slidesToShow:1,slidesToScroll:1,infinite:!0,dots:!0}}]}}(t),function(e){switch(e){case"Media":return kn.map((function(e){return c.a.createElement(ba,e)}));case"BiblioDigest":return An.map((function(e){return c.a.createElement(va,e)}));case"PrivateReports":return wn.map((function(e){return c.a.createElement(Dn,e)}));default:return c.a.createElement("div",null,"Collections of this nature do not exist")}}(e)))};function In(){var e=Object(S.useMediaQuery)({maxDeviceWidth:1200});return c.a.createElement("div",{className:e?"policy-div-mobile":"policy-div-desktop"},c.a.createElement("iframe",{title:"PrivacyPolicy",className:e?"policy-frame-mobile":"policy-frame-desktop",src:"https://app.termly.io/embed/terms-of-use/796fdf5d-ba75-4a21-9e54-4360f4fc9ccc"}))}function Ln(){var e=Object(S.useMediaQuery)({maxDeviceWidth:1200});return c.a.createElement("div",{className:"col-12 page fill terms pb-2"},c.a.createElement("div",{className:e?"static-mobile":"static-content"},c.a.createElement("h1",{className:"col-12 pb-2"},Y("TermsOfUse")),c.a.createElement("div",{className:"col-12 pb-3"},c.a.createElement("p",{className:"p-2"},Y("WhoSerotrackAndPartnersDisclaimer1")),c.a.createElement("p",{className:"p-2"},Y("WhoSerotrackAndPartnersDisclaimer2")),c.a.createElement("p",{className:"p-2"},Y("WhoSerotrackAndPartnersDisclaimer3"))),c.a.createElement("h3",{className:"col-12 p-2"},Y("DisclaimerListHeader")),c.a.createElement("ol",null,c.a.createElement("li",{className:"p-2"},Y("DisclaimerList1")),c.a.createElement("li",{className:"p-2"},Y("DisclaimerList2")),c.a.createElement("li",{className:"p-2"},Y("DisclaimerList3")),c.a.createElement("li",{className:"p-2"},Y("DisclaimerList4")),c.a.createElement("li",{className:"p-2"},Y("DisclaimerList5")),c.a.createElement("li",{className:"p-2"},Y("DisclaimerList6"))),c.a.createElement("div",{className:"pb-2"},Y("DisclaimerFooter"))))}var Mn=function(){var e=Object(l.useContext)(ee),t=Object(g.a)(e,2),a=t[0],n=t[1];return localStorage.getItem("acceptedCookies")||a.showCookieBanner||n({type:"OPEN_COOKIE_BANNER"}),a.showCookieBanner?c.a.createElement("div",{className:"cookie-banner flex"},c.a.createElement("div",{className:"fill flex center-item"},c.a.createElement("div",{className:"col-md-6 p-3 flex column"},c.a.createElement("div",null,Y("CookiePolicyBody",null,null,[!1,!0]),c.a.createElement(me.a,{to:G("CookiePolicy")},Y("CookiePolicy"))),c.a.createElement("div",{className:"flex right"},c.a.createElement(je.a,{color:"blue",onClick:function(){localStorage.setItem("acceptedCookies","true"),n({type:"CLOSE_COOKIE_BANNER"})}},Y("Accept")))))):null},zn=a(395),jn=a.n(zn),Fn=function(){var e=Object(l.useState)(""),t=Object(g.a)(e,2),a=t[0],n=t[1],i=Object(l.useContext)(ee),s=Object(g.a)(i,2),o=s[0],u=s[1],d=Object(l.useState)(!1),m=Object(g.a)(d,2),p=m[0],h=m[1],b=Object(l.useState)(!1),v=Object(g.a)(b,2),y=v[0],E=v[1],k=Object(f.g)(),A=function(e){var t=k.location.pathname;t=t.replace("/".concat(o.language,"/"),"/".concat(e,"/")),u({type:"SELECT_LANGUAGE",payload:e}),k.push(t)};!function(){var e=Object(f.h)();Object(l.useEffect)((function(){n(e.pathname)}),[e])}();var w=function(){return c.a.createElement("div",{className:"App-title col-auto py-3 px-0"},c.a.createElement(me.a,{to:G("Explore"),className:"flex align-items-center"},c.a.createElement("img",{src:jn.a,width:23,height:23,alt:""}),c.a.createElement("div",{className:"col-auto px-2 align-middle"},"SeroTracker")))},T=function(){return c.a.createElement(Ct.a.Menu,null,ht.map((function(e){return c.a.createElement(Ct.a.Item,null,c.a.createElement(me.a,{to:G("Partnerships/".concat(e.routeName))},Y("PartnershipsList",[e.routeName])))})),c.a.createElement(Ct.a.Item,null,c.a.createElement(me.a,{to:G("Unity")},Y("WhoUnity"))))},P=function(){return c.a.createElement(Ct.a.Menu,null,o.language!==r.english?c.a.createElement(Ct.a.Item,{onClick:function(){A(r.english)}},r.english.toUpperCase()):"",o.language!==r.french?c.a.createElement(Ct.a.Item,{onClick:function(){A(r.french)}},r.french.toUpperCase()):"",o.language!==r.german?c.a.createElement(Ct.a.Item,{onClick:function(){A(r.german)}},r.german.toUpperCase()):"")},O=function(e){return c.a.createElement(he.a.Content,{active:e,className:"ml-2"},ht.map((function(e){return c.a.createElement("p",null,c.a.createElement(me.a,{to:G("Partnerships/".concat(e.routeName))},Y("PartnershipsList",[e.routeName])))})),c.a.createElement("p",null,c.a.createElement(me.a,{to:G("Unity")},Y("WhoUnity"))))},N=Object(S.useMediaQuery)({maxDeviceWidth:1200});return c.a.createElement("header",{className:"App-header col-12 px-3"},c.a.createElement(w,null),N?function(e,t,a,n,i,s){return c.a.createElement(Ct.a,{icon:"bars",direction:"left",simple:!0},c.a.createElement(Ct.a.Menu,null,c.a.createElement(Ct.a.Item,null,c.a.createElement(me.a,{to:G("Explore")},Y("Explore"))),c.a.createElement(Ct.a.Item,null,c.a.createElement(me.a,{to:G("Analyze")},Y("Analyze"))),c.a.createElement(Ct.a.Item,null,c.a.createElement(me.a,{to:G("Data")},Y("Data"))),c.a.createElement(Ct.a.Item,null,c.a.createElement(me.a,{to:G("Publications")},Y("Publications"))),c.a.createElement(Ct.a.Item,null,c.a.createElement(me.a,{to:G("About")},Y("About"))),c.a.createElement(Ct.a.Item,null,c.a.createElement(he.a,{fluid:!0},c.a.createElement(he.a.Title,{active:e,index:0,onClick:a,className:"flex center-item py-0"},Y("Partnerships"),c.a.createElement(ge.a,{name:"dropdown",className:"ml-5 ".concat(e?"dropdown__icon":"dropdown__icon--active"," ")})),O(e))),c.a.createElement(Ct.a.Item,null,c.a.createElement(he.a,{fluid:!0},c.a.createElement(he.a.Title,{active:t,index:0,onClick:n,className:"flex py-0"},o.language.toUpperCase(),c.a.createElement(ge.a,{name:"dropdown",style:{marginLeft:"107px"},className:"".concat(t?"dropdown__icon":"dropdown__icon--active"," ")})),o.language!==r.english?c.a.createElement(he.a.Content,{active:t,onClick:function(){i(r.english)},className:"ml-2"},r.english.toUpperCase()):"",o.language!==r.french?c.a.createElement(he.a.Content,{active:t,onClick:function(){i(r.french)},className:"ml-2"},r.french.toUpperCase()):"",o.language!==r.german?c.a.createElement(he.a.Content,{active:t,onClick:function(){i(r.german)},className:"ml-2"},r.german.toUpperCase()):""))))}(p,y,(function(){return h(!p)}),(function(){return E(!y)}),A,o.language):function(e,t,a){return c.a.createElement("div",{className:"App-tabs col-auto space-evenly p-0"},c.a.createElement("div",{className:e("/Explore")},c.a.createElement(me.a,{to:G("Explore")},Y("Explore"))),c.a.createElement("div",{className:e("/Analyze")},c.a.createElement(me.a,{to:G("Analyze")},Y("Analyze"))),c.a.createElement("div",{className:e("/Data")},c.a.createElement(me.a,{to:G("Data")},Y("Data"))),c.a.createElement("div",{className:e("/Publications")},c.a.createElement(me.a,{to:G("Publications")},Y("Publications"))),c.a.createElement("div",{className:e("/About")},c.a.createElement(me.a,{to:G("About")},Y("About"))),c.a.createElement("div",{className:"nav__item col-auto h-100 flex center-item"},c.a.createElement(Ct.a,{text:Y("Partnerships")},T())),c.a.createElement("div",{className:"col-auto h-100 px-0"},"|"),c.a.createElement("div",{className:"nav__item col-auto h-100 flex center-item cursor"},c.a.createElement(Ct.a,{text:a.toUpperCase()},P())))}((function(e){return a.includes(e)?"nav__item--active col-auto h-100 flex center-item":"nav__item col-auto h-100 flex center-item"}),0,o.language))},Un=a(235),Wn=a.n(Un),Bn=a(396),Vn=a(236),Hn=a.n(Vn),Gn=a(237),_n=a.n(Gn);var qn=function(e){Object(Gt.a)(a,e);var t=Object(_t.a)(a);function a(e){var n;return Object(Ke.a)(this,a),(n=t.call(this,e)).state={filters:e.filters,parameters:e.parameters},n}return Object(Qe.a)(a,[{key:"componentDidMount",value:function(){this.initTableau()}},{key:"componentWillUnmount",value:function(){this.refreshTimer&&(clearInterval(this.refreshTimer),this.refreshTimer=null)}},{key:"componentWillReceiveProps",value:function(e){var t=e.url!==this.props.url,a=!Hn()(this.props.filters,e.filters,this.compareArrays),n=!Hn()(this.props.parameters,e.parameters),r=this.state.loading;t&&this.initTableau(),t||!a||r||this.applyFilters(e.filters),t||!n||r||this.applyParameters(e.parameters),e.token!==this.props.token&&this.setState({didInvalidateToken:!1}),e.refreshSeconds!==this.props.refreshSeconds&&("undefined"!==typeof this.refreshTimer&&clearInterval(this.refreshTimer),e.refreshSeconds>0&&(this.refreshTimer=setInterval(this.refresh.bind(this),1e3*e.refreshSeconds)))}},{key:"compareArrays",value:function(e,t){if(Array.isArray(e)&&Array.isArray(t))return e.sort().toString()===t.sort().toString()}},{key:"onComplete",value:function(e,t){Bn.Promise.all(e).then((function(){return t()}),(function(){return t()}))}},{key:"getUrl",value:function(){var e=this.props.token,t=Wn.a.parse(this.props.url,!0),a="?:embed=yes&:comments=no&:toolbar=yes&:refresh=yes";return!this.state.didInvalidateToken&&e?(this.invalidateToken(),function(e,t){var a=Wn.a.parse(e,!0),n=a.protocol,r=a.host,i=a.pathname;return"".concat(n,"//").concat(r,"/trusted/").concat(t).concat(i)}(this.props.url,e)+a):t.protocol+"//"+t.host+t.pathname+a}},{key:"invalidateToken",value:function(){this.setState({didInvalidateToken:!0})}},{key:"applyFilters",value:function(e){var t=this,a=_n.a.FilterUpdateType.REPLACE,n=[];for(var r in this.setState({loading:!0}),e)this.state.filters.hasOwnProperty(r)&&this.compareArrays(this.state.filters[r],e[r])||n.push(this.sheet.applyFilterAsync(r,e[r],a));this.onComplete(n,(function(){return t.setState({loading:!1,filters:e})}))}},{key:"applyParameters",value:function(e){var t=this,a=[];for(var n in e)if(!this.state.parameters.hasOwnProperty(n)||this.state.parameters[n]!==e[n]){var r=e[n];a.push(this.workbook.changeParameterValueAsync(n,r))}this.onComplete(a,(function(){return t.setState({loading:!1,parameters:e})}))}},{key:"refresh",value:function(){"undefined"!==typeof this.viz&&this.viz.refreshDataAsync()}},{key:"initTableau",value:function(){var e=this,t=this.props,a=t.filters,n=t.parameters,r=t.refreshSeconds,i=this.getUrl(),s=Object($.a)(Object($.a)(Object($.a)(Object($.a)({},a),n),this.props.options),{},{onFirstInteractive:function(){e.workbook=e.viz.getWorkbook(),e.sheets=e.workbook.getActiveSheet().getWorksheets(),e.sheet=e.sheets[0],e.props.onLoad(new Date)}});this.viz&&(this.viz.dispose(),this.viz=null),this.viz=new _n.a.Viz(this.container,i,s),r>0&&(this.refreshTimer=setInterval(this.refresh.bind(this),1e3*r))}},{key:"render",value:function(){var e=this;return c.a.createElement("div",{ref:function(t){return e.container=t}})}}]),a}(c.a.Component);qn.defaultProps={loading:!1,parameters:{},filters:{},options:{},refreshSeconds:0,onLoad:function(e){}};var Kn=qn;a(686);function Qn(e){var t=Object(l.useContext)(ee),a=Object(g.a)(t,2),n=a[0].language,r=(a[1],Object(S.useMediaQuery)({maxWidth:1200})),i=n in e.url?e.url[n]:e.url.en,s={};return s=r?e.mobileOptions?e.mobileOptions:{}:e.desktopOptions?e.desktopOptions:{},c.a.createElement("figure",{className:"tableau-embed ".concat(e.className)},c.a.createElement(Kn,{url:i,options:s}))}function Jn(){var e=Object(S.useMediaQuery)({maxWidth:1200}),t=Object(l.useContext)(ee),a=Object(g.a)(t,1)[0].language,n=function(t){return 20+(e?362.5:625)*t};return c.a.createElement("div",{className:"page col-12"},c.a.createElement(Qn,{url:k,key:"AnalyzeTableau".concat(a),desktopOptions:{width:"82vw",height:"5000px"},mobileOptions:{width:"90vw",height:"2900px"}}),c.a.createElement("section",{id:N.Analyze.ByCountry,style:{position:"absolute",top:n(0)}}),c.a.createElement("section",{id:N.Analyze.ByPopulation,style:{position:"absolute",top:n(3)}}),c.a.createElement("section",{id:N.Analyze.AdditionalGraphs,style:{position:"absolute",top:n(4)}}))}function Yn(e){var t=e.partnershipconfig,a=Object(l.useContext)(ee),n=Object(g.a)(a,1)[0],r=Object(l.useState)([]),i=Object(g.a)(r,2),s=i[0],o=i[1],u=Object(l.useState)(),d=Object(g.a)(u,2),m=d[0],f=d[1],b=Object(l.useState)(!1),v=Object(g.a)(b,2),y=v[0],E=v[1];Object(l.useEffect)((function(){var e=new Xe;(function(){var a=Object(h.a)(p.a.mark((function a(){var n,r,i;return p.a.wrap((function(a){for(;;)switch(a.prev=a.next){case 0:return E(!0),a.next=3,e.getCountryPartnershipData({country:[null===t||void 0===t?void 0:t.routeName]});case 3:n=a.sent,r=n.records,i=n.estimateGradePrevalences,o(r),f(i[0]),E(!1);case 9:case"end":return a.stop()}}),a)})));return function(){return a.apply(this,arguments)}})()()}),[t,n.explore.estimateGradePrevalences]);var k=Object(S.useMediaQuery)({maxDeviceWidth:1200});if(void 0===t)return c.a.createElement(c.a.Fragment,null);var A=k?function(e,t,a){return c.a.createElement(Pt,{mapConfig:e.mapboxMapOptions,countriesConfig:{estimateGradePrevalences:t?[t]:void 0,countryFocus:null===e||void 0===e?void 0:e.iso3},studyPinsConfig:{records:a}})}(t,m,s):function(e,t,a,n){return c.a.createElement(c.a.Fragment,null,c.a.createElement("div",{className:"col-9 h-100"},c.a.createElement(He.a,{indeterminate:!0,active:n}),c.a.createElement(Pt,{mapConfig:e.mapboxMapOptions,countriesConfig:{estimateGradePrevalences:t?[t]:void 0,countryFocus:null===e||void 0===e?void 0:e.iso3},studyPinsConfig:{records:a}})),c.a.createElement("div",{className:"col-3 h-100"},c.a.createElement(ra,{hideLayers:!0}),c.a.createElement("div",{className:"mt-1"},Y("PartnershipsView",["MapNote1"])),c.a.createElement("div",{className:"mt-1"},Y("PartnershipsView",["MapNote2"],{WEBSITE:"ourworldindata.org"}))))}(t,m,s,y),w=k?"50vw":"70vh";return c.a.createElement("div",{style:{height:w},className:"row"},A)}function Zn(e){var t=e.partnershipConfig,a=Object(l.useContext)(ee),n=Object(g.a)(a,1)[0];return c.a.createElement(c.a.Fragment,null,c.a.createElement("h1",{className:"mt-5"},Y("PartnershipsPageTitle",[t.routeName])),c.a.createElement("div",{className:"mt-2"},Y("PartnershipsPageDescription",[t.routeName,"PartOne"],null,[!1,!0]),c.a.createElement("a",{target:"_blank",rel:"noopener noreferrer",href:"https://www.covid19immunitytaskforce.ca/"},Y("PartnershipsPageDescription",[t.routeName,"PartTwo"],null,[!1,!0])),Y("PartnershipsPageDescription",[t.routeName,"PartThree"],null,[!1,!0]),c.a.createElement("a",{target:"_blank",rel:"noopener noreferrer",href:"https://www.covid19immunitytaskforce.ca/seroprevalence-modelling/"},Y("PartnershipsPageDescription",[t.routeName,"PartFour"],null,[!1,!0]))),c.a.createElement("div",{className:"mt-5 mb-1"},c.a.createElement("h3",null,Y("SeroprevalenceEstimatesInRegion",null,{NAME:q(t.routeName,n.language,"CountryOptions")}))),c.a.createElement(Yn,{partnershipconfig:t}),c.a.createElement(Qn,{className:"row",url:t.tableauUrl,key:t.tableauKey,desktopOptions:{width:"100%",height:"3100px"},mobileOptions:{width:"100%",height:"2700px"}}))}var Xn=function(e){return c.a.createElement("div",{className:"container ".concat(e.className)},c.a.createElement("div",{className:"row"},c.a.createElement("div",{className:"col-md-auto"},e.children)),e.includeMaintenanceModal&&c.a.createElement(da,{isOpen:!1,headerText:""}))};function $n(){var e=Object(f.i)().name,t=ht.find((function(t){return t.routeName===e}));return c.a.createElement(c.a.Fragment,null,void 0!==t?c.a.createElement(Xn,{includeMaintenanceModal:!0},function(e){var t=e.partnershipConfig,a=void 0;switch(t.routeName){case"Canada":a=c.a.createElement(Zn,{partnershipConfig:t})}return a}({partnershipConfig:t})):c.a.createElement(f.a,{to:"/404"}))}function er(){var e=Object(l.useState)(!0),t=Object(g.a)(e,2),a=t[0],n=t[1];Object(l.useEffect)((function(){localStorage.getItem("SubscribePopupSeen")||"true"===localStorage.getItem("returnUser")&&setTimeout((function(){n(!1),localStorage.setItem("SubscribePopupSeen","true")}),3e4)}),[]);var r=function(){n(!0)};return c.a.createElement("div",{className:"newsletter-popup",onClick:r,style:{visibility:a?"hidden":"visible"}},c.a.createElement(je.a,{className:"newsletter-popup-close-button",icon:!0,onClick:r},c.a.createElement(ge.a,{className:"newsletter-popup-close-button-icon",name:"close"})),c.a.createElement("iframe",{src:"https://serotracker.substack.com/embed",width:"480",height:"320",className:"newsletter-popup-content",frameBorder:"0",scrolling:"no"}))}var tr=function(){var e=Object(l.useContext)(ee),t=Object(g.a)(e,2),a=t[0],n=a.language,i=(a.explore,t[1]);J(n),Object(l.useEffect)((function(){var e=new Xe;(function(){var t=Object(h.a)(p.a.mark((function t(){var a,n,r,s,o;return p.a.wrap((function(t){for(;;)switch(t.prev=t.next){case 0:return t.next=2,e.getAllFilterOptions();case 2:a=t.sent,n=a.options,r=a.updatedAt,s=a.maxDate,o=a.minDate,i({type:"GET_ALL_FILTER_OPTIONS",payload:n}),i({type:"UPDATED_AT",payload:r}),i({type:"MAX_MIN_DATES",payload:{maxDate:s,minDate:o}});case 10:case"end":return t.stop()}}),t)})));return function(){return t.apply(this,arguments)}})()(),localStorage.getItem("returnUser")||localStorage.setItem("returnUser","true")}),[]),Object(l.useEffect)((function(){localStorage.getItem("acceptedCookies")&&i({type:"ACCEPT_COOKIES"});var e=function(){var e=.01*window.innerHeight;document.documentElement.style.setProperty("--vh","".concat(e,"px"))};window.addEventListener("resize",e),e()}),[i]);var s,o=Object(f.g)();(s=o.location.pathname).includes("/en/")&&n!==r.english?i({type:"SELECT_LANGUAGE",payload:r.english}):s.includes("/fr/")&&n!==r.french?i({type:"SELECT_LANGUAGE",payload:r.french}):s.includes("/de/")&&n!==r.german&&i({type:"SELECT_LANGUAGE",payload:r.german});var u=ne();return u.unity_aligned_only=!0,c.a.createElement("div",{className:"App"},c.a.createElement(Fn,null),c.a.createElement(Mn,null),c.a.createElement(er,null),c.a.createElement(f.d,null,c.a.createElement(f.b,{path:"/:language/About"},c.a.createElement(ze,null)),c.a.createElement(f.b,{path:"/:language/Explore"},c.a.createElement(ma,{key:"Explore"})),c.a.createElement(f.b,{path:"/:language/Dashboard"},c.a.createElement(f.a,{to:"/:language/Explore"})),c.a.createElement(f.b,{path:"/:language/Analyze"},c.a.createElement(Jn,null)),c.a.createElement(f.b,{path:"/:language/Partnerships/:name"},c.a.createElement($n,null)),c.a.createElement(f.b,{path:"/:language/Data"},c.a.createElement(ga,null)),c.a.createElement(f.b,{path:"/:language/PrivacyPolicy"},c.a.createElement(In,null)),c.a.createElement(f.b,{path:"/:language/CookiePolicy"},c.a.createElement(Be,null)),c.a.createElement(f.b,{path:"/:language/TermsOfUse"},c.a.createElement(Ln,null)),c.a.createElement(f.b,{path:"/:language/Publications"},c.a.createElement(Cn,null)),c.a.createElement(f.b,{path:"/:language/Unity"},c.a.createElement(ma,{initialFilters:u,key:"Unity"})),c.a.createElement(f.a,{exact:!0,from:"/",to:"/".concat(n,"/Explore")}),n&&["About","Explore","Analyze","Data","PrivacyPolicy","CookiePolicy","TermsOfUse","Publications","Canada"].map((function(e){return c.a.createElement(f.a,{from:"/".concat(e),to:"".concat(n,"/").concat(e)})})),c.a.createElement(f.b,null,c.a.createElement(We,null))),c.a.createElement(Oe,null))};a(687),Boolean("localhost"===window.location.hostname||"[::1]"===window.location.hostname||window.location.hostname.match(/^127(?:\.(?:25[0-5]|2[0-4][0-9]|[01]?[0-9][0-9]?)){3}$/));var ar=a(41);X.a.initialize("UA-170798489-1",{titleCase:!1,debug:!1,gaOptions:{cookieDomain:"auto"}});var nr=Object(ar.a)();d.a.render(c.a.createElement(c.a.StrictMode,null,c.a.createElement(f.c,{history:nr},c.a.createElement(de,null,c.a.createElement(se,null,c.a.createElement(tr,null))))),document.getElementById("root")),"serviceWorker"in navigator&&navigator.serviceWorker.ready.then((function(e){e.unregister()})).catch((function(e){console.error(e.message)}))},71:function(e,t,a){}},[[408,1,2]]]);
//# sourceMappingURL=main.e8b9ed15.chunk.js.map